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Abstract 
This thesis details a study into aging-related neurodegeneration of Notho-
branchius guentheri and the affect of resveratrol-treatment on this neurode-
generation. The goal of the study was to identify cytological probes by which 
to study neurodegeneration and use these to deliver novel findings pertaining 
to Nothobranc:hius aging and resveratrol induced neuroprotection. 
The SMI31 (against phosphorylated neurofilamant protein), GA-S anti-
GFAP (against glial fibrillary acid protein in radial glia), DAKO Z0334 anti-
GFAP, anti-TNR antibodies (against Tenasdn-R on oligodendrocytes) and E587 
antiserum (against goldfish 11 which is implicated in synaptic plasticity) were 
shown to react against Nothobranchius tissue with high fidelity. By western 
blot and immunofluorescent microscopy evidence is presented that these anti-
bodies are identifying the corresponding epiptopes in Nothobranchius as other 
species. BS-I Isolectin was shown to bind to microglia in the optic nerve and 
retina but not the brain (where no microglia have thus far been detected). 
Using the SMI31 antibody we demonstrate that neuronal density declines 
with age in the stratum griseum superficale of the optic tectum. Resveratrol-
treatment did not decrease this neuron loss even though it extended lifespan of 
N. guentheri. Using the E587 antiserum it was shown that resveratrol-treated 
fish had more ES87 immunoreactive neurons than age-matched controls. The 
ES87 antiserum was used in conjunction with the GA-5 antibody to label and 
count radial glia in the stratum griseum superficiale. It was found that the den-
sity of radial glia declined with age but was rescued by resveratrol-treatment. 
Western Blots indicated that the ratios of the GFAP isoforrns change with age 
and resveratrol-treatment maintains youthful GFAP isoform proportions. The 
density of perineuronal nets, using the anti-TNR antibody, was also observed 
to decline with age. Resveratrol-treatment protected against this decline. 
Five antibodies and a lectin were tested against Nothobranchius guentheri 
tissue and found to be useful. Using these antibodies novel data was gathered 
suggesting that resveratrollifespan extension is not strictly associated with the 
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Bet your life there's something killing you, 
Its a shame we have to die my dear, 
No one's getting out of here alive. 
DOA, the Foo Fighters. 
Alzheimer's Disease (AD) is a leading cause of death among people 65 years 
of age and older [1]. AD (as well as other forms of dementia), cancer and heart 
disease are most prevalent among individuals of the 60 to 80 year old demo-
graphic; and are thus considered aging-related diseases. In western society, 
on account of a declining birth rate and advances in medicine, this demo-
graphic is increasing disproportionately to the younger (economically active) 
populations [2]. This threatens severe social and economic problems for the 
future, particularly in countries where a large proportion of the population 
is dependent on state welfare in old age. These dire conditions call not just 
for more research in aging-related disease but faster research into alleviating 
the burden of aging-related diseases on society. That is, to ensure that the 
aging-population remains healthier and active for longer so the burden does 
not unnecessarily fallon the state. This dire situation calls for a shorter-lived 
model organism which is a vertebrate with comparative cell composition but 
which is also anatomically simple. Such an ideal organism must manifest a 
well defined aging process which includes, among other maladies, a neurode-
generative phenotype with age. Such an organism is found in the fish of the 
genus Nothobranchius [3]. 
1.1 Nothobranchlus In review: 2006 to the present 
Nothobranchius furzeri is an ideal model organism for aging research based on 
its extremely short lifespan, ease of culture and vertebrate nature [4]. Genade 
et a1. [3] reviewed the body of knowledge concerning Nothobranchius and 
presented evidence that well established biomarkers of aging are present in 
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biomarkers by resveratrol-treatment Was reported by Valenzano et a1. [5] one 
year later (in 2006). 
Valenzano et al. [5] demonstrated that with age there was an increase 
in neurodegeneration as well as a decline in operant learning and muscle 
strength. Resveratrol-treatment reduced the level of neurodegeneration com-
pared to age matched controls while operant learning ability and muscle 
strength improved relative to age matched controls. Resveratrol-treatment 
increased median lifespan from 8.5 weeks to 11 weeks. These results consti-
tuted the first evidence that resveratrol could modulate vertebrate lifespan and 
health. Furthermore, this body of research was completed in less than one year 
proving the claim that Nothobranchius provided an opportunity to accelerate 
aging research. 
Since Valenzano et a1. [5] Nothobranchius aging research has progressed 
rapidly in spite of the small number of researchers working with these fish. 
It has been demonstrated that a general reduction in chemical reaction rate 
through the maintenance of N. furzeri at lower temperatures prolonged their 
functional Hfespan [6]. This phenomenon was also demonstrated by Podrab-
sky & Somero [7] and Liu et al. [81 for other annual fish species of the Cyprin-
odontidae family (Austrofundulus and Austrolebias respectively). Dietary re-
striction has been proven to extend lifespan in N. furzeri along with reducing 
the levels of lipofuscin accumulation and neurodegeneration in the short-lived 
Gonarezhou strains but reduced the median lifespan of the long-lived MZM-
04/1 OP strain from Mozambique [9]. Maximum lifespan was increased for 
both the Gonarezhou and wild derived strains. Differences in lifespan and sur-
vival graph patterns have been published for the inbred Gonarezhou and wild 
derived strains [10] suggesting that differences at the genetic level may under-
pin the differences in dietary restriction response by the different strains. 
A linkage map has been published making the genetic mapping of lifespan 
altering loci possible [11]. This linkage map has already revealed the pres-
ence of sex chromosomes in this species as well as the linking of tail color to 
these sex chromosomes. Reichwald et aL [12] report a high number of tan-
dem repeats in the genome of N. furzeri and that the Gonarezhou strain is 
highly inbred. Studies of N. furzeri telomere length and telomerase activity 
revealed that there is a significant shortening of telomere length in the MZM-
04/3 wild derived strain of N. furzeri but there was no significant shortening 
in the Gonarezhou strain. Furthermore, telomerase expression was seen to in-
crease with age. Hsu et a1. [13] report telomere shortening in N. rachovii as 
well as no significant change in telomeraseactivity with age. Interestingly, no 
change in telomerase activity was detected in the naked molerat, whose telom-
eres are abnormally short, suggesting that telomere length may have nothing 
to do with aging, though it may provide protection against cancer [14]. 
Hsu et a1. [13}, using N. rachovii, demonstrated the same increase in senes-
cent associated ~-galactosidase activity (sA~gal) as well as lipofuscin, as was 
reported by Genade et al. [3] using N. furzeri. In addition to these two biomark-










Chapter 1.2. The need for Nothobranchius specific CNS cellular markers 3 
age whereas the activities of catalase, glutathione peroxidase and superoxide 
dismutase decreased with age. Lipid peroxidation was also demonstrated in N. 
korthausae [15]. The studies on N. korthausae also revealed that its lifespan 
can be modulated by photoperiod and that this sensitivity to photoperiod dif-
fered between Mafia Island and mainland Tanzania populationsl [17]. These 
observations in N. korthausae have since been elaborated on and aging-related 
changes in diurnal rhythm and morphology further analyzed [18]. 
di Cicco et al. [19] have published data indicating that the frequencies of 
neoplasias not only increases with age, as first shown in N. guentheri [20,21], 
but that there are differences in neoplasmic frequency between the short and 
long-lived N. furzeri strains. In addition, mitochondrial function is observed 
to decline with age as in other species [22]. These advances support the asser-
tion of Genade et al. [3] that Nothobranchius can serve as general models of 
aging. 
1.2 The need for Nothobranchlus specific eNS cellu-
lar markers 
The study of neurodegeneration in N. furzeri employed both behavioral and 
histological markers of aging [5.6, 9]. The behavioral assays consisted of an 
active avoidance assay of operant learning efficiency; and a spontaneous loco-
motion assay. Neurodegeneration could not be studied at a cellular level in the 
central nervous system (CNS). While the accumulation of lipofuscin [23] and 
FluoroJade-B (FJB) [24] signal is linked to neurodegeneration they do not label 
a particular cell type. 
Valenzano et al. [5] (of which T.G. was a co-author), linked the increase in 
FJB signaling with neurofibrillary tangles (NFTs) on account of FJB staining 
degenerating neurons [24] and the presence of fine FJB stained fibers in the 
N. furzeri QT. Schmued, who developed FJB, did not see evidence to support 
this link (pers. comm). His skepticism was validated in 2007 when Damjanac 
et al. [25] published data showing that FJB labelled gliotic astrocytes and mi-
croglia and very few, if any, neurons or NFTs in a mouse model of AD. This 
emphasizes the need for cell-type and protein specific markers of neurodegen-
eration. In Terzibasi et al. [9], glial fibrillary acid protein (GFAP) levels were 
seen to increase in the course of normal aging in N. furzeri. An increase in 
GFAP expression is regarded as a sign of neurodegeneration [26]. In the course 
of dietary restriction experiments N. furzeri showed an increase in GFAP im-
munoreactivity compared to the age-matched controls. Terzibasi et al. [9] had 
used the 6F2 and GA-5 anti-GFAP antibodies for their study. This result in the 
dietary restriction fish was unexpected and needs to be further investigated. 
Additional cellular markers are needed to study neurodegeneration and neu-
roprotection in N. furzeri. What is more, it is important to have means to study 
1 The mainland populations have since been described as a distinct species, Nothobranchius 
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the morphology and structure-function relationship of specific cells within the 
CNS. 
For this study we selected antibodies (Table 1.1) based on an interest in 
CNS injury as well as regeneration and antibody availability. BS-I isolectin was 
used in this study because of its success in labeling microglia in degenerating 
brain tissue by Kim et al. [27]. The role of microglia, astrocytes and proteins 
targeted by the successful antibodies are reported in Chapter 4 together with 
the evidence of their effectiveness within Nothobranchius. 
1.3 Investigating neurodegeneratlon 
Nothobranchius research to date, in particular with reference to resveratrol 
lifespan extension, leaves several critical questions unanswered. The questions 
addressed in this thesis are as follows: 
1. Can cell-type specific markers be identified by which neurodegneration 
and protection can be studied in this fish? 
2. What changes are there at the cellular level in the aging Nothobranchius 
CNS, and how does this relate to changes observed in other model organ-
isms and humans? 
3. With resveratrol-treatment, which of the above documented changes dif-
fer between treated and control animals? 
4. How does the frequency of gliotic and/or atrophied astrocytes differ be-
tween young, aged and resveratrol-treated animals; and how does this 
correlate with the levels of GFAP among these groups? 
5. Does resveratrol achieve neuroprotection in Nothobranchius by prevent-
ing neuron death or damage, or by preserving or promoting neurogenesis 
in aged fish? 
These questions are, in turn, addressed in Chapters 5 through 6. 
Aging-related neurodegeneration will be reviewed in Chapter 2 with the 
goal of drawing the reader's attention to the similarities in the aging processes 
between species and what one would expect to encounter in Nothobranchius 
as they aged. Senile Plaques (SPs) and NFTs are used as exemplary pathologies 
to the important topics of CNS protein and extracellular matrix (ECM) home-
odynamics. The role of neurons and glia with respect to neurodegeneration 
are discussed with respect to these two central topics and referred back to the 
current state of Nothobranchius research. 
The anti-aging and neuroprotective properties of polyphenols are exten-
sively reviewed in Chapter 3. The chapter addresses theories of the mechanism 
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L1 neuronal cell adhesion molecule on astrocytes, 
ependyma, endothelial cells and neural processes 
glial fibrillary acid protein in astrocytes 
glial fibrillary acid protein in astrocytes 
neurofilament protein in neurons and their processes 
Tenascin-Ron oligodendrocyes 
labels microglia and endothelial of blood vessels 
between the competing theories or falsifying defective theories have been given 
much attention. A crucial question pertaining to polyphenol induced neuro-
protection is "what dose?" An entire section addresses this subject within the 
theory of hormesis. These theories will be compared to the expected degener-
ative signs observed in Nothobranchius and what is expected to be observed 
based on neurodegeneration in other species. The role of resveratrol will not be 
reviewed in any great depth but will be discussed in the experimental chapters 
in relation to experimental observations. 
Pertinent issues raised in these two review chapters will be highlighted 
briefly in the experimental Chapters. The subjects of neurodegeneration and 
polyphenol bioactivity are vast, spanning many thousands of articles and hun-
dreds of reviews. The two review chapters are, in this respect, brief and fo-
cused on the study direction of the Author which involves extensive use of 
antibodies for studying the ECM and protein homeodynamicsi and the dosing 
of resveratrol to achieve a neuroprotective outcome. 
In spite of great research effort, both the neuroprotective mechanism of 
resveratrol and the general causative mechanisms of neurodegeneration re-
main clouded in a mystery of contention and conflicting research outcomes. 
Results of in vitro and in situ experiments often contradict each other, with 
respect to both the experimental outcomes and resveratrol concentration, and 
there are large differences in results between model organisms used. Further 
complicating matters, there is still confusion as to what constitutes an age-
dependent pathology and an age-related disease (such as AD). What is re-
quired is a model organism which ages rapidly and so allows for rapid ex-
perimentation, dissection of cause and effect relationships, and testing of hy-
potheses. This model organism must be so evolutionary disparate to other 
model organisms so that evolutionary conserved mechanisms of neurodegen-
eration and neuroprotection are more easily discerned through the framework 












molecular mechanisms and 
cellular interactions 
Well you asked me if I will forget my baby, I guess I will some day. 
I don't like it but I guess it happens that way. 
Guess things happen that way, Johnny Cash. 
2.1 Introduction 
Alzheimer's Disease (AD), Parkinson's Disease (PO) and Huntington's Disease 
are diseases characterized by massive neuronal loss in specific brain regions 
[28]. This is not the case with normal aging where there is more glial atrophy 
than neuron loss [28, 29]. Much of the research into neurodegeneration has 
focused on diseased as opposed to normal aging. The afore mentioned diseases 
are aging-associated, which is to say that with age the likelihood of developing 
the disease increases. The question is how can we make use of our knowledge 
of these diseases in the context of normal aging; and how can this be applied 
to Nothobranchius aging? 
Aging manifests as the accumulation of biological changes over time that 
cause the organism progressively more likely to die [30]. The manifesta-
tion of this aging process, neurodegenerative-aging, is the topic of this thesis. 
Neurodegenerative-aging is characterized by the gradual decline in cognitive 
ability which could eventually give way to dementia [31]. Whether dementia 
is inevitable (a matter of the individual simply living long enough to manifest 
the disease) or a consequence of specific causes is not known. 
The goal is to stave off death, that is to delay aging and the role of the eNS 
in aging appears to be critical. There is good evidence that neuroprotection 
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emphasized that when it comes to anti-aging interventions what is sought is 
a healthy long life, not simply longer life. Understanding how the brain ages 
and how its cells and tissues malfunction is critical to ensuring a healthier and 
longer life. 
The collective knowledge of neurodegeneration is now so vast that a single 
review cannot contain all the information pertaining to the subject in detail 
as well as frame it in a broader context. My goal is to frame this information 
within the context of normal aging. The starting point will be the etiology of 
the pathologies observed during the progression of AD (SPS and NTIs) which 
are also related to aging. SPs and NFfs are the two best studied pathologies 
and best correlated with cognitive decline (which serves as the best measure 
of neurodegenerative-aging). The etiology of these pathologies involves a dis-
turbed homeostasis at the level of the intra-cellular systems as well as extra-
cellular milieu in which the cell lives. This milieu is composed of both the 
extracellular matrix (ECM) and the other cells living in that matrix. 
Little is known about Nothobranchius aging and neurodegeneration but 
there is enough data to forge links with current thinking regarding neurode-
generation. Whether the FJB used by Valenzano et a1. [5] actually indicates 
an increase in NTIsl or some other manifestation of neurodegeneration is 
secondary to the observation that neurodegeneration is occurring in Notho-
branchius. The nature of this neurodegeneration needs to be determined but 
it is safe to say that it will entail one or another form of protein aggregate [34]. 
Besides SPs and NFI's, which are the hallmarks of AD, there are many 
other pathologies pertaining to neurodegeneration, such as the Lewy bodies 
of Parkinson's Disease. The mechanisms of degeneration pertaining to these 
other diseases goes beyond the scope of this chapter. The next section will 
chiefly discuss the protein aggregates: SPS and NFI's. 
When a neuron finally dies, due to SP or NFT formation, its remains have 
to be disposed of by means of the support cells of the CNS: the astrocytes and 
microglia. These will be the subject of Section 2.3. It is not only the neurons 
which begin to fail with age but the entire CNS milieu begins to malfunction. 
A critical constituent of this milieu is the ECM which is discussed Section 2.4. 
The ECM plays host to the interactions between gUa and neurons and its in-
tegrity changes in the course of aging and neurodegeneration. The ECM is laid 
down by the glia and neurons at great cellular expense. Protein synthesis and 
export is an energetically expensive activity. Protein trafficking and the phe-
nomenon of endoplasmic reticulum (ER) stress are the subject of Section 2.5. 
In Section 2.5 a general mechanism of neurodegenerative-aging, which affects 
all the cells of the CNS, will be presented. 
Where information pertinent to Nothobranchius aging is available it will 
be interjected into the narrative. In the concluding section of this chapter the 
nature of neurodegenerative-aging will be reflected upon and the usefulness of 
Nothobranchius for aging research recapitulated with respect to this review. 
1 Verily. the FJB does stain neurons in aged fish as shown in Figure 7 of Terzibasi et a!. [101 but 
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The blood brain barrier and vasculature have been excluded from this re-
view. These subjects will be touched on in the next chapter. For the reader, the 
information presented in this chapter must be kept in mind in preparation for 
the next chapter. In the next chapter the various mechanisms of polyphenol 
neuroprotection will be discussed. As the experimental work is discussed the 
content of this and the next chapter must be kept in mind. 
2.2 Protein aggregates: plaques and tangles 
Old models of neurodegeneration put forward a degenerative cascade whereby 
misprocessing of amyloid precursor protein (APP) results in amyloid~ (A~) 
oligomerization. These oligomers aggregate and form SPs which poison neu-
rons, causing the development of NFfs and ultimately killing the neuron [35]. 
This Amyloid Cascade Hypothesis has been contested and is now considered 
unsatisfactory as a general mechanism of neurodegeneration. From kokanee 
salmon [36] to humans [37] A~ deposition has been observed as a downstream 
product of neurodegeneration and its abundance has neither correlated with 
NFf abundance nor cognitive decline. On the other hand Dani et a1. [38] re-
port that SP burden correlates with age. Armstrong [35] concludes that SPs 
and NFfs are independent lesions and are themselves products of degenera-
tive processes rather than the cause. While correlation doesn't necessary imply 
causation an unavoidable link between SP pathology and NFT development 
remains [39]. SPs and NFTs remain the diagnostic hallmarks of AD. And, re-
ferring to the kokanee salmon [36], SP formation does correlate with age in fish 
as it does humans [38]. 
2.2.1 Senile plaques and amylold,8 
The development of SPS are reviewed by Haass [40] and Unger [41] and is 
outlined in Figure 2.1. The development of this pathology will be discussed in 
sOme depth as many of the enzymes involved are mentioned repeatedly in this 
and later chapters. As will be discussed in the next chapter, many polyphenols 
have been shown to affect the process of SP development. 
A~ is not in itself neurotoxic: both the 40 and 42 amino acid peptide frag-
ments play roles in healthy brain function and in particular neural plasticity 
[42, 43]. Similarly, the other fragments of the APP also serve physiological 
functions. These functions and the processing of the fragments are reviewed 
by Zhang et a!. [44]. Those parts of the process relevant to later discussion 
will be recapitulated here. The soluble alpha fragment (sAPPa) plays a role 
in plasticity as well as inhibiting cyclin dependent kinase 5 (Cdk5) which 
has been reported to play a role in NFT development [45]. APP is processed 
by a-disintegrin-and-metalloproteinase (ADAM) 9, 10 and 17. Many of these 
ADAMs are produced by astrocytes and other glia [46] and their dysregulation 
is implicated inneurodegeneration [47]. a-processing prevents the generation 










Chapter 2.2. Protein aggregates: plaques and tangles 









Figure 2.1: The development of senile plaques from amyloid precursor protein (APP) involves cleav-
age first by fJ-secretase to produce the APP C-terminal fragment fJ (APP-crFfJ) followed by cleavage 
of the presenilin/y-secretase complex. This second cleavage yields either the 40 amino amyloidfJ 
product (AfJ40) or the 42 amino acid product (AfJ42) which aggregate, forming senile plaques. The 
intracellular domain (ICD) is obtained by processing the remainder of the APP-CTFfJ by Notch. This 
fragment partakes in intracellular signaling processes. Information obtained from Haass (40). 
which catalyzes the p-secretase step. This yields the APP C-terminal fragment 
and soluble APPP which plays a role in axon pruning and neuronal cell death. 
The C-terminal fragment is then processed by y-secretase, a complex of four 
subunits: presenilin (PS, PSI or PS2), nicastrin, anterior pharynx-defective-
1, and presenilin enhancer-2; y-secretase activity is believed to rest in prese-
nHin. Mutation of PSI or 2 has been identified in cases of familial AD. The y-
secretase complex resides mostly in the endoplasmic reticulum (ER) and Golgi 
with smaller amounts in the endocytic compartments and lipid rafts at the 
cell surface [48]. APP cleavage happens in the golgi. The cleavage of APPP 
generates 40 or 42 amino acid Ap peptides and intracellular domains which 
partake in cellular communication and playa role in the trafficking of APP. In 
the course of diseases the 40 and 42 amino acid Ap oligomerize and aggregate 
to form insoluble fibrils which deposit on the cell surface, forming plaques 
[40]. No correlation has been found between Ap concentration and dementia, 
but patients who later developed dementia did have a low AP42/ Ap40 ratio 
compared to controls [49] suggesting underlying problems in protein process-
ing. The AP42 is less soluble than AP40, and AP40 fibrils recycle faster than 
Ap42 fibrils [50], suggesting that it is the increase in Afl42 incorporation in 
fibrils which spurs on SP formation. It will become clear from this and the 
next chapter that while SP formation may not in itself be neurodegenerative, 
this process is affected by and effects other processes implicated in neurode-
generation. Neuroprotective therapies also affect this process. 
Zhang et a1. [44] review the factors affecting APP trafficking and report 
that AP levels accumulate intracellularly long before they accumulate extra-
cellularly. APP-CTFa participates in feed-forward signaling, regulating the 
cellular trafficking of APP to the cell surface where it is cleaved to generate 
sAPPa instead of Ap. Retromer, which is involved in retrograde transport 
from the endosome to the Golgi, is also implicated in APP processing [51]. 
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ing the AP42:AP40 ratio2 which is linked to clinical outcomes of cognitive 
decline [49]. Slower retrograde transport could result in slower Golgi func-
tion meaning more time for APP to be processed in the Golgi and ER by BACE 
and y-secretase. The spontaneous aggregation of Ap in the Golgi apparatus, or 
the disproportionate recruitment of Heat Shock Protein 70 (Hsp70) to stabilize 
the Ap would put tremendous pressure on the resources of the Golgi and ER to 
maintain order and put additional strain on the power supply of the cell. This 
subject is dealt with more extensively in Section 2.5, page 20. 
2.2.2 Neurofibrillary tangles 
NFfs are the hallmarks of AD and many other dementias. Even though high 
concentrations of amyloid-P may be present, dementia only develops in the 
presence of advanced NFl's [37]. NFfs have been found in all sampled brains 
of people over 75 years of age and in brains as young as 45 years. The hip-
pocampal region of the human brain is especially vulnerable. 
NFTs form as a consequence of hyper-phosphorylation of the protein tau 
[52,53]. Properly phosphorylated tau (3 phosphates per molecule) is needed 
to organize and stabilize the microtubule network in the neuron and its pro-
cesses. Hyperphosphorylated tau (6-12 phosphates per molecule) is unable to 
stabilize the microtubules, giving rise to the formation of paired helical fila-
ments in axons (that form the aggregates referred to as NFfs) and neurophil 
threadsfound in dystrophic dendrites [52]. The development of NFfs is linked 
to the unregulated activity ofkinases within the neuronal cells [52] as well as a 
decline in protein phosphatase 2A (PP2A) concentration and activity [45, 54]. 
A schematic summarizing the progression of functional tau to hyperphospho-
rylated tau is shown in Figure 2.2. A wide range of kinases can affect tau pro-
cessing. 
PP2A is the phosphatase responsible for dephosphorylating tau [54] as well 
as regulating cell signaling through dephosphorylating mitogen-activated pro-
tein kinases (MAPKs) [45]. The decline in PP2A activity is concomitant with 
the increase in glucose synthase kinase 3p (GSK3P) activity [45, 53] as well as 
an increase in the activities of MAPKs such as extracellular signal-regulated 
kinase 1 and 2 (ERK 1/2), Cdk5, p38, c-Jun N-terminal kinase (JNK) [55], S6 
kinase (S6K) [56] and cyclic adenosine monophosphate (cAMP) regulated pro-
tein kinase A (PI<A) [45]. All of these kinases have been reported to phospho-
rylate tau. The dysregulated activity of these kinases is viewed as causing the 
NFf pathology. PP2A is inactivated by S6K on activation by mTORCI (mam-
malian target of rapamycin) [56]. The mTOR pathway is known to be dysreg-
ulated in degenerate neurons and can be activated by various means: growth 
factor receptor signaling, cytokines, hormones and calcium influx [57]. 
PI<A and Protein Kinase C (PKC) have important roles in the response of 
the axon growth cone to extracellular cues [58] and are essential for memory 
2 A low serum AfJ42:AfJ40 ratio would imply that more AfJ42 is deposited in SPS. implying that 
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perphosphorylated tau detaches from the microtubules and is free to associate 
with other tau, forming pair helical filaments and finally neurofibrillary tan· 
gles [64]. Free tau is ordinarily pumped out of the cell body by a retrograde 
barrier in the axon initial segment operating as cellular rectifier [65]. This 
barrier only allows antegrade movement of tau into the axon and dendrites, 
keeping it out of the cell body. Its function relies on tau being able to bind to 
the microtubule scaffold of the cell. This missorting of tau has been observed 
in cell culture [66] and AD model mice brains [67] using the SMI31 antibody. 
The SMI31 antibody reacts against abnormally phosphorylated neurofilament 
proteins which is found within NFfs generated by hyperphosphorylated tau 
[68-70]. But Cdk5 is not the kinase believed to be the culprit. 
GSK3p is reported as the single most likely candidate kinase responsible 
for taupathies [52]. It and its roles in neurodegeneration are reviewed by Giese 
[71]. GSK3p expression in Drosophila was required to cause the development 
of advanced taupathies [72] though in vitro combination of PKA, Cdk5 and 
CAMKII was able to hyperphosphorylate tau and trigger its spontaneous as· 
semblyinto tangles [45]. The activity of GSK3p is regulated by Akt [53]. Using 
confocal microscopy, activated Akt has been seen to co-localize with GSK3p in 
the vicinity of hyperphosphorylated tau. The PI3KI Akt/GSK3P pathway is, in 
part, regulated by APP and its products [73]. The sAPPa fragment, via neu-
rotrophin receptors, activate PI3K, ultimately inactivating GSK3p. Conversely, 
The AP peptide inhibits neurotrophin activation of PI3K and the inactivation 
of GSK3p . 
GSK3p is observed to be dysregulated in a myriad of pathologies [74] sug-
gesting to the Author that it is more likely a symptom than the root cause of 
the pathology. That GSK3p knock-out Drosophila [72] or GSK3p inhibition 
by LiCl prevent the development oftaupathies is hardly convincing evidence 
for GSK3p being the prime suspect. Over expression of active GSK3p would 
cause NFfs as surely as excess Ap peptide would inhibits GSK3p inactivation. 
GSK3p has mUltiple targets, not all of which have been identified Or properly 
studied, and there is little understanding of how GSK3p, its activators and its 
substrates integrate in proper cellular function. 
PKC is also a negative regulator of GSK3p activity [I]. In AD brains there 
is a decline in PKC activation that is linked to a decline in abundance of the 
scaffolding protein RACKI that ferries activated PKC to cellular targets [I]. 
RACKl has also been observed to decline with age [75] making its decline 
more relevant to the cognitive deficit associated with normal aging. RACKI 
also ferries cAMP-specific phosphodiesterase-4D5, linking it to the regulation 
of cAMP levels and thus the suppression of PKA activity [76]. Another PKC 
chaperone, Hsp70, has been reported to decline with age [77]. Without Hsp70, 
PKC will interact randomly with the microtubule cytoskeleton [78]. PKA is 
also tethered to anchOring proteins which keep PKA in close proximity to S6K, 
its inhibitor [56). PP2A, B and C are all associated with the microtuble net-
work in the cell [79]. Kinase and phosphatase activity is carefully regulated 
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the individual signaling pathways, the crosstalk between them as well as sig-
nal integration is reviewed in Carlson et a1. [61]. By simultaneously activating 
the priming kinases together with the inhibitors of the hyperphosphorylating 
kinases the cell instigates protective measures to prevent NFfs. In an abnor-
mal cell these protective measures do not reach their target, be it because of a 
decline in RACKI or some other cause. 
ERK and JNK activity is linked to pre-dementia neurodegeneration [55]. 
In LTP ERK is activated, and with declining PP2A activity, its inactivation 
could become problematic. Activated ERK can reinforce the activation of both 
PKA and PKC by phosphorylating ion channels and receptors in the plasma 
membrane [80]; and in so doing reinforce its own activation in a dysregu-
lated system. Similarly, Ap can open ion channels linked to neurotrophin re-
ceptor channels allowing Ca2+ to enter the cell and activate kinases such as 
Cdk5 [63]. Calcium homeodynamics is known to be perturbed in degenerat-
ing brain tissue [81]. CAMKII activates Nitric Oxide Synthase (NOS) which 
produces nitric oxide (NO) [82]. NO causes mitochondrial uncoupling. Un-
coupling results in the generation of reactive oxygen species (ROS). NO also 
causes S-nitrosylation of proteins and this nitrosylation denatures them [83]. 
The thioredoxin and glutaredoxin systems work to counter this [84]. These 
systems rely on an abundant supply of ATP equivalents from mitochondria. In 
this scenario the electron transport chain is now uncoupled causing a drop in 
ATP equivalent supply [85]. A relative increase in AMP (due to a decrease in 
ATP) would activate AMPK in order to restore the energy deficit but AMPK is 
also able to phosphorylate tau at the critical Thr-231 residue [86]. Without a 
functional microtubule network it is unlikely AMPK could fulfill its intended 
function. NADPH oxidase activation at the cell membrane via Rac/PI3K sig-
naling also generates ROS [87]. Transient ROS is required for proper cellular 
signaling whereas chronic ROS has a detrimental effect. The activation of NOS 
and other ROS generating enzymes must be strictly controlled. With age the 
mTOR/S6K/NOS pathway is dysregulated [88, 89]. 
The kinase, p38, is dysregulated along with ERK and JNK in patients who 
have manifested dementia [55], and p38 can also prime tau for hyperphos-
phorylation. Increased ROS as well as cytokines can activate p38 via MEKKl-
4/MKK3/6 pathway [90]. This pathway can also activate JNK and more space 
will be devoted to this subject in the next chapter. 
Given the complex interplay between the kinases, phosphatases and sec-
ond messengers, it is unlikely that any single kinase is responsible for NFf 
formation. In vitro experiments demonstrated that the application of PP2A 
alone was enough to not only dephosphorylate tau but to cause the disassem-
bly of paired helical filaments [45]. The lack of dephosphorylation could be 
more important than the over activity of the kinases. In the catalytic site of 
tyrosine phosphatases is a cysteine residue which is particularly susceptible to 
oxidation [91] and is repaired by glutaredoxin using glutathione (GSH) [92]. 
These enzymes can only reduce oxidized cysteine that hasn't been oxidized be-










Chapter 2.2. Protein aggregates: plaques and tangles 14 
levels of ROS this oxidation beyond the sulfenic form is possible but as yet un-
demonstrated. Excessive ROS generation can permanently inactivate tyrosine 
phosphatases which could explain the observed decline in PP2A activity with 
age. 
One of several mechanisms can lead to Ca2+ influx, kinase activation, ROS 
generation and PP2A deactivation causing MAPK activity to spiral out of con-
trol. If a culprit needs to be singled out then that culprit is mTOR. mTOR, as 
well as being activated by Akt, can also activate Akt [93, 94]. Akt activation 
inhibits FoxO activation which is needed for neuroprotection [32]. mTOR also 
activates S6K which, in addition to phosphorylating tau, inhibits autophagy 
and lysosomal degradation of protein and increasing tau expression. The role 
of mTOR in aging and neurodegeneration is discussed by Blagosklonny [94] 
and Garelick & Kennedy [57]. 
2.2.3 Protein aggregates: the cause of neurodegeneratlon? 
Protein aggregates, such as NFTs and SPs, are typical of neuropathologies [34] 
and while they may be the intermediary cause of neurodegeneration in certain 
cases neither can be considered as the basis for a general mechanism of neu-
rodegeneration. What should be clear from the previous section is that there 
are many means by which to cause the accumulation of SPs andNFTs. It could 
be a mutation in a gene causing a misprocessed protein, an external insult 
causing excessive Signal transduction, a decline in one or another scaffolding 
protein or chaperone, or a chronic lack of ATP equivalents. Whatever the root 
cause the outcome is a misprocessed or misfolded protein which is a threat to 
cellular homeodynamics. 
Ordinarily, misfolded protein is degraded in the proteosome or sequestered 
to the aggresome (a cellular compartment distinct from the lysosome) [95]. 
The aggresome is composed of a core of ubiquitinated protein enclosed in a 
vimentin cage. Disruption of microtubule networks3 block the formation of a 
neat aggresome and the misfolded protein then becomes distributed out along 
the cell periphery. Experiments in C. e1egans showed that protein aggregation 
increases with age and that the aggresome is enriched for proteins which can 
assemble into jJ-sheets [97] (such as AjJ). Hsp70 is critical to the maintenance 
of the aggresome machinery but is itself susceptible to protein aggregation. 
Mention has already been made to its role in regulating the kinases involved 
in tau phosphorylation. Additionally, it is well known that the ubiquitin-
proteosome system is perturbed in Alzheimer's and other neurological diseases 
(reviewed by Riederer et al. [98]) where protein aggregation occurs, suggesting 
that the aggresome system may already be overloaded or impaired (perhaps 
by excessive mTOR signaling) before SP and NFT pathologies develop. Con-
versely, a more efficient cellular response to misfolded protein may allow the 
cells to accumulate NFTs and AjJ fibrils to the point where they are the diag-
nostic hallmarks of the disease even though they are merely a symptom of an 
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underlying problem. This subject will be revisited in Section 2.5 after a look at 
other aspects of neurodegeneration. 
Neurons are a small subset of the cells making up the CNS and the contri-
bution of other cell types to neurodegeneration should be taken into account. 
It is worth mentioning, on the outset, that even astrocytes develop protein ag-
gregates: Rosenthal fibers in Alexander's Disease [99]. NFTs also accumulate 
in glia, causing glial fibrillary tangles [100]. In addition to protein misfold-
ing there are also problems with protein degradation in astrocytes as the CNS 
ages [101J. The glial contribution to neurodegeneration will be discussed in 
the next section before we return to protein processing. 
2.3 The role of gila In neurodegeneratlon 
In rats it has been observed that with advancing age there is an increase in acti-
vated astrocytes and microglia [27J. There are similar observations for humans 
with the exception that activation of astrocytes and microglia are only associ-
ated with SPs and NFTs [41]. In general, there is a priming for immune sys-
tem hyperactivity while both the CNS [102J and whole-body immune system 
senesces [103 J. The growing dysfunction of the human neuroimmune system 
is reviewed by von Bernhardi et al. [104 J. 
Hyperactive microglia are a source of ROS [103, 105J. This is the Inflam-
Aging hypothesis of aging where the dysregulation of the innate immune sys-
tem (giving rise to unchecked inflammation) causes the pathologies associated 
with aging [106J.Experiments in aged rats have revealed that animals sub-
jected to excitotoxic damage had more widespread microglial activation 12 
hours postlesioni and greater microglial density three days postlesion [107J. 
Aged rats also had more cyc1ooxygenase-2 positive cells postlesion. Inducible 
NOS was also more abundant in the aged brains. Together, these seemingly 
disparate bits of data suggest a trend towards a much greater inflammatory 
response with age. But it has been found that senescent dystrophic microglia 
are associated with tau pathology and that their senescence precedes the on-
set of symptomatic AD [102J. This dystrophy of the microglia correlates with 
age indicating that the neuroimmune system senesces much like the rest of 
the organism. This research may settle the question as to whether microglia 
are neuroprotective or neurotoxic. The remaining activated microglia, insuffi-
cient in number to effectively respond to a CNS insult, remain active causing 
damage instead of rescuing the surrounding neurons. 
The immune system is not the only source of ROS and free radicals. Pro-
tein aggregates, intra- and extracellularly, can also generate free radicals [1 08J. 
It would be these extracellular aggregates-the remains of dead neurons and 
astocytes-which the astrocytes and microglia would be required to clear from 
the ECM. Without active microglia these extracellular aggregates would cause 
damage to the surrounding ECM and cells where the endogenous antioxidant 
defenses cannot undo the damage. 
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to specific regions of the AD brain while s100B and GFAP (as measured using 
GFAP antibodies against Western Blots and immunohistochemistry) increases 
in the course of normal aging without widespread neuronal death [41]. Gliotic 
astrocytes are believed to be pathological [109]. The gliotic astrocytes lay down 
dense scar tissue composed of GFAP which inhibits CNS regeneration but this 
belief is slowly changing. Neurons can subsist in glial scars indefinitely and 
remain functional. It is now believed that gliotic astrocytes fulfill a beneficial 
role in the CNS [26]. Following CNS insult the astrocytes react to nurture the 
surviving neurons and clear the debris. There is a stronger correlation between 
atrophic astrocytes and CNS dysfunction than gliotic astrocytes [101,110]. As 
with microglia the problem may not be over-active astrocytes as much as an in-
adequate number of reactive astrocytes capable of meeting the challenge posed 
by the insult. 
The protein s100B is tightly correlated with CNS injury [111] and its ex-
pression is up-regulated by activated astrocytes. S100B has been shown to 
activate GSK3p and JNK in neuronal precursor cells [112]. JNK (and p38) are 
also activated in response to cellular stress (such as caused by ROS) [55]. JNK 
can activate AP-1 (through phosphorylation of c-Jun or fos) [78, 113] as well as 
activate Fox03a [114] while inhibiting survival signaling though the PI3K-Akt 
pathway [106]. The simultaneous activation of AP-1 and Fox03a can lead to 
the activation of cell death programs, such as autophagy or apoptosis. These 
aspects of cellular signaling will be discussed in Chapter 3.3. While astrocytes 
exhibit many aging-related changes [115] a decline in antioxidant capacity is 
not one of them [116] suggesting that antioxidant capacity is not the problem. 
The greater problem is that they cannot respond to their surroundings. 
With age astrocytes develop protein degradation problems [101], i.e. lyso-
somal disruption. This chronologically related astrocytic malfunction has been 
observed in many species [26]. Lysosomal disruption (caused by microtubule 
disruption) in the course of autophagy results in an increase in y-secretase ac-
tivity [117]. Whether the increase in presenilin-1 and y-secretase activity also 
occurs during hyperphosphorylation of tau caused microtubule disruption is 
an unanswered question. Degenerate astrocytes could create the environment 
required for the pathological misprocessing of Ap. As the NFTs inhibit apop-
tosis [118], the degenerate neurons persist, misprocessing APP and poisoning 
surrounding neurons and astrocytes. 
The sequence of plaque formation described by Nagele et al. [119] involves 
a mechanism whereby Ap accumulates in the ECM and on neurons. The neu-
rons degenerate and the astrocytes attempt to clear the SPs by internalizing 
it. The aged astrocytes have no means of metabolizing these insoluble protein 
aggregates and are in tum poisoned and die. In the interim, the dying neu-
ron as well as stressed astrocyte, have secreted cytokines to summon microglia 
for help. The microglia accumulate in the SPs and begin to clear the Ap but 
they also cannot metabolize the Ap. They accumulate aggregates in them and 
they secrete more cytokines. Ikeda et al. [120] who showed intimate contact 










Chapter 2.4. The role of the extra cellular matrix 17 
in what are termed ghost tangles-the end stage of the plaque. Also, in exper-
iments where astrocytes were exposed to AfJ, the resulting gliotic astrocytes 
were not only unable to support neurons, they appeared to secrete some sort 
of neurotoxin killing neurons which were not in immediate contact with the 
gliotic astrocyte [121]. In this scenario the development of SPs may appear to 
be the first cause of the degenerative cascade but the preceding sections must 
be recalled: SPS are already the product of an underlying problem in protein 
processing. 
2.4 The role of the extra cellular matrix 
Axon guidance and newborn neuron migration is facilitated by the surround-
ing tissue [58) which guides the neuron or cell process though repulsion and 
attraction signals received by the growth cone ofaxons or leading process of 
migrating neurons. These signals activate PKA, PKC, Ras-MAPK as well as 
Wnt signaling which employs GSK3fJ [53, 58,59]. PKA is also activated in 
the process of fastening synaptic contact and LTP [59]. Brain areas such as 
the hippocampus of humans [122], and the optic tectum of fish are dynamic 
with new neurons and glia being generated and new connections being forged 
[123-127]. It may be no coincidence that it is in these dynamic brain areas, 
where PKA and CAMKII are persistently activated, that taupathies develop 
and why AfJ deposits can spread randomly through the rest of the brain with 
little consequence. 
The expression of axon guidance receptors has been shown to change with 
age and developmental stage [58,123,128]. Furthermore, the integrity of the 
ECM has been shown to deteriorate with age [129,130]. With age (in mice and 
humans) there is an increase in the abundance of fibrillar granules composed 
of laminin and heparan sulfate proteoglycan (and other proteins) around astro-
cytes [131]. The deposition of ECM proteins is an early event in the pathogensis 
of SPS and is reviewed in Jucker & Ingram [131]. As well as deterioration in 
the quality of the ECM there are also aging-associated changes in the volume 
of the extracellular space on account of both metabolic and structural changes 
by aged neurons and glia [132]. These changes can directly affect the ability of 
neurons to form and maintain synaptic contacts. 
The role of matrix metalloproteinases (MMP) are reviewed by Romero et a1. 
[130] and Ethell & Ethell [133]. Gliotic astrocytes cause a local increase in 
glutamate concentration4 which leads to the activation of MMP-9 which is or-
dinarily involved in plasticity. The dysregulation of MMP-9 has neurotoxic 
consequences (one of which is the potential destruction of laminin). Similarly, 
microglia express MMP-7 which ordinarily is involved in tissue remodeling 
and wound repair. MMP-7 activates MMP-9. Healthy astrocytes produce tu-
mor necrosis factor-a as well as inhibitors of MMP-9 (thrombospondins) which 
improve synaptic efficiency. As neurodegeneration is linked to prolonged 
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microglial activation, the extended activation of MMP-7, and resulting over-
activation of MMP-9, can explain why regeneration instead turns into degen-
eration. Astrocyte transplants restore plasticity [134] suggesting that it could 
be the intrinsic aging of astrocytes which initiate neurodegenerative-aging. If 
aged astrocytes are unable to maintain proper protein homeodynamics within 
themselves it is unlikely that they can maintain the ECM which they secrete. 
Both microglial and astrocyte activation cause a local increase in ROS. The 
chondroitin sulfate proteoglycans (CSPGs) in perineuronal nets (PNNs) are hy-
pothesized to provide an antioxidant defense for the neurons encased in the 
PNN [135}. PNNs also appear to protect the neurons they encase from tau 
pathology [136]. PNNs form around parvalbumin containing GABAergic5 neu-
rons in the brain [137]. Following pilocarpine excitotoxic insult these GABAer-
gic neurons are lost even though there is an upregulation of TNR as the axons 
reorganize. PNNs serve a role in stabilizing synapses, striking a balance be-
tween plasticity and stability, as well as compartmentalization of the neuronal 
surface [13S]-in essence: they anchor the cortical columns to their sensory 
inputs. They are also believed to play roles in neurite sprouting and synapse 
pruning [13S]. The loss of these neurons and their PNN results in a loss of 
functional plasticity which occurs via top-down circuit modulation of the cor-
tical column [139]. 
PNNs are laid down by neurons as well as glia: astrocytes and oligoden-
drocytes [138]. They consist of, in addition to CSPG: TNR, hyaluronan acid, 
neurocan, brevican, versican, aggrecan and phosphacan [140]. Brevican is pro-
duced by astrocytes while neurocan and aggrecan are produced by neurons; 
and versican and TNR by oligodendrocytes [140, 141]. Each cell type con-
tributes to the formation of the PNNs implying careful cooperation between 
the cell types. Brevican is up-regulated during late brain development [142] 
and knock-out mutants display poorly defined· PNNs and have severe impair-
ment of LTP. Abnormal brevican processing was observed in AD model Tg2576 
mice [143] while PNN staining differences were found between senescent-
accelerated prone mouse strain S and senescent-accelerated resistant mouse 
strain 1 [144]. Similarly, TNR knock-outs also display reduced LTP [145, 146]. 
PNNs are reported to be lost in brain regions associated with age-related 
loss of function [147] and as Nothobranchius display both an increase in neu-
rodegeneration and decrease in muscle control it is expected that PNNs would 
be lost in the course of Nothobranchius aging. If behavioral enrichment (i.e. 
exercise) rescued the loss of the PNNs in aged rats it will be interesting to see 
if resveratrol-treatment has any affect on PNN density in light of its other anti-
aging effects in Nothobranchius. This question can be answered by using the 
TNR antibody to label the PNNs and then count them. 
TNR is located in lipid rafts where it forms a scaffold for receptor/signaling 
networks [14S]. y-secretase activity is also associated with lipid rafts [4S] 
where they are tethered to the Notch receptor which partners with tyrosine 
kinases and integrin receptors. The receptors of the Wnt pathway are fixed to 
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lipid rafts in the cell membrane [149]. These lipid rafts are rich in highly un-
staturated fatty acids which are particularly susceptible to lipid-peroxidation, 
in particular w-6 fatty acids. The levels of w-6 fatty acids, specifically docosa-
hexaenoic acid, is observed to decrease with age [119]. The decline of w-6 fatty 
acids is linked to various neurological disorders (including dementia).w-6 fatty 
acids supplementation was able to remedy the disorder. 
Lipofuscin is a well characterized lipid-peroxidation product and 
biomarker of aging [150]. It is probable that lipofuscin accumulation can 
lead to a change in membrane fluidity and permeability [lSI). This can affect 
the activity and cooperation of the cell surface receptors that activate kinases 
within the axon and dendrites [152]. These signal transduction pathways reg-
ulate the cytoskeleton6 and determine the pathway choices of axonal growth 
cones [154] as well as dendritic spine growth [155]. In addition, the disruption 
of the integrin receptors in the lipid rafts disrupts neurogenesis [112]. Changes 
in membrane permeability can affect depolarization of the cell and thus acti-
vation of CREB7 (Via PKA and PKC) that is ordinarily needed to sustain and 
guide the growing axons and establish synapses [58]. Young rats can clear lipid 
peroxides from their membranes while old rats cannot [156}. The lipid perox-
ides are cleared via autophagy to lysosomes where lipofuscin is then formed. 
This lipofuscin can then go on to disrupt proteosome autophagocytosis [23]. 
The Ll neuronal cell adhesion molecule (Ll-NCAM, or L1 for short), which 
is also associated with lipid rafts where it interacts with integrin receptors, is 
crucial for synaptic plasticity [157,158]. It is also modified by y-secretase and 
two metalloproteinases, ADAM10 and 17 [159}. The serum levels of Ll were 
shown to be increased in the brains of patients with dementia and schizophre-
nia [47}. There was also a correlation between the levels of cleaved NCAM 
(neuronal cell adhesion molecule) fragments with both the age of the patients 
and whether or not they had AD. L1 and NCAM are involved in neuronal plas-
ticity, neuronal cell adhesion, migration of neural progenitor cells and neurite 
outgrowth [159}. In particular, Ll has been observed to stabilize the axon-
axon and axon-glia contacts [160,161]. Its expression appears to be carefully 
restricted. In the hippocampus of the rat it is absent from spine synapses but 
present on those of mossy synapses [162]. Becker & Becker [163] have reported 
a role for Ll in spinal regeneration and Lang et al. [123], using the E587 an-
tiserum, have reported its involvement in the regeneration of the optic nerve 
of fish. Developmentally, a lack of Ll has been shown to result in disorderly 
nerve fasicles [164]. 
NCAM is known to signal via phospholipase C and PKC. Both Ll and 
NCAM interact with integrins to signal via Raf, Rac1, PI3K and other part-
ners in src tyrosine kinase signaling but only as long as the receptor complex 
is tethered to the cytoskeleton. Disruption of the Ll link to actin results in the 
inhibition of ERK. The inhibition of ERK directly and via PLCy has been ob-
6These are also essential in regulating the cytoskeleton of astroctyes and are reviewed by Theo-
dosis et al. [153]. 
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served to reduce cell surface sialylation and fucosylation. This had a negative 
effect on neurite outgrowth and cell survival [165]. NCAM sialylation is crucial 
for plasticity and has been observed to be upregulated in response to dietary 
restriction in aged rats [166]. Disruption of Ll signaling has serious conse-
quences: impaired cell survival, inability to make and retain synapses, and 
an impaired ability for neuronal progenitor cells to migrate through the ECM. 
The disruption of L1 signaling can culminate in neurodegeneration. One of 
the dysregulated kinases implicated in the hyperphosphorylation of tau, Cdk5 
[45], is crucial in the migration of newborn neurons [167] and the regulation 
of Cdk5 involves proper integrin activation [168] which is in turn dependent 
on both Ll and TNR integrin interaction in lipid rafts. 
y-secretase processes a variety of ECM proteins, such as L1 [159] and 
GFAP [169]. While AfJ may accumulate in the course of neurodegeneration 
y-secretase activity declines [170]. Competition for y-secretase could be a 
mechanism of neurodegeneration which engages all participants in CNS tissue 
homeostasis. If this is the case then efforts to inhibit y-secretase as a treatment 
for AD [171] may prove worse than a failure. 
2.5 ER stress and catabolic malfunction 
In the preceding sections the formation of protein aggregates was mentioned. 
AfJ oligomers may accumulate internally long before they manifest as plaques 
in the extracellular matrix [44] and NFTs may persist for decades without con· 
sequence [172]. Quality control mechanisms within the ER serve to suppress 
the formation of aggregates [173]. The propensity of proteins to aggregate is 
made clear by David et al. [97] who found that widespread protein aggrega-
tion was an inherent part of C. elegans aging. The protein aggregates retrieved 
from old worms were enriched with proteins which tend to self-organize into 
fJ-sheets and which contained polyglutamine repeats-a feature common to 
several neurodegenerative diseases such as Huntington's Disease. These ag-
gregates were also enriched with chaperone proteins. 
The processing of proteins in the ER and how this changes with advancing 
age are reviewed by Naidoo [174]. The process is outlined in Figure 2.3 (page 
21). 
The ER processing of protein requires an abundant supply of ATP equiva-
lents and is a carefully orchestrated process. Including the investment of ATP 
equivalents in translating mRNA into a polypeptide, large amounts of ATP 
equivalents are used in folding the protein, setting the sulfide bridges and gly-
cosylation as well as maintaining the appropriate ER environment. In order 
to set the disulfide bridges an optimized oxidative environment needs to be 
retained and to ensure correct glycosylation the calcium concentration is crit-
ical. Both maintaining the oxidative environment and calcium concentration 
of the ER requires a constant supply of ATP equivalents. Should a protein be 
processed correctly still more energy is needed to shunt it into the Golgi ap-
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the proteosome for digestion. Still more energy is needed to transport pro-
teins via the Golgi to their end destination. Should a protein be misfolded in 
such a manner that the protein cannot be ferried to the proteosome it needs 
to be chaperoned by binding immunoglobulin protein (BiP), a chaperone of 
the Hsp70 family, for reprocessing or sequestering in the aggresome. Synthe-
sizing more BiP is energetically expensive. Given the energy intensive nature 
of protein processing any disruption in ATP equivalent flux could be catas-
trophic. This section reviews a simple mechanism underlying ER catastrophe 
based neurodegeneration. 
The first protein effecting quality control in the ER is BiP8 [174]. As the 
RNA transcript is translated the nascent polypeptide is chaperoned and folded 
by BiP. Naidoo et al. [175] have reported that with age the basal expression of 
BiP in the mouse cortex declines and Paz Gavilan et al. [176] have reported 
the same for rat hippocampus. A similar decline has been observed in other 
brain regions of the rat as well as the lung, liver, heart, spleen and kidney 
[177] which suggests this is a phenomenon of intrinsic aging and not the con-
sequence of a specific pathology. BiP has also been reported to show increased 
propensity to carbonylation in the course of oxidative damage [178, 179]. As 
BiP is intimately involved in protein processing and protein aggregates can 
generate ROS [108] the increase in BiP carbonylation with age could indicate 
an escalation in protein misprocessing with age. 
BiP is also the means by which ER stress is sensed by the cell [174]. It binds 
to and inhibits the activities of three proteins: PKR-like ER kinase (PERK), in-
ositol requiring element-1 (IREl), and activating transcription factor 6 (ATF6). 
These proteins serve to execute the unfolded protein response (UPR), As can be 
seen in Figure 2.3 there is competition for BiP. Should the amount of nascent 
poplypeptide or misfolded protein increase there would be an increased de-
mand for BiP which would come at the expense of the fraction of BiP binding 
the UPR proteins. The unbound UPR proteins would then signal the synthesis 
of more BiP and in so doing close the negative feedback loops to terminate the 
UPR 
Activation of the UPR proteins also triggers an antioxidant response 
through the NF-E2-related factor 2 (Nrf2) transcription factor (which is af-
fected by polyphenols). Nrf2 is activated by PERK which also phosphorylates 
eukaryote initiation factor 2a which reduces translation-lessening the de-
mand for BiP [180]. IRE1 activation enables it to execute endoribonuclease 
activity against the mRNA of X-box binding protein 1, producing a splice vari-
ant which can facilitate the transcription of genes involved in ER expansion 
and quality control [181-185]. X-box binding protein 1 transcription is reg-
ulated by ATF6 [185] along with that of the transcription of BiP and GRP94 
[186], thus correcting the ER stress caused by a reduction in available BiP. 
Redox dependent folding is mediated by protein disulfide isomerase (POI) 
which is a member of the thioredoxin family. Its activity has been shown to 
decline with age [178], particularly in the rat hippocampus [176], and is sensi-
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tive to oxidation [178, 179, 187]. PDI formation of disulfide bonds relies on the 
ratio of GSH to glutathione disulfide (GSSG) [188]. GSH levels are known to 
decline with age in several tissues [189]. This problem is all the more pressing 
given the need to maintain an oxidative environment in the ER to facilitate the 
formation of the disulfide bridges. The proteins of the ER are especially prone 
to oxidative damage [190]. 
Calnexin (CXN) is a calcium binding chaperone involved in glycoprotein 
folding and quality control and whose activity is dependent on calcium con-
centration in the ER. Like other ER proteins it is highly susceptible to oxida-
tion [187] and its cellular levels decline with age [176, 191]. The loss of CNX 
also sensitizes cells to apoptosis [192]. As the protein is folded, glycosylated 
and redox modifications needed to assume the correct tertiary conformation 
are made, ERp57 and CXN keep the protein in the ER. ERp57 is also a mem-
ber of the POI family and it interacts with glycoproteins in the ER in asso-
ciation with CXN. Once correctly folded the immature folded glycoprotein is 
released into the Golgi for further processing and delivery [174]. If the protein 
is misfolded it is reglucosylated by uridine diphosphate glucose:glycoprotein 
glucosyl transferase which is able to recognize misfolded protein conforma-
tions. If the protein is released by CXN it is ignored by uridine diphosphate 
glucose:glycoprotein glucosyl transferase even if it is misfolded. Such termi-
nally misfolded proteins are chaperoned by BiP. Unless the misfolded protein 
is reglucosylated it cannot be ferried to the proteosome for degradation and is 
instead sequestered to the aggresome [95]. 
It should be clear that protein homeostasis is dependent on a steady sup-
ply of ATP equivalents to synthesize and maintain proteins in their functional 
state. A decline in mitochondrial efficiency is associated with age in several 
species: humans [193], rats [85,194] and Nothobranchius furzeri [22]. 
The Mitochondrial Cascade hypothesis of Swerdlow et al. [195] postulates 
that as one ages the mitochondria of quiescent cells, such as neurons which do 
not divide, deteriorate and the rate of deterioration is dependent on the qual-
ity of the mitochondria inherited through the matemalline. Their hypothesis 
stands in contrast to the received wisdom [196] which holds that mitochon-
drial dysfunction occurs during the late stages of neurodegeneration. This is 
not supported by the data indicating that there is significant mitochondrial 
dysfunction by 50 years of age [193], long before debilitating symptoms of 
neurodegeneration manifest. An alternative hypothesis is that of De Grey's 
Survival of the Slowest [197]. De Grey proposes that mutated mitochondria 
with lower rates of respiration would suffer less ROS damage and thus escape 
autophagy recycling longer than more active mitochondria. As consequence, 
with passing rounds of mitogenesis in the course of normal chronological ag-
ing, the cell is enriched for "slow" mitochondria which cannot readily adjust 
their flux to meet ATP equivalent demand and eventually are incapable of 
meeting the pace of ATP equivalent consumption. This leads to the Catabolic 
Insufficiency Theory of Aging, proposed by Terman [198] in 2006. This idea 















cC""',p'"'"'~'C'""'C'""c'<"""'''''''""'',"',",,m".,,"'"""'"','''',, ____________________ ,'' 
Ferrer [199] review, the evidence for general metabolic dy, function which 
c.Ull;e. widespread o,id.liw damage Tequiring energy fOT Tep>.ir and protein 
recycling and , ynthe,;, _ Fe-rreT [199] goes On to point out that IbeTe i •• 
shoruge of 0}-3 poIyun,aturated fatty adds---<ritk.l fatty add component. eX 
~pid T,fts-which has knock-"" effects on intra- and cell-cell communication 
as well as ERfGolgi and endo""me t,..fficking rcOllI!mg in the mi,pn><e.sing 
of APP which proceeds to c.use oxidative ""mage within the EeM. Proper 
ER/GoIgi processing use. large amounts of ATP and NADPH. Thefuel supply 
to neUTOn. and a,trocyte. i , oullin~ in FigUTe 2.4 .:Jong with the Wurce. of 
ATP equivalent . , 
It has been di.covered that fuel rnetaboli, m in the bntin i , di.rupt"" with 
age [194], Astrocyte> feed Ihe neuron, lactate but with ag~ the neurons are Ie .. 
• ble 10 utilize the lactate as the mitochondria malfunction . Thi, malfunction 
wu drlOfmined to be due to Complex IV diminishing relative to Compl~x II. 
The neurons, in tum, actively COTIwrt pyruvate into lactate due to a shift in 
""pre"ion from the lactate dehydTOgen."e A to B Uoenzyrn~. 
Phosphorylated AMPK w ... found in degenerating neuron, prior to th~ de-
velopment of tangle, and plaque> [86] adding w";ght to the argument that 
mitochondrial dy,function and power supply could be the underlying mecha-
nism of neurodegeneration of both neuron. and gli •. A .imilar energy deficit 
gl YC O;Wfl 
astrocyte 
" , 
Fi g.. .. 2A, Co~ (Of tlx! ,,,,,,,,ytc·"",,,,,,. n"",ooi;c ndw<><k whereby """'1'" ' ''PP'''' ,he ,not"bot;, """d, of 
""~,,,"'_ A"tocyt<, abootb glueo,e (Gle) lrom the blood whkh i< conve,,<"<1 to glucoo,-o-pru' pl"<;It< (G6P) which 
i , .Jlber CO<lv<rt,J 10 glYOO!irn or """.OOllz<"<1 to pyruvot< (Py'). Som. of tho Prr is ... ed by tbe ,"'ocr« lor ito 
"",,_.botk need> ODd the re" is oonwrt<"<1 to l.ctat, (Lac) which i. nponed to tho "",,,,n. In the .",ocyto Pyr i, 
u..,d to doY< til< C;tric AciJ cyclo (CAe) and P"nto.., Phospho,. P.thway (PPP) to ~O"O .... NAlJPH whkh i, us<d 
tu 'fJltb<.iu GSH. '[be GSIl i . u .. <l to rod"" d<hydroo",orbic Kid (lJIlM) to ",,,,,bi< .odd (AA). The Uc ,.\;.n 
up by tho neuron 1> ,onv",.d lo Pyr .,.d this P)"" i. _v.,-t"; to o«tyl-CoA In tho mitochondria ond conv. rtod to 
dtra,.. Citrat. i. ""pone<! !Tom II>< mllocl1ondna vi. 'ho dtr .... hutt" to 11<""'''. oytoool;, « etyl-CoA whkh is 
~ • .,; to ""<tylol< p"'.dn,_ Protob « otylotio<l i. ~..,d to monitor ",,11u1>, pow« ond ""OU,C< , ~pply_ lofonnOh(>n 










Chapter 2.5. ER stress & catabolic malfunction 25 
is observed in aging skeletal muscle [193]. Both the ATP production capacity 
as well as expression of mitochondrial NADH dehydrogenase (part of Com-
plex I) and NADP+ isocitrate dehydrogenase 2 (a source of NADPH) decline 
with age. A decline in mitochondrial activity of complex I-IV has also been 
observed in middle age rats [201]. In the rats there was a decline in NAD+ 
which is essential for the acceptance of electrons during glycolysis. Without 
NAD+ glycolysis will slow down or stall, leading to glucose-6-phosphate accu-
mulation which may cause the increase in GSK3p activity9. Low mitochondrial 
activity would upset the levels of acetyl-CoA which drives lysine acetylation 
(by lysine acetyltransferases). The role of lysine acetyltransferases in integrat-
ing transcriptional programing and fuel/resource abundance are reviewed by 
Patel et al. [202]. Sirtuins and histone deacetylases (HDACs) do the opposite, 
deacetylating lysine residues using NAD+ as an electron carrier. 
Catabolic insufficiency leads to a lower ratio of ATP to ADP, NAD+ to 
NADH and higher levels of acetyl-CoA. Lower rates of ATP supply mean that 
protein processing (and other energy consumptive processes) are limited by an 
ever dwindling supply of ATP equivalents. This culminates in misfolded pro-
tein which can't afford to be repaired. Rising levels of acetyl-CoA and decreas-
ing levels of NAD+, due to a catabolic bottle neck in the slow mitochondria, 
impair the activities of NAD+ dependent deacetylases (which would need to 
work against the cellular acetyl-CoA concentration). In this scenario cellular 
catastrophe is inevitable the moment mitochondrial energy effiCiency first be-
gins to wane. In addition to high acetyl-CoA and low NAD+ and ATP, there 
would be lower levels of NADPH required for fatty acid synthesis [203] and 
GSH replenishment [92]10. For the CNS, this also means that there would be a 
slower rate of vitamin C replenishment [205]. The rising levels of acetyl-CoA 
coupled with declining NAD+ will set in motion the synthesis of lactate: 
pyruvate + NADH + H+ --lactate + NAD+ 
The lactate serves as an electron sink, replenishing NAD+, as well as clear-
ing excess pyruvate. The cell could possibly persist in this state but it would 
be in no condition to cope with the vicissitudes of life. 
David Fell reports that the actual enzymatic rates of enzymes within their 
metabolic pathways are 100to 10 000 times lower than the maximal rate (VmllX) 
[206]. As the flux approaches VmllX the response coefficient, R, of the system 
tends to zero. Cells wherein slow mitochondria have multiplied are less able 
to respond to increased demand for ATP by the ER. This idea can be presented 
mathematically: 
RERpf _ CERpf BiP ATP - BiP e ATP 
The above expression (originally derived by Kacser & Burns [207] in the 
development of the mathematical framework for Metabolic Control Analysis) 
9GSK3,6's role in glycolysis is to activate glycogen synthase in the presence of excess glucose-6-
phosphate. 
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describes the response (R) of ER protein folding to ATP, where the ER protein 
folding (ERpf) is controlled (C, the control coefficient) by the enzymatic activ· 
ity of BiPi and how this response is a product of the control exercised by BiP 
over the ER protein folding and the sensitivity (Elasticity, e) of BiP to the ATP 
supply. 
This foray into enzyme kinetcs and control analysis is to emphasize that 
the processes in the cell are connected in an complex network and that small 
changes in one pathway can have large effects on others. Central to the theory 
of Kascer and Bums is that no single enzyme controls flux through a pathway 
but instead control is shared among all members of the metabolic system, i.e 
there is no rate limiting step [208]. This applies to transcription factors and 
signaling cascades as well. As cells in the CNS are interconnected metaboli· 
cally this means that neurodegenerative-aging cannot be understood by reduc-
ing the CNS to its components. 
Catabolic insufficiency leading to chronic ER stress can explain both the 
manifestation of misfolded proteins and protein aggregates as observed in 
studies of neurodegeneration as well as many of the chronically activated sig-
naling pathways, such as the AMPK cascade. If de Grey's Survival of the Slow-
est or Swerdlow's Mitochondrial Cascade hypothesis are correct (in only some 
of the cases of disease, and they are not mutually exclusive either) then it would 
mean that rather than free radicals being the cause it is the cell's excellent re-
sponse to ROS damaged mitochondria which sets the stage for later catastro-
phe. 
2.6 Conclusions 
The chapter began by reviewing the aging-related pathologies of SPs and NFTs. 
Much was made of their mysterious etiology but potentially rendering the mys-
tery of SPs and NFTs irrelevant is the growing doubt as to whether NFTs are 
in any way detrimental [172]. They are encountered in viable neurons with 
intact microtubule networks as well as persisting for decades in the cytoplasm 
without consequence. They are encountered in significant numbers in cogni-
tively intact elderly people. Furthermore, tau hyperphosphorylation inhibits 
apoptosis by stabilizing p-catenin [118] which would be a neuroprotective role 
by NFTs. This stabilization is brought about by competitive inhibition of the 
p-catenin phosphorylation activity of GSK3p by tau. This anti-apoptotic effect 
of tau may be the emergency response of neurons which have lost contact with 
other neurons or laminin with the "hope" that contact can be reestablished 
and the neuron rescued. The question then is why aren't synaptic connections 
reestablished? 
The idea of catabolic insufficiency leading to chronic ER stress and ensu-
ing cellular degeneration is a simple idea which both links up many of the 
observations made in conjunction with Ap and NFTs pathology as well as ex-
plains how protein aggregates can accumulate to pathological levels. High-
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have been found to be associated with extreme old age in humans and lifespan 
in C. elesans [209]. It is worth making mention of the ideas of Gavrilov & 
Gavrilova (210] who offer the Reliability Theory of Aging. This theory is based 
on the observation that organisms have an initial high load of damage which 
is compensated for by system component redundancy. As the redundancy is 
depleted (e.g. as the functional mitochondria are diluted by dysfunctional mi-
tochondria) systems begin to malfunction until the organism dies. Their theory 
explains why mortality rates at advanced age are similar between populations 
even though the populations may exhibit vastly different average lifespans. AD 
and other dementias can be viewed as an expedited exhaustion of redundant 
capacity. Aging can be interpreted as the manifestation of the accumulated 
cellular insults and system malfunctions. Aging does not cause the insults, the 
insults cause the aging. 
By limiting the insults or encouraging regeneration it may be possible to ex-
tend the healthspan and thus the median lifespan of humans. Whether or not 
the maximum lifespan can be affected is another matter which will be returned 
to in Chapter 7. 
Together, the conspiracy of aging-related changes in cell function produce 
neurodegenerative-aging by the inability of the cell to keep pace with the en-
ergy demands for cellular maintenance. Once a critical number of neurons or 
gUa have died or atrophied the system begins to malfunction and dementia, 
sensory or kinetic disorders manifest. In this scenario there is no need to in-
voke ever shortening telomeres11 nor the Free Radical Theory of Harman [211] 
(which will be dealt with in Section 3.1 of the next chapter). All that is required 
is for one genetic error, be it slow mitochondria or defective y-secretase, to be 
present for the entire system to collapse in later life. There may be a plethora 
of undetected genetic errors quietly conspiring to cause catastrophe later when 
the capacity of the cellular repair machinery is exceeded (as during disease) or 
the redundant units are exhausted (as during aging). 
Nothobranchius offer several advantages for the study of 
neurodegenerative-aging. Nothobrancruus possess only radial gIia lining 
the brain surface and ventricles [212], by using wholemounts it is possible 
to study the neuron-glia interaction without introducing sectioning artifacts. 
A subpopulation of neurons exists in the stratum griseum superficiale of 
the optic tectum in close proximity to the radial glia. Using the antibodies 
listed in Table 1.1 it is possible to study SMI31 and GFAP accumulation, 
the distribution of Ll (via £587 antisera) as well as the abundance of TNR 
immunoreactive PNNs. 
It is expected, using these antibodies, that SMI31 would be observed to ac-
cumulate in the OT neurons of normally aged fish and that resveratrol would 
counter this along with preserving neurons into advanced age. E587 im-
munoreactivity on neurons is also expected to decline with age and be pro-
tected by resveratrol-treatment based on the results of Valenzano et al. [5]. As 
FJB is now believed to m:dicate malfunctioning gIia [25] and the FJB stained 
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sections of Nothobranchius show considerable staining in the surface layer of 
the OT some level of radial glial degeneration is expected. This degeneration 
will most likely be concomitant with one or another form of protein mispro-
cessing. Exercise has been shown to preserve (and restore) PNNs lost with age 
in rats [147], whether resveratrol will have the same effect is an open ques-
tion. The data of Valenzano et al. [5] implies that the neural circuitry de-
generates with age and is preserved by resveratrol. This indicates that the 
PNNs are also preserved. These questions will be answered in Chapters 5 
and 6. The next chapter will serve to better equip the reader with what they 












Mechanisms of polyphenol 
neuroprotection 
Is there a way to find the cure for this implanted in a pill? 
Well strip the bark right off a tree and just hand it this way. 
Don't even need a drink of water to make the headache go away. 
Girl, you have no faith in medicine, The White Stripes. 
The question at hand is whether certain polyphenols have anti-aging prop-
erties, in particularly against neurodegenerative-aging; and if so, are certain 
polyphenols more beneficial than others and will ingesting more of these en-
able us to live healthier and longer lives? There are a multitude of reviews 
concerning the biological actions of polyphenols. In this review only those ac-
tivities of polyphenols pertaining to neuroprotection or eNS metabolism will 
be addressed in any detail. Information from other fields will be drawn on to 
gain perspective of the effects that polyphenols have on cellular signaling. This 
review is not a search for a unifying hypothesis of the mechanism of polyp he-
nol neuroprotection. The goal is not to review every bit of information but to 
present the information in such a way as to represent the multi potent prop-
erties of polyphenols which necessitate whole-animal experimentation. It is 
the assertion of the Author that polyphenol neuroprotection cannot be under-
stood except by taking into account the many mechanisms by which they can 
synergistically affect physiological outcomes. More could be written but the in-
formation presented within the follOwing pages is already more than adequate 
to present an integrated look at polyphenol action so far as neuroprotection is 
concerned. 
A second goal in writing this chapter is to address the question of "what 
dose?" The fish experimented on by the Author were previously [5], and as 
part of this study, given 121'g/fishl day. Large full grown N furzeti have a mass 
of ~ 6 g at 12 weeks of age with smaller fish being ~ 3 g. Adult N. guentheti 
are not much smaller. This equates to 4-8 mg/kg fishl day. How does this dose 
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The polyphenol rich diet of laboratory rodents together coupled with their 
low-risk environment has drawbacks for aging research. Barger et a!. [213] re-
port that resveratrol (at 4.9 mg/kg mouse/day) did not increase median lifes-
pan in non-obese mice but did decrease the disease burden. This result fits 
neatly with Gavrilov's Reliability Theory of Aging [210] but also highlights 
why mice, kept in low-risk environments, are not advantageous in assess-
ing the healthspan altering affects of polyphenols. The healthspan increas-
ing effect of resveratrol was noticeable in high calorie fed obese mice (fed 
22.4 mg/kg mouse/day) [214] because of the high extrinsic healthspan risk as-
sociated with this diet. Unless the animal model is exposed to healthspan risks 
which can deplete the redundant capacity of the animal no effect on median 
lifespan would be apparent. To this end insectivorous Nothobranchius are 
exposed both to low levels of dietary polyphenols and to extrinsic healthspan-
risks in the aquarium water. Nothobranchius are superior model organisms to 
rodents in assessing the anti-aging properties of polyphenols. 
As the molecular tools to study Nothobranchius physiology are poorly de-
veloped the only option is to employ antibody probes in search of aging-related 
and resveratrol-treatment dependent differences between experimental groups 
which can be inferred back to possible molecular mechanisms. There are sev-
eral means by which polyphenols can exert a neuroprotective affect. These 
mechanisms proposed by other researchers will be briefly reviewed. Fol-
lowing the discussion of these the expectations of Nothobranchius low-dose 
resveratrol-treatment will be discussed and linked with the signs of neurode-
generation expected to be visible in Nothobranchius as discussed in the pre-
ceding chapter. 
Several polyphenols will be discussed in this chapter. The structures of 
some of these neuroprotectively relevant polyphenols and structurally related 
compounds are presented in Figure 3.1. Also shown are two steroids, ursolic 
acid (a triterpenoid), and thioflavin-T which are reported to be neuroprotec-
tive. These are structurally similar compounds to polyphenols and will be 
discussed further on in this chapter. These compounds exert a neuroprotec-
tive affect despite not having a significant antioxidant potential. The chemical 
character of polyphenols empower them to act as antioxidants. 
3.1 The Direct Antioxidant Hypothesis 
The direct antioxidant hypothesis of polyphenol neuroproteetion is born of 
the Free Radical Theory of aging which is reviewed by Beckman & Ames [215]. 
This theory holds that aging is a result of cumulative oxidative damage in the 
course of aerobic respiration and therefore antioxidants would prevent this 
damage and in so doing slow aging. Polyphenol compounds have direct an-
tioxidant properties and they seem to retard aging or the onset of aging-related 
diseases. Therefore (according to proponents of the direct antioxidant hypoth-
esis) polyphenols retard aging through their antioxidant properties. The Free 
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Figure 3.1: Structures of several biologically significant polyphenol compounds. Note 
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on account of the naked mole rat, transgenic mice and C. elegans experiments. 
The naked mole rat, Heterocephalus glaber, exhibits an exceptionally long 
life (more than 28 years) in respect to its diminutive size and also develops dis-
proportionately high levels of oxidative damage to its proteins, DNA and lipids 
compared to other species of the same size and age [216J. It also has lower lev-
els of antioxidant defense in the form of reduced GSH and redox status (as 
measured by the ratio of GSH to GSSG). In a mouse experiment where GPx4 
(glutathione peroxidase 4, a phospholipid hydroperoxide glutathione peroxi-
dase which is the key enzyme in the detoxification of lipid hydroperoxides) was 
knocked down the result was not early mortality but longer lifespan [151J. SO 
far as rodents are concerned the Free Radical Theory of aging does not apply to 
them and probably not to C. elegans either. Experiments on C. elegans where 
superoxide dismutase (SOD) genes were systematically deleted the deletion of 
sod-2 resulted in an increase in oxidative damage to proteins and extended 
lifespan rather than shortening it [217J. The gene sod-2 codes for a SOD which 
localizes to the mitochondria so the mitochondrial Free Radical Theory of ag-
ing is also falsified as a general model of aging. Its deletion was compensated 
for by the upregulation of genes which increased mitochondrial efficiency and 
underpins the aging-related malfunction of cells and tissues (as discussed in 
the preceding chapter). Increased ROS does not result in a shorter lifespan as 
the Free Radical Theory predicts. 
Further refutation of the antioxidant hypothesis of anti-aging comes from 
the experiments of Selman et al. [218J who report that life long vitamin C sup-
plementation did not affect lifespan in mice but did decrease the expression of 
antioxidant protection genes. Mice might be poor subjects for such a study as 
they can synthesize vitamin C (unlike humans). Vitamin C supplementation, 
through negative feedback metabolic processes, could inhibit the synthesis of 
vitamin C synthesizing genes along with other antioxidant genes whose reg-
ulation is coded by the same response element. Human epidemiological data 
also yields no support for exogenous antioxidant supplementation having any 
effect on lifespan [219]. A recent placebo double-blind study has again pre-
sented evidence that long-term antioxidant supplementation has no effect on 
real or perceived health benefits [220). This is to say that increasing the con-
centration of antioxidants beyond the minimum daily requirement does not 
affect healthspan nor, so far, lengthen lifespan as predicted from the Free Rad-
ical Theory of aging. 
Experiments using the synthetic polyphenol, pterostilbene 
(40 mg/kg diet), produced plasma concentrations of 26 ng/mL (:::" 0.095 11M) 
and a total of 1.3 ng in the rat hippocampus [221]. At these concentrations 
pterostilbene was able to reverse cognitive behavioral deficits in old rats. The 
improvement in working memory was correlated with the pterostilbene levels 
in the hippocampus. 150 11M quercetin was required to prevent oxidative 
stress in C. elegans [222]. It was estimated that 0.04 to 0.12 nmol quercetin 
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adult volume of approximately 8.4 x 10-9 L I, translating to 6.9-20.4 JlM2 tis-
sue concentration. The adult rat hippocampus has a volume of approximately 
50 x 10-6 L [224], implying a pterostilbene concentration of ~0.14 JlM, some 
49 times less than for the worms incubated in quercetin. For comparison, the 
concentration of vitamin C in the human hippocampus ranges from 150 to 
300 Jlg/g (wet weight) [225] which equates to between 1.2 and 2.4 JlM which is 
at least five times less than for quercetin in C. eJegans and nine times greater 
than for pterostilbene in the rat hippocampus. It is important to note that the 
rat brain is not limited in vitamin C. It is hard to accept that pterostilbene is 
acting as an antioxidant when surrounded by such an abundance of vitamin C. 
In in vivo antioxidant assays by Ruweler et aL [226],luteolin and galangin 
almost completely quenched the oxidative activity of CUmene hydroperoxide 
at 5-10 JlM (Table 3.1). In this assay. these two polyphenols were more po-
tent than quercetin. While quercetin may have had an antioxidant activity at 
150 JlM in the C. elegans culture medium, it cannot be expected to have much 
of an antioxidant activity in situ at 6.9 JlM when it lacks such potency, and 
where vitamin C is abundant. 
It is important to reemphasize that pterostilbene reversed aging-related 
cognitive impairment in the rats [221]. Somehow the polyphenols were able 
to set the senescent cellular machinery in motion. Young rats can clear lipid 
peroxides from their membranes while old rats cannot [227]. The adminis-
tration of rooibos tea3 enabled aged rats to clear the lipid peroxide products 
from their membranes [156]. Inanami et al. [156] do not supply data concern-
ing the rooibos dosage but a steeped aqueous extract has a polyphenol content 
of ~ 26 mg/mL and rats ingest ~ 11 mL/I00 g rat per day [228] suggesting a 
polyphenol dose of ~ 286 mg/kg rat/day. Lipid peroxides, unless immediately 
iCalculated from (223). 
2 Assuming 70% wet weight being water. 
3 A beverage prepared by steeping the dried fermented twigs of the Rooibos (red bush), As-
palathus Iinearis, and which is rich in polyphenolics, particularly aspalathin. 
Table 3.1: Table of intracellular potencies of polypbenol antioxidants. Values are 1Csos 
against 500 14M cumene bydroperoxide as measured using the C~ cell assay and a cell-
free Trolox equivalent antioxidant capacity assay [226]. 
Polyphenol ICso for C6 cell assay (14M) blots ICso for cell-free assay (14M) 
luteolin 1.0±0.5 2.48 ± 0.23 
ganlangin 2.1±0.6 2.0S.±0.11 
kaempferol S.O±O.1 1.45 ± 0.08 
quercetin 13.0±1.2 4.84±0.45 
resveratrol 17.7±6.8 2.8S±0.15 
genistein 22.2±6.8 2.96 ± 0.49 
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reduced, rapidly spread to adjacent lipids by acryl-radical cross-linking in a 
spontaneous and irreversible chain-reaction [229, 230}. The polyphenols of 
rooibos tea do not slow the process of lipid peroxide accumulation but reverse 
it. 
The Author does not assert that ROS and the damage it causes are of 
no consequence in neurodegeneration, but instead that in the course of 
neurodegenerative-aging ROS is not the cause but a symptom of some other 
cellular dysfunction. The nature of that dysfunction is disputed. The Author 
believes it to be Catabolic Insufficiency (2.5, page 23) associated with mito-
chondrial inefficiency. Catabolic Insufficiency would result in ER stress and 
impair Golgi function which would prevent efficient recycling of cellular mem-
branes and thus interfere with the maintenance of synaptic contacts. 
The role of endogenous cellular and extracellular antioxidant measures are 
of critical importance in the nervous system. Lipofuscin accumulation alters 
the fluidity and permeability of the lipid membrane among many other poten-
tially deleterious effects [23, 151}. This can affect the activity and cooperation 
of the cell surface receptor kinases and their detection of the ligands in the 
ECM [152}. As was discussed in Chapter 2, page 6, many of the CNS signaling 
complexes are imbedded in lipid rafts [48,149, 157}. These rafts are enriched 
with polyunsaturated fatty acids which are especially sensitive to free radical 
attack and lipofuscin generation through acryl-radical cross-linking [231}. To 
protect against lipid peroxidation antioxidant enzymes are imbedded in the 
cell and organelle membranes. One such enzyme is GPx [232}. 
GPx enzymes use GSH to reduce oxidative damage on proteins and lipids 
[189}, generating GSSH which is in turn reduced to GSH using NADPH [233}. 
It has been reported that GPx expression and activity declines with age in hu-
man endothelial progenitor cells [234}, serving as a possible reason for the 
increase in lipofuscin levels with age. This may be interpreted as evidence for 
lipofuscin increase and GPx decrease being of importance in the aging pro-
cess but as mentioned earlier there is at least one experiment suggesting that 
this is not the case. The GPx knock-down mice (retaining only 50% of GPx 
activity) lived longer than control mice and had a lower incidence of tumor 
lymphoma and glomerulonephritis but an increased susceptibility to oxida-
tive stress-induced apoptosis [151]. Still, it was found that by supplying rats 
GSH monoester many of the membrane based aging-related enzyme deficits 
[81] were restored suggesting that the endogenous supply of GSH may be im-
paired in aging. But this is not the case with astrocytes which one study reports 
as showing no decline in GSH productivity [116}. 
In the nervous system the GABAergic neurons in the cortex seem espe-
cially prone to ROS damage follOWing excitotoxic insult [137}. These GABAer-
gic neurons of the hippocampus are ensheathed in PNNs. A decline in PPN 
ensheathed neurons have been observed in the motor cortex of the rat [147]. 
PNNs are made up of several proteins, many of which are glycosylated, such 
as CSPG [140]. CSPG affords these neurons protection from free radical dam-
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maintenance of the CSPG level is dependent on astrocyte activity [138] and 
an age-correlated atrophy of astocytes has been observed in AD model mice 
which is independent of SPs [110]. While astrocytes may retain their antioxi-
dant capacity into old age there may be far fewer productive astrocytes later in 
life. This would also imply that there is a reduction in GSH supply necessary 
to maintain the ECM. 
Without question the endogenous antioxidant defenses are critical to main-
taining healthy cellular function into old age but it is unlikely that polyphe-
nols are playing a direct role as antioxidants in vivo. There is evidence for 
polyphenols playing an indirect role as modulators of the endogenous antiox-
idant systems. For example: blueberry extracts administered before primary 
hippocampal neurons where exposed to AfJ caused an increase in ROS but re-
duced the toxic effects of the AfJ [235]. Further experimentation revealed that 
the blueberry extracts caused an increase in GSH levels in the cells via ERK 
and CREB signaling. This phenomenon of a mild stressor causing resistance to 
later stress is called hormesis and is the subject of the next section. 
While the measurement of GSH levels is beyond the scope of this study it is 
expected that resveratrol would increase GSH supply. This could be achieved 
by either increasingGSH synthesis or preventing the age-associated atrophy of 
astrocytes. We know already from the research of Valenzano et a1. [5] that lipo-
fuscin levels are reduced in the livers of resveratrol-treated N. furzeri which 
indicates an improvement in GSH supply and membrane recycling relative to 
aged-match controls. As endogenous antioxidant supply is also vital to the 
maintenance of PNNs it is expected that resveratrol would also preserve these 
into old age. Both the question of resveratrol-treatment preserving astroglia 
and PNNs into old age will be answered in Chapter 6 using the GFAP and 
TNR antibodies. 
3.2 Hormesis and energy metabolism 
((Hormesis refers to a process in which exposure to a low dose of a 
chemical agent or environmental factor that is damaging at higher 
doses induces a beneficial effect on the cell or organism." 
The above quote from Mattson et a1. [236] succinctly defines the concept of 
hormesis. It is an old idea popularized through homeopathy hocum. Hormesis 
is the simplest theory by which to explain the myriad of effects of polyphenols. 
The sections that follow should be interpreted in the light of this section. While 
polyphenols may be reported to work through native signaling cascades this 
effect is achieved by an exotic compound causing an unnatural activation of 
the signaling cascades. Given the rigorous regulation of these cascades this 
unnatural activation should be considered a source of cellular stress. 
In the previous section itwas reported that blueberry extracts induced ROS 
and this ROS caused a response which afforded protection against AfJ toxi-
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uct (acetyl-CoA) inhibition. This hypothesis relies on the cell being healthy to 
start with. Both middle age humans [193] and rats [201] show a decline in mi-
tochondrial activity. In the rats, this decline was concomitant with a decline in 
the NAD+ /NADH ratio as well as sirtuin activity. There was also an increase 
in acetylated p53 indicating to the Author that unless there is sufficient mi-
tochondrial fitness sirtuin cannot switch genomic expression programs from 
death to life. 
There is evidence for sirtuin activation causing cell death in energeti-
cally compromised cells [240]. It can be expected that unsavable neurons 
would therefore be cleared from the brains of Notbobranchius on resveratrol-
treatment (as resveratrol activates cell survival expression modules, and not 
because it necessarily activates sirtuins). Whether this neuron loss would be 
detectable among the neuroprotective effect of resveratrol is impossible to pre-
dict. Neuron numbers can be quantified using the SMI31 antibody. What effect 
resveratrol has on neuron survival will be revealed in Chapter 5. 
Blueberry extracts (as well as spinach and strawberry extracts) can reverse 
age-related mental decline [237, 241] which suggests that a sirtuin based hy-
pothesis (which simply protects cells against death) cannot fully explain the 
observations. Further complicating matters, while neuroprotection of adult 
rat hippocampal neurons relied on ERK activity [235], experiments employing 
mouse cerebral microglia and neuron cultures produced neuroprotection us-
ing blueberries by inhibiting ERK activity [242]. In the latter experiment, blue-
berry extract was effective at only 25 Jlg/mL (~30.6 JlM) and the extract was 
added to the cell together with the Af3, so at a lower concentration blueberry 
extract can prevent Af3 toxicity but through a different mechanism in a differ-
ent cell type. This neuroprotective effect was only visible after 72 hours. At 
higher concentrations, Significant neuroprotection was visible from 48 hours 
indicating a concentration dependent adaptive response was required in accor-
dance with the Hormetic Theory of neuroprotection. 
Son et al. [243] review the neurohormetic action of polyphenols. Their pro-
posed mechanism is presented in Figure 3.3. A range of poylphenols have 
been observed to activate a variety of kinases, instigating the activation of a 
variety of expression modules. One such expression module is the antioxi-
dant response element (ARE). The ARE is in part controlled by the activity 
of Nrf2. Nrf2 is kept inactive through covalent binding to Keapl (via sul-
fide bridges). Sulforaphane, which is not a polyphenol, from broccoli has 
been shown to disrupt the sulfide bridges, allowing Nrf2 activity as well 
as inhibiting Nrf2's degradation. ARE expression results in the upregula-
tion of antioxidant enzymes such as manganese superoxide dismutase (Mn-
SOD), glutathione S-transferases, glutathione reductase, GPx, epoxide hydro-
lase, hemeoxygenase-l (HO-l), catalase. NAD(P)H dehydrogenase quinone I, 
UDP-glucuronosyltransferase (which is involved in the reprocessing of mis-
folded proteins) and various protein chaperones including Hsp70. Many of 
these have been shown to decline with age, be up-regulated in anti-aging ther-
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tration of 0.14 pM in the hippocampus. In Krikorian et a1. [237], humans of 
76.2 years average age, were given ~ 7 mL blueberry juice per kilogram per 
day. This equated to 11.27 mg polyphenolics6 per kilogram per day. This low 
dose was sufficient to produce a significant improvement in cognition. In an-
other study, adults with mild cognitive impairment (78.2 years age average) 
were given approximately 7.5 mL concord grape juice per kilogram per day 
which also improved memory [249]. It is hard to believe that this low dose 
would approach 0.14 pM let alone 2.4 pM resveratrol at a cellular level. More 
impressive still, 4.9 mg resveratrol/kg mouse retarded several aging param-
eters in mice suggesting that very little is required to elicit beneficial effects 
[250]. 
Other polyphenols have been observed to exert biologically meaningful ef-
fects at low concentrations. A protective response to curcumin was observed 
at only 1 pM based on increases in RANTES7 expression [251]. The curcumin 
was added to the cells for only one hour and then fresh medium was added 
and the cells left to recover for a further 23 hours. 50 mg/mL green tea extract 
was administered orally for 6 months to senescence accelerated mice with an 
improvement in spatialleaming and the upregulation of synaptic plasticity re-
lated proteins: brain derived neurotrophic factor (BDNF), post-synaptic den-
sity protein-95 and CAM1<lI [252]. The same green tea dose given to C57BL/6J 
mice corrected the aging-related decrease in SOD and GPx activities as well 
as reduced the levels of thiobarbiturix acid reactive substances [253]. The 
loss of post-synaptic-density-95 and N-methyl-d-aspartate-receptor-l in the 
hippocampus was also reduced as well as the activity of NF-fCB. Rats given 
0.96 mg/mL total green tea phenolics for 19 months had a higher GSH:GSSG 
ratio as well as higher activity of other antioxidant enzymes [254]. The lev-
els of activated CREB and BDNF and Bcl-2 expression was also increased with 
green tea administration but there was no change in NF-fCB activity suggest-
ing that NF~fCB activation may play no role in the long-term anti-aging re-
sponse to green tea. Rats given 0.25 mg/kg genistein had a lower mean arte-
rial blood pressure, increased NO bioavailability and lower malondialdehyde 
levels [255]. 
Rats given 200 mg/L grape seed flavanols in their drinking water devel-
oped less lipofuscin than controls [256] while rats given port flavanols did not 
benefit from the polyphenol content suggesting that the quality of the polyphe-
nols could be important. A 592.5 mg grape seed extract per gram feed experi-
ment on AD model mice, possessing the APP(Swe)/PSldE9 mutation, resulted 
in a reduction of Ap deposition and inflammation [257]. A 0.7 mg/g feed dose 
of curcumin given to the same mouse strain also reduced inflammation and 
Ap deposition, indicating that some polyphenols are more potent than others 
at indUCing a protective response. A range of blueberry extract fractions, ap-
plied at 0.5 mg/mL phenolics elicited various protective effects depending on 
6Blueberry juice contains 734 mglL hydroxycinnamic acid ester and 877 mg/mL anthocyanins. 
7RANTES, regulated on activation normal T expressed and secreted, a cytokine which is ex-
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the fraction [258]. None of the individual polyphenol fractions had the same 
efficacy as the whole extract though each displayed different potencies against 
dopamine, ai342 and lipopolysaccharide cytotoxicity. Most fractions as well as 
the whole extract increased levels of MAPK, INK, p38 and NF-1CB activity. The 
different fractions had different effects on the ROS levels depending on the 
stressor but in general increased ROS. 
The Author has already referred to the importance of energy balance and 
mention was made as to the importance of the cellular levels of NAD+ and 
acetyl-CoA. These levels, as far as they effect sirtuin activity, may be irrele-
vant to the anti-aging effects of polyphenols. Barger et a1. [213] report that 
the bioactive dose of 4.9 mg/kg body weight/ day resveratrol had no effect on 
Sir2 activity. The role of sirtuin in FoxO signaling will be discussed in Sec-
tion 3.3.1. At low cellular concentrations of resveratrol there is an increase in 
AMPK activity [246] which is discussed in in Section 3.3.2. 
Reviews of the bioactivity of resveratrol and other polyphenols neglect to 
report that they are inhibitors of the F} Fo-ATP synthase of various species 
[259-262]. The 1Cso values of the various polyphenols are given in Table 3.2. 
It is interesting to note that the two most physiologically potent polyphenols, 
(-)-epigallocatechin gallate (EGCG) and resveratrol, rank near the top. 
It has been shown, using crystallography, that resveratrol, piceatannol and 
quercetin are non-competitive inhibitors binding to a common site between the 
i3TP and y subunits of the FlFo-ATPase/synthase [263]. This binding impairs 
the rotary action of the ATPase and inhibits both ATPase and ATP synthase 
activities. While the ICso values far exceed the polyphenol concentrations 
achieved in tissues this does not imply that they do not have an inhibitory ac-
tion on ATP production. Fell {206] reviews non-competitive inhibition and its 
effect on the flux through pathways. The inhibitor effect varies with the control 
of the target enzyme over the flux through the system. For enzymes with a high 
flux control coefficient the response to the inhibitor quickly tends to zero with 
increasing concentration but grows more acute with decreasing concentration. 
Low levels of inhibitor can cause relatively large changes in flux. For enzymes 
with a low flux control coefficient the affect of the inhibitor is less severe at all 
concentrations but by no means negligible. 
In brain and kidney ti~sue ATP synthase has a high flux control coefficient 
(0.26 and 0.27 respectively) over oxidative phosphorylation [264]. Complex I 
and pyruvate carrier have coefficients of 0.25 and 0.26 respectively in the brain. 
These three enzymes comprise 77% of the control over the production of ATP 
in the brain. Polyphenols can attain 0.1-1 pM in the bloodstream [265]. Based 
on the data of Zheng & Ramirez [259] this could imply a 0.26-2.6% decrease in 
the flux through oxidative phosphorylation. Theaflavins (from black tea) have 
been reported to inhibit both ATP synthesis and Complex I in vitro [266]. It 
was able to do this without increasing superoxide production. The ICso values 
against ATP synthase by the theaflavins ranged between 10-60 pM for mem-
brane bound enzyme and 0.7-4 pM for unbound enzyme. ICso values against 
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Table 3.2: 1Cso values of various polyphenols for the inhibition of FoFl ATP synthase. 
Values taken from [259]. The concentrations for tannic acid (1701.2 g/mol), theaflavin 
(554 g/moI) and grape seed proanthrocyanidins (575 g/mol) were calculated using their 
respective average molecular masses and the mg/mL concentrations provided: 5, 20 
and 30 respectively. Given the large size and complex structure of tannic acid, which 
would hinder its bioavailability, its low 1Cso is probably an artifact of the assay. 
Polyphenol concentration (JIM) 
tannic acid 2.9 
piceatannol 8 




( -)-epicatechin gallate 45 
quercetin 50 
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have high control coefficients polyphenols could, at physiological concentra-
tions, have a physiologically significant affect on oxidative phosphorylation. 
Whether this inhibitory affect would cause the level of AMP to rise and ac-
tivate AMPK is an open question. AMPK activation would lead not only to 
the execution of the ARE expression module but also the mitogenesis modules 
[267,268]. This would correct any energy deficits as well as increase the con-
centration and supply of ATP equivalents (enabling the cell to better respond 
to its maintenance needs). In addition, more NAD+ would be available, allow-
ing for faster clearance of acetyl-CoA; improved fatty-acid synthesis and more 
mitochondrial endogenous antioxidants as well as GSH to counter ROS dam-
age to the mitochondria. Ultimately, the consequences of the malfunctioning 
mitochondria of Short et a1. [193] and de Grey [197] would be mitigated. The 
role of mitogensis and cellular stress in respect to aging and hormesis are re-
viewed by Calabrese et a1. [268] who put particular focus onneurodegenerative 
disorders and neuroprotection showing that the inability to cope with cellular 
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ments ameliorate this proteotoxic stress through expression of what the aU-
thors call vitagenes (antioxidant and Phase n enzymes) and mitogensis. Short 
term blueberry enriched diet (20 mg blueberry extract/g feed/day) reverses 
object recognition memory loss in aging rats [269] implying a short stress can 
instigate a reparative response. It could also reverse aging-related AfJ deposi-
tion. 
As the polyphenols can also inhibit the ATPase activity this could disrupt 
protein processing triggering the unfolded protein response. This would make 
more BiP and other chaperones available to enSUre proper protein processing 
and recycling. This hypothesis has not yet been explored. 
Polyphenols can interact with proteins in other ways. A range of polyphe-
nols were tested by Riviere et a1. [270] against AfJ aggregation. The results are 
shown in Table 3.3. The most effective polyphenols were stilbene dimers fol-
lowed by resveratro1. The ICso of resveratrol was 2.5x higher than the tissue 
concentration achieved by Vingtdeux et at [246]. Resveratrol has been shown 
to selectively remodel soluble AfJ oliogmers, fibrillar intermediates and amy-
loid fibrils but not effect the autopoesis of non-toxic oligomers [271]. 
Resveratrol was found to block the lateral growth of the oligomer fJ-sheets 
[271]. With age there was a predilection for the aggregation of proteins in C. 
e1egans which formed fJ-sheets [97]. It is possible that resveratrol could, in 
part, slow aging by hindering the aggregation of fJ-sheet proteins. Thioflavin-
T, a small molecule (see Figure 3.1, page 31) which selectively binds to proteins 
which form fJ-sheets, was able to extend the lifespan of C. elegans. Thioflavin-
T extended lifespan by 60% at 50 pM whereas 100 pM curcumin achieved 45% 
lifespan extension and there was no additive effect observed in combining 
the two compounds. The action of thioflavin-T relied on heat shock factor 1 
and SKN-l, the C. e1egans Nrf20rtholog. C. elegans Hsp70 mRNA was up-
Table 3.3: The ability of polyphenols to disrupt AfJ aggregations is given in the table 
below as percentage inhibition and as ICso values (where available). Only the most 
effective polyphenols are listed as well as two polyphenols mentioned previously in the 
text which were effective at retarding age-related cognitive decline. Data from [270] 
Polyphenol % Inhibition ICso {JIM} 
e-viniferin glucoside 93±3 0.2±0.3 
scirpusin A 80±9 0.7±0.3 
resveratrol 63±6 6±2 
piceid 62±6 6±2 
ginsenoside A 46±7 10±2 
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regulated along with several other genes. 
/3-sheets are common structures in the cell [203]. Molecules that disrupt 
the stability of /3-sheets could cause extensive cellular stress, prompting the ex-
pression of the unfolded protein response and Nrf-21 ARE modules to restore 
cellular homeodynamics. Indeed, several polyphenols (chlorogenic, ferulic, 
and gallic acids, quercetin, rutin, and isoquercetin) have been shown to bind 
to a range of proteins under physiological ionic conditions: human serum albu-
min, bovine serum albumin, soy glycinin, and lysozyme [272]. These polyphe-
nols showed greater affinity to a-helices than /3-sheets. As polyphenols are 
predominantly hydrophobic they are most likely to concentrate in membranes 
where proteins which are a-helix rich interact to maintain cellular homeo-
dynamics (explaining why higher polyphenol concentrations are needed to 
achieve ATP synthase inhibition when the enzyme is membrane bound instead 
of in solution). 
The physiological concentrations achieved by several polyphenols, most 
notably resveratrol, can both disrupt protein folding as well as ATP synthesis. 
One of the more biologically active polyphenols, genistein, could also cause 
ROS stress. This is accomplished at concentrations low enough to be consid-
ered hormetic. There is great interest in discovering the signaling mechanisms 
whereby this hormetic response is generated. This is with the hope that more 
potent stimulants can be designed to address specific ailments. There are four 
problems with this. Firstly, altering protein homeodynamics is far from a spe-
cific means to address a problem and secondly, as there does not appear to be 
any additive effect by administered polyphenols, a side salad rich in quercetin 
or ECGC rich cup of green tea might supply all the effective polyphenols one 
needs. Thirdly, the effectiveness of polyphenols may lie in their multipotent 
ability to disturb several cellular processes at once rather than a specific pro-
cess, explaining why polyphenol-engineering attempts have largely failed to 
result in increased lifespan [273]. Lastly, as pointed out by Calabrese et a1. 
[244] many polyphenols are toxic at higher concentrations though they may 
be beneficial at lower doses. A more potent hormetic could be toxic at much 
lower concentrations and circumvent the goal of producing a more effective 
hormetic. This toxic effect is manifest in the papers of Baur et al. [214] and 
Valenzano et a1. [5] where resveratrol-treated groups exhibited a higher mor-
tality rate in early phases of the experiment when compared to age-matched 
controls. This effect was absent at the lower dose used by Pearson et a1. [250]. 
3.3 Polyphenols and cellular signaling 
Polyphenols have been reported to affect several Signaling pathways. The most 
notable is the PI3K/ Akt/FoxO pathway but they also effect the activity of JNK, 
p53, AMPK and mTOR signaling. The subject of polyphenol signaling will be 
discussed with the purpose of pointing out that none of the individual path-
ways fully explain the effect polyphenols have on physiology, but that each 










Chapter 3.3. Polyphenols 8r cellular signaling 44 
study of polyphenollifespan extension cannot be conducted by only examin-
ing one pathway in a petri dish or focusing on one pathway in the animal. The 
organism must be studied as a whole. 
3.3.1 P13K, Akt, FoxO and slrtulns 
The PI3KI Akt/GSK3p signaling cascade is linked to the development of tau-
pathies and AP associated neurodegeneration [53, 73]. This same cascade is 
linked with longevity signaling to the FoxO transcription factors [114], Figure 
3.4. This family of transcription factors play roles in development, cell cycle 
check points, stress response and regulates apoptosis. 
Upon expression, FoxO transcription factors move into the nucleus where 
they remain unless phosphorylated by Akt where upon they are exported from 
the nucleus into the cytosol [274]. The transcriptionally active acetylated 
Fox04a (the functional equivalent of the DAF-16 transcription factor of C. ele-
gans) transcribes genes concerned with cell cycle arrest and apoptosis. Fox04a 
also suppresses PP2A and PP2B activity as well as allows the transcription of 
insulin- and insulin-like receptor genes ensuring a negative feedback loop to 
keep FoxO activity under control [275]. The activation of FoxO transcription 
factors by resveratrol resensitizes PI3K-Akt [275] (resetting energy-state sens-
ing) signaling among many other functions. Some of these other functions are 
up-regulating the expression of several cellular antioxidant enzymes (catalase 
and MnSOD) [276] and the unfolded protein response [277] which includes the 
up regulation of Hsp70 [276]. The activation of sirtuins (Figure 3.2), suppos-
edly by resveratrol [106], results in the activation of the cell-survival proper-
ties of the mammalian Fox03a (and c. elegans ortholog DAF-16) transcription 
factor [114, 278]. Resveratrol-treatment did restore PKC activity, a negative 
cell 






Figure 3.4: The P13KI AlctIFoxO cascade and life and death decisions. Activated Akt 
phosphorylates FoxO causing it to dissociate from DNA and be exported from the nu-
cleus. Deacetylation by sirtuin causes it to switch from expressing cell cycle check-point 
proteins and apoptosis sensitizing factors to the expression of cell survival modules 
such as the antioxidant response element and Phase II enzymes. Unphosphorylated 
FoxO transcribes both inhibitors of PP2B (which dephosphorylates Akt) as well as in-
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regulator of GSK3p, which is dependent on chaperones to orchestrate its activ-
ity [1]. The resensitization of the PI3K/ Akt pathway may also be instrumental 
in suppressing aberrant GSK3p activity. 
Kaeberlein et at [279] did not find any evidence of resveratrol activation of 
Sir2 in three strains of yeast nor any modulation of their lifespan by resveratrol. 
In vitro assays did demonstrate a substrate~specific activation of sirtuins (Sir2 
and SIRTl) by resveratrol but only against the synthetic Fluor de Lys peptide. 
It was shown that SIRTl does not normally have a high binding affinity to the 
Fluor de Lys peptide, but resveratrol improved this binding 8-fold [280]. The 
call by Kaeberlein et at [279] to reexamine the putative sirtuin mechanism of 
longevity has been all but ignored. Instead, this mechanism still enjoys large 
support [281]. The observation that Sirtl inhibitors are also neuroprotective 
have further complicated the issue inspiring Tang [239] to hypothesize that 
resveratrol may be neuroprotectivebecause it is not a direct activator of Sirtl. 
Experimental results were recently published indicating that prior evidence 
that sirtuin over-expression increased lifespan was an artifact caused by not 
out-breeding the genetically modified experimental animals [282]. In outbred 
strains of C. elegans and Drosophila sirtuin over-expression had no effect on 
lifespan. Tang [239] believes that the AMPK pathway is the means by which 
resveratrol executes its protective effects. AMPK will be discussed in Section 
3.3.2. 
The effects of several polyphenols have been reported to be mediated via 
the PI3K/ Akt pathway. Quercetin's lifespan extending effects were shown to 
be dependent on age-l/daf-2 (the homologs of PI3K and insulin-like growth 
factor receptor) signaling [283] and that there was a three fold increase in FoxO 
nuclear localization [222]. Curcumin mediated neuroprotection involved the 
activation of PI3K and MAPK signaling networks [251]. Whether or not cur-
cumin activated Akt was not reported in that study. EGCG caused the upreg-
ulation of several FoxO regulated genes [284] but again no mention was made 
of Akt activity. 
Interestingly, to increase longevity in C. elegans DAF-16 activity is only 
needed in the neuronal cell lineage [32]. Furthermore, lifespan extension via 
dietary restriction was reliant on a small group of neurons, the amphid neu-
rons, which express insulin/insulin-like growth factor like ligands [285]. This 
offers the promise that long healthy life can be attained simply by preserving 
CNS function. This topic will be continued in Section 3.3.2 on AMPK. 
Where does this leave the PI3K/ Akt/FoxO pathway and sirtuins? Experi-
ments in several model organisms reveal that the proper function of this path-
way is vital to long and healthy life. Direct interaction was discovered between 
SIRTl and the gene locus encoding presenilin 1 [286]. The increase in pre-
senilinexpression by SIRTI activation resulted in an increase in glycosylated 
APPa and a decrease in APP fragments. In addition, there was a preserva-
tion of neuronal stem cell proliferative capacity in the mouse hippocampus. 
But when Balducci et a1. [171] inhibited y-secretase there was a reduction in 
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that the upregulation of presinilin via increased SIRT1 activity may not be as 
meaningful as it first appears. Barger et al. [213] report that resveratrol had 
no effect on the PI3KI Akt/FoxO pathway but the age-related decline in glu-
cose uptake was prevented in their mice. Bastianetto et al. [77] conducted a 
comprehensive review and report that resveratrol has no effect on the Akt and 
MAPK pathways. What does this mean? Experiments where SIRT or FoxO sig-
naling has been disrupted only prove one thing: that the removal of SIRT or 
FoxO has detrimental consequences. Pietsch et a!. [283], from their quercetin 
work, conclude that PI3KI Akt/FoxO signaling was coincidental to lifespan ex-
tension and not causal. The attenuation of lifespan and CNS healthspan is 
dependent on the concerted actions of several pathways working in symphony. 
As was claimed by Kascer and Bums back in 1979: control is shared among all 
members of the system [208]. The PI3KI Akt/FoxO pathway and sirtuins have 
an important share in this control but not a critical one. 
3.3.2 Stress signaling 
Both INK and NF-1CB are Redox sensitive. Via Redox sensing they are able to 
regulate cell survival programs. The activity of both are affected by polyphe-
nols and the outcomes are generally beneficial. This section will briefly review 
the role of JNK and NF-1CB in polyphenol protection in relation to the signaling 
pathways discussed previously and how they relate to AMPK signaling. 
The p50 subunit of NF-1CB is glutathionylated and the oxidation of the GSH 
group leads to the inhibition of NF-1CB DNA binding [287] as does deacetyla-
tion by sirtuin [288]. The significance of this is debatable. NF-1CB has a Jekyll 
and Hyde role in cell physiology. While its activity is associated with inflam-
mation and cell survival functions there is evidence for its malfunction in the 
immune system being a protagonist in aging-related diseases [105, 289]. Sup-
porting the idea of NF-1CB driven inflam-aging, the suppression of NF-1CB by 
resveratrol, curcumin and catechins result in neuroprotection in vitro and in 
disease model animals [290]. 
Resveratrol, quercetin [291] and curcumin [292] are known to inhibit the 
inflammatory response or reduce the cellular activity of NF-1CB [293-296]. 
In the case of microglia NF-1CB suppression seems key to neuroprotection 
[288]. NF-1CB levels were reduced in a model of D-galactose induced brain 
injury when the aged mice were given purple sweet potato color polyphe-
nols [247]. Likewise, NF-1CB activity was reduced in another neuroprotective 
chronic green tea study on CF8BL/6J mice [253]. Conversely, in experiments 
testing the long term effect of green tea on age-dependent decline in hippocam-
pal signaling there was no difference in NF-1CB activation between treated and 
age matched controls [254]. The lack of NF-1CB activity could be the result of 
the polyphenols preventing the neuronal insult which would ordinarily cause 
an inflammatory response. This would however also be evidence for NF-1CB 
being inconsequential to neuroprotection. NF-1CB plays an important role in 
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Figure 3.5: The INK/SIRT /FoxO cascade and Redox switching between life and death. 
INK can be activated by ROS in two ways: through the ROS activation of the Ral GT-
Pase or by oxidation of GSH on glutathionylated INK. Ral phosphorylated INK activates 
sirtuins which switch FoxO from cell cycle arrest to cellular repair. Sustained activa-
tion of INK by GSH oxidation causes INK to phosphorylate FoxO activating apoptosis 
programs. 
in certain cell types within the Hormetic Theory [236]. 
NF-KB does not function independently. Instead it is entangled in a compli-
cated signaling network involving the PI3K/ Akt/FoxO pathway as well as the 
JNK network and proinflammatory pathways [106]. It is impossible to experi-
mentally determine the affect of NF-KB in polyphenol neuroprotection unless 
these complimentary pathways are simultaneously assessed. 
The combination of Fox03a and AP-1 activation by JNK puts into operation 
cell death programs that the additional deacetylation of Fox03a by sirtuins 
can turn into cell survival responses [114, 297]. JNK plays a role in this switch 
from death to life, as illustrated in Figure 3.5. This switching is reviewed by 
Lam et a1. [114]. In brief, JNK can be activated by the small GTPase, Ral. Ral 
phosphorylates JNK which in tum phosphorylates Fox04a and SIRTl (which 
then deacetylates Fox03a) switching it from cell cycle arrest/death expression 
modules to cell survival and repair expression modules [238]. The target of 
JNK, c-Jun, is acetylated at its C-terminus and its deacetylation enables cell 
death transcription programs [298]. The acetylation of c-Jun is a response me-
diated by p300, an acetyltransferase under the control of ERI< [299]. If the 
cell is stressed and energy supplies are low then c-Jun deacetylation may not 
occur on account of a build-up of NADH and acetyl-CoA (which would simul-
taneously drive acetylation). JNK is also glutathionylated and the oxidation of 
GSH results in sustained activity of JNK which then mediates the expression 
of apoptotic expression modules [300]. 
Ral is activated by a decline in the ratio of GSH to GSSG [238]. If, under 
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JNK is cell death in response to stress, then under conditions of excess ROS 
the oxidation of the GSH groups of JNK and NF-ICB deactivates the cell sur-
vival expression modules controlled by NF-ICB while activating the cell death 
expression modules of JNK. This is a simple means by which the cell can differ-
entiate between mild damage (which can be repaired) and severe irrecoverable 
damage (where apoptosis would be preferential). 
What roles do polyphenols have in JNK signaling? While resveratrol has 
not been shown to alter Ras-MAPK signaling, it does result in the down-
regulation of the small guanine nucleotide exchange factor, Ras-GFRI which is 
AP-l inducible [301] suggesting that resveratrol promotes the survival/repair 
programs by suppressing AP-1.Recalling that Fox03a activity can resensi-
tize Akt, Akt can suppress JNK activation through its activation of IICB kinase 
[106] which would also activate NF-ICB. In this model, transient activation of 
JNK leads to Fox04a activation which in tum deactivates JNK (should the GSH 
group be in the reduced form). Further more, several polyphenols, including 
resveratrol, curcumin and catechins, are known to elevate the levels of GSH 
[189] and so ensure that JNK is not switched into sustained activation mode. 
Genistein (from legumes) has been observed to have a pro-oxidant effect at 
low concentrations [226]. This pro-oxidant effect started at the concentration 
of only 2 pM. This effect may be severe enough to lead to a drop in GSH levels 
and activate the Ral/JNK/SIRT /Fox03a pathways. Inhibition of ATP synthase 
[259] or disruption of P-sheet protein folding [270, 271] by resveratrol and 
otherpolyphenols could lead to cellular stress culminating in lowered GSH 
levels as well as the activation of AMPK [239]. Genistein has neuroprotective 
properties and will be discussed further on. 
AMPK is the medium whereby whole body energy status is transmitted 
from the hormonal messengers to the requisite signaling networks to set in 
motion the correct transcription modules [302]. In most tissues it is acti-
vated by leptin and adiponectin (among other compounds). Both leptin and 
adiponectin are produced by adipocytes in response to low glucose levels. 
They activate AMPK which facilitates the merger of GLUT4 transporter-filled 
endosomes with the cell membrane. AMPK is negatively regulated by tumor 
necrosis factor-a and insulin. Leptin inhibits AMPK activation in the brain 
where adiponectin and ghrelin activate it. AMPK activation inhibits fatty acid 
synthesis and promotes p-oxidation. It also facilitates the transcription of the 
ARE, Phase II enzymes and mitogensis [239]. This response is evolutionary 
conserved from C. elegans to humans [93]. 
AMPK is also activated in response to increasing concentrations of AMP, 
Figure 3.6 [93, 239, 302]. Its activation by AMP allows more glucose to enter 
the cell as well as promote p-oxidation to correct the ATP deficit. AMPK also 
promotes gluconeogenesis, suppressing GSK3p activity. Insulin secretion in 
response to high blood glucose would deactivate AMPK via PI3K/ Akt signal-
ing and promote fatty acid synthesis, completing the negative feed back loop. 
AMPK negatively regulates the mTOR signaling cascade [267]. The mTOR 
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Figure 3.6: AMPK facilitation of lifespan extension through the depletion of ATP levels, 
brought on by cellular stress or nutrient deprivation. Activated AMPK inhibits mTOR 
which would ordinarily activate AId to deactivate FoxO. The lack of nutrients and pres-
ence of leptin lead to FoxO activation through Akt inhibition. AMPK activation leads 
to the expression of mitogenic, ARE and phase II enzyme modules to extend lifespan. 
nutrient supply levels (particularly essential amino acids such as methionine) 
[303]. While adequate nutrient levels are maintained mTOR is active and sup-
presses autophagy. mTOR signaling activates Akt and Akt activates mTOR to 
enforce cell growth during periods of adequate nutrient supply. 
The mTOR pathway is emerging as the central pathway pertaining to life-
and healthspan [94] and successfully explains the observations previously at-
tributed to the inadequate Free Radical Theory of Aging. Inhibition of mTOR 
has resulted in lifespan extension of several species &om C. elegans to mice 
[304]. Inhibition results in increased macro-autophagy and nutrient recycling. 
As mTOR inhibition and AMPK activation suppress protein synthesis, stimu-
late mitogensis and autophagy, activation of AMPK would address chronic ER 
stress and the resulting misfolding of proteins which culminate in APP mis-
processing and neurodegeneration. 
It is worth recalling from Chapter 2 that an impairment of autophagy re-
sults in an increase of PS-1 expression and y-secretase activity [117]. Resvera-
trol, at 12.5 I'M and above, has been found to suppress autophagy via S6K (the 
target of mTOR) [305]. This is contrary to what is expected of the polyphe-
nol but this resveratrol dose is several times greater than what is shown to be 
beneficial in vitro. Using a much lower dose of 0.1-1 I'M (i.e. physiological 
concentrations) resveratrol was shown to be cardioprotective by means of au-
tophagy [306]. At 5 I'M resveratrol was toxic to endothelial progenitor cells as 
well as several other healthy cell types while lower doses were protective [244]. 










Chapter 3.3. Polyphenols 8r cellular signaling 50 
press S6K and mTOR activity to stimulate macro-autophagy and mitogenesis 
in accordance with the Theory of Hormesis. 
Leptin has been shown to regulate tau phosphporylation and suppress AP 
production [307}. Several polyphenols have been observed to increase AMPK 
activity, these are EGCG, ginsenoside, resveratrol and quercetin [267]. Resver-
atrol has been shown to stimulate AMPK activity and impede Ap formation at 
the low cellular concentration of 1.7 nmol/g wet weight brain material [246]. 
As discussed in Section 3.2 (page 35), green tea at similarly low concentrations 
was also able to invoke neuroprotective effects. EGCG has been reported to 
facilitate glucose uptake via an AMPK dependent mechanism. While leptin 
stimulates AMPK activity in most tissues, in the hypothalamus leptin sup-
presses AMPK activity in the periventricular and arcuate nuclei [302]. This 
causes appetite suppression, explaining the appetite suppressive properties 
of green tea. Dietary restriction was mediated via the nutrient sensing am-
phid nuclei in the C. e1egans brain [285] and white adipose tissue lipolysis is 
under direct control by the sympathetic nervous system [308]. It is to tempt-
ing not to speculate that there may be a link between whole-body nutrient 
sensing and lifespan in vertebrates as there is in C. elegans. Quercetin has 
been demonstrated to reduce the expression of corticotropin-releasing factor 
and plasma levels of adrenocorticotropic hormone in Wistar rats administered 
10 mg quercetin per kilogram [309]. Under fasting conditions this would in-
hibit cortisol production and glucogon cannot exert a gluconeogenic effect 
without cortisol [310]. Glucogon and cortisol also increase protein catabolism, 
which increases plasma levels of amino acids and free fatty acids. Together 
they act to counter a nutrient and fuel shortage which would suppress AMPK 
activation and mTOR inhibition (completing a feedback loop). Polyphenols 
can create physiological conditions which favour AMPK activation and mTOR 
inhibition. A refreshing cup of quercetin rich black tea between meals may 
be all that is needed to cause enough physiological stress to trigger a hormetic 
response via AMPK. There are several studies, reviewed by Ramassamy [293} 
and Mukhtar & Ahmad [294], linking black tea with increased lifespan and 
reduced probability of dementia. 
AMPK has been observed to be dysregulated in AD where it phosphorylates 
tau, causing tangles [86]. AMPK is activated in pretangle neurons suggesting 
that there is a chronic energy deficiency leading up to tangle formation. This 
fits well with the Catabolic Insufficiency Theory of Terman [198]. This also 
suggests that polyphenol action via AMPK must be evoked before chronic en-
ergy insufficiency and metabolic collapse set in. This may not be strictly true 
in the case of neurodegenerative-aging where massive neuron loss is absent. 
That many polyphenols have been observed to reverse cognitive impairments 
in the aged suggests that the neuroprotective effects of polyphenols cannot be 
mediated through AMPK and mTOR alone. 
The kinase p38 MAPK has important roles in cell survival [311]. Its role 
in polyphenol neuroprotection is still ambiguous. It has been explored with 
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studies find an affect while others do not. An astrocyte study found that 
polyphenols increased p38 activity but this was in cells in culture and at a 
100 11M resveratrol concentration [312] which is toxic to many cell types [244]. 
At 100 11M quercetin was shown not to alter p38 activity but this was in ex-
periments designed to cause cell death [313]. A decline in p38 underlies 
immunosenescence in C. e1egans [314] and increased lifespan is correlated 
with improved immunocompetence [315]. As polyphenols exert many bene-
ficial effects, particularly in lifespan experiments, it would be expected to see 
an age-associated aberration in p38 activity which is restored by polyphenol-
treatment. 
3.3.3 Phytoestrogen potential 
Several years ago phytoestrogens (such as genistein) and estrogen mimics were 
a popular research paradigm. There was great scientific interest and public 
alarm about chemicals in foods, plastics and drinking water which could have 
an estrogen-like effect on our biology, causing everything from the alleged sud-
den upsurge in male infertility to breast cancer. Surprisingly, few have taken 
the time to point out that the chemical structure of many polyphenols (and 
thioflavin-T) share a resemblance with that of the two steroids implicated in 
the aging process: estrogen and DHEA (Figure 3.1, page 31). 
The decline in DHEA with age has been made into the explanation for ag-
ing, which one set of authors term "DHEA deficiency syndrome" [316]. The 
decline in DHEA levels has been implicated in a plethora of age-related dis-
eases. Most notably, the decline in DHEA and its sulfate, DHEAS, are linked to 
aging-related and disease-related immune system malfunction [317]. DHEA 
is also linked to several neurological illnesses for which supplementation has 
proven a reliable treatment [318]. Likewise, the decline in estrogen levels in 
post menopausal women has been reported as the primary risk factor for de-
mentia in women [319] and estrogen treatment has been beneficial in decreas-
ing this risk [320]. Could polyphenols be acting as DHEA or estrogen substi-
tutes? To properly explore this question we must remember that DHEA can be 
converted to estrogen in a three step processes catalyzed by 3p-hydroxysteroid 
dehydrogenase/isomerase, 17 ketosteroid reductase and P450 aromatase. All 
three enzymes are expressed in the CNS [321-323], chiefly the glia. DHEA 
may never reach neurons but its metabolites, particularly estrogen, may [324]. 
There is evidence that resveratrol can act as a mixed agonist/antagonist of 
the estrogen receptors a and p [325,326] as well as bind to the androgen recep-
tor [327], as can EGCG with a ICso of 0.4 11M [328]. Resveratrol inhibited estro-
gen receptor activity at only 0.1 mM (329], well within the range of the biologi-
cal concentration reported by Vingtdeux et al. [86]. Resveratrol induced stress 
resistance and MnSOD upregulation "Via estrogen receptor-p activation [330]. 
Blocking estrogen receptor-p activation prevented this effect while blocking 
estrogen receptor-a activation had no effect. Also, via the estrogen receptor, 
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activity and an increase in HO-l expression levels, protecting the rats against 
the effects of intestinal injury after trauma-hemorrhage [331]. Both MnSOD 
and HO-l upregulation are a response common to most polyphenols. Estro-
gen has also been shown to induce the expression of HSPs in brain arteries, glia 
and neurons the same way as polyphenols do [332]. 
It is thus unsurprising that specific binding sites have been observed for 
both resveratrol and EGCG (as well as other polyphenols) in both the skin 
and the brain [333, 334]. Resveratrol displayed a Kj of 102 nM and EGCG a 
Kj of 25-45 nM. EGCG has been observed to up-regulate ADAM 10 via ERa 
[335]. This EGCG upregulation of ADAM 10 promoted non-amyloidogenic 
processing of APP. Genistein prevented A~ induced inflammation in cultured 
astrocytes [336]. Estrogen had the same effect and both caused an increase 
in peroxisome proliferator activated receptor-y expression [336]. The anti-
inflammatory effect of estrogen in glial cells is mediated by RACKI [337], the 
same PKC scaffolding protein involved in DHEA decline related memory loss 
[75] and is necessary for the neuroprotective effect of resveratrol [338] and 
EGCG [339]. Quercetin has also been reported to exert effects via estrogen 
receptor-a [340]. 
Han et a1. [333] found that the resveratrol binding sites were widespread 
in the rat brain and enriched in the choriod plexus and subfomical organ. The 
choroid plexus, as well as being enriched for resveratrol binding sites, is also 
enriched for leptin receptors [341] (see section 3.3.2, page 46). Plasticity in the 
arcuate nucleus is determined by neurosteroid neuro-glial interaction [342]. 
This neuro-glia plasticity is dependent on polysialic acid rich NCAM expres-
sion which dietary restriction preserves into old age (166). Han et a1. [333] also 
point out that the choroid plexus secretes transthyretin8 which is believed to 
playa neuroprotective role [343]. Watanabe et a1. (344) has shown that Gingko 
biloba extracts were neuroprotective and up-regulated transthyretin mRNA. 
Estrogen has been shown to be neuroprotective and to exert this neuroprotec-
tion via glia [345, 346), such as the ependyma which line the choroid plexus. 
Several other studies implicate glia in playing a role in polyphenol-induced 
neuroprotection [248, 251, 347-350) and dietary restriction [166). 
DHEA, its biological functions and its binding partners are reviewed by 
Webb et a1. [351). As well as binding to estrogen receptors (activating them), 
it also leads to the activation of peroxisome proliferator activated receptor-a, 
though apparently not by direct binding. Webb et a1. [351) report that there 
are dedicated DHEA receptors in the brain, heart and other tissues; and that 
DHEA, at concentrations ranging from 0.010-10 JIM, activated these mem-
brane receptors and triggered kinase signaling cascades. Whether polyphenols 
can bind to these DHEA receptors and activate them remains to be determined. 
What is interesting is that DHEA is implicated in many aging-related diseases. 
DHEA and polyphenols both partake in a myriad of signaling cascades. 
Another class of compounds, triterpenoids (Figure 3.1, page 31), are also 
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worth considering in this review. The physiological effects of the triterpenoids 
oleanolic and ursolic acid are reviewed by [352]. These compounds can be ex-
tracted from the waxy cuticle of fruits of the genus Vaccinium (e.g. blueberries) 
[353] and grapes [354]. UrsoIic acid has been shown to protect neurons against 
excitotoxicity via the NMDA receptor [355]. The same has been reported of 
curcumin [356], EGCG [357] and resveratrol [358]. These compounds have 
been shown to exert the same effect on cancer growth and vascular function 
(the subject of the next Section) as polyphenols. 
The multipotency of neuroactive steroids and polyphenols with regards to 
cellular signaling and physiological outcomes, together with the conserved 
structure, suggest that polyphenols could exert many of their effects by di-
rectly modulating steroid associated signaling cascades. As regards estrogen 
signaling, they can modulate estrogen signaling at concentrations well within 
the physiological concentrations achieved by polyphenols. 
Studying the effects of resveratrol and other polyphenols on signaling cas-
cades in Nothobranchius would be difficult. While identifying antibodies to 
active/inactive forms of the various kinases and transcription factors may be 
possible this would be a time consuming and expensive research direction and 
falls outside the scope of this study. Nevertheless, the body of research al-
ready suggests that their should be an upregulation in certain proteins such 
as protein chaperones (Hsp70) and proteins associated with synaptic plastic-
ity (such as L1 which can be detected by the E587 antibody). If enough well 
characterized proteins can be identified it may be possible to nominate spe-
cific signaling cascades for further investigation. An important consideration 
to keep in mind is that the polyphenols may exert different affects not only 
in different cell types but cells of the same type in different locations may re-
spond differently. Merely dissecting out a brain and extracting the proteins 
to develop on Western Blots may not be sufficient to detect the small changes 
in activity which may occuri and small changes in activity can have large ef-
fects [206]. The use of microarrays could also be useful but one cannot simply 
equate a change in expression with a change in protein concentration nor infer 
a change in the flux through a particular pathway. 
The current data does suggest that glia would be affected by polyphenol-
treatment. This should be apparent both by means of microscopy (assessing 
glial numbers and morphology) and by measuring the levels of GFAP and its 
isoforms [26]. 
3.4 Vascular health and neurogensis 
The content of this section goes beyond the scope of the present study and is 
presented in brief because no review of the mechanisms of polyphenol neuro-
protection would be complete without it. 
Resveratrol and quercetin have been shown to cause changes in gene ex-
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which correlates well with resveratrol concentrations achieved in the rat brain 
[246] and is orders of magnitude below that achieved in human circulation 
[359]. Berry polyphenols have also been reported to reach plasma concentra-
tions well above 0.1 JlM [360]. The effects of polyphenols on vascular function 
and how these relate to vascular diseases (such as stroke and dementia) are 
reviewed by Ghosh & Scheepens [361] and West [362]. 
EGCG fed to aged guinea pigs at 30 mg/kg food/day for 28 days caused an 
improvement in vascular tone and sensitivity in addition to a decrease in ery-
throcyte malondialdehyde content and aggregation together with an improve-
ment in erythrocyte deformability and viscosity [363]. This resulted in better 
oxygen supply and exchange rates. 15 days of high-polyphenol content dark 
chocolate (which is rich in chalcones and catechins) caused a reduction in blood 
pressure in glucose-intolerant hypertensive patients (as well as improved in-
sulin sensitivity) [364]. Cranberry juice administered to patients with coro-
nary artery disease resulted in a decrease in arterial stiffness [365]. Blueberries 
were also shown to improve vascular sensitivity [366] and tone [269] in both 
physiologically normal Sprague-Dawley and spontaneously hypertensive rats 
[367]. In other experiments on spontaneously hypertensive rats resveratrol 
prevented endothelial NOS uncoupling and the development of hypertension 
[89]. This uncoupling of NOS was attributed to S6K hyperactivity in endothe-
lial cells and resveratrol or rapamycin treatment inhibited this hyperactivity 
[88]. Genistein improved NO bioavailability in aged Wistar rats [255] sug-
gesting NO availability as one means by which polyphenols improve vascular 
function. This hypothesis is reviewed by Schewe et al. [368). EGCG was shown 
to act through AMPK to inhibit the mTOR/S6K pathway [94, 267, 369). 
Grape wine procyanidins have been linked to vascular health [370] and 
have been experimentally shown to improve the endothelium-dependent di-
lation of rat cerebral arterioles [371]. Other research shows that grape 
polyphenols do not affect vascular function in healthy men [372) im-
plying that polyphenols do not disturb healthy physiological function. 
45 mg/kg mouse/day resveratrol was able to regulate pathological angiogen-
sis in mice and this was independent of sirtuin activity [373). While blueberry 
supplementation did not affect vascularization of rat neural transplants it did 
improve graft growth and the efficiency of the blood-brain barrier [374] sug-
gesting that there is more to the effects of polyphenols on the vasculature than 
improving vascular tone. 
Ghosh & Scheepens [361] discusses the link between proper vascular func-
tion and stem cell maintenance. Resveratrol has been reported to reduce en-
dothelial progenitor cell senescence [375] and rats fed resveratrol showed in-
creased neurogensis [286]. Compound P7C3 has been shown to be proneuro-
genic as well as neuroprotective [376]. Interestingly, it also has a polyphenol-
like structure and was active at very low concentrations. No data is available 
pertaining to how it affects the vascular system. 
Whether polyphenols are having a direct effect on quiescent stem cells is 
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to 251'M resveratrol was necessary [375J. Stem cells are sensitive to oxygen 
supply and nutrient availability and their neurological niches are tightly as-
sociated with blood supply [377J. Regular exercise improves CNS blood flow 
and oxygen supply and has also been shown to increase neurogenesis [378J. 
Furthermore, alleles positively associated with cardiovascular health are more 
frequent in long-lived human popUlations [379, 380J suggesting that main-
taining vascular health may be all that is needed to ensure health into old age. 
Polyphenols have been demonstrated to improve vascular function. This pro-
vides a simple mechanism whereby they can benefit multiple systems at low 
doses and increase healthspan. 
3.5 Conclusions 
The Direct Antioxidant Hypothesis of polyphenol action, while not impos-
sible under certain circumstances, fails to explain the multipotent effects of 
polyphenols. Furthermore, given the simplicity of the phytoestrogen activity 
and its affect on the vascular system at physiological polyphenol doses the Di-
rect Antioxidant Hypothesis is also unnecessary. The bioactive and structural 
similarities between polyphenols and steroids is something which cannot be 
ignored. Polyphenols certainly exert effects via estrogen-mimic activities. The 
concept of polyphenols acting as hormetics which prime the organism's stress 
responses is a viable general explanation of the diverse actions of polyphenols. 
As mentioned in the above section exercise (which is also a hormetic inter-
vention) protects the cardiovascular system as well as being neuroprotective 
and neurogenerative. There is evidence for polyphenols not only remediat-
ing vascular problems associated with disease and old age, but that they act 
via signaling pathways implicated in lifespan regulation as were discussed in 
Section 3.3. Evidence for polyphenols binding to specific sites of receptors as 
well as interrupting ~-sheets has also been diSCussed suggesting that polyphe-
nols could trigger stress reactions by upsetting signaling cascades or by initi-
ating them. Returning to hormesis, the inhibition of ATP synthase could be 
the trigger needed to activate AMPK whose activity is linked to the beneficial 
outcomes of polyphenol-treatment. Certainly the inhibition of ATPases would 
cause chaos in the cell. 
As the same polyphenol can have multiple effects there cannot be one 
mechanism of polyphenol neuroprotection. As natural products, such a blue-
berries, contain mUltiple polyphenols there can be many different polyphe-
nols affecting multiple pathways which can work synergistically. Many of the 
pathways converge onto common end effectors with common outcomes. While 
many individual polyphenols may have overlapping effects there is evidence 
that different polyphenol mixes can have different effects [258 J which together 
can effect a common beneficial outcome. Joseph et al. [258J suggest that the 
naturally derived mix of polyphenols are more effective than the individual 
components. 
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search. In simplifying the system to a single polyphenol acting on a single cell 
type or even single protein it is inevitable that incorrect or misleading conclu-
sions will be drawn. While high doses are needed to elicit beneficial effects in 
culture much smaller doses are needed to elicit beneficial effects in situ (such 
as on the vascular system) which can have beneficial knock-on effects which 
are missed in reductionist experimental methods. What is morej reductionist 
methodologies neglect that these polyphenols are extensively metabolized in 
situ and mostly absorbed as conjugates [359]. As such, the beneficial effects 
can be missed in experiments using the basic compound when the beneficial 
effects are caused by or enhanced by the conjugates. There is evidence that glu-
coside and other conjugated stilbenes are more effective than the unconjugated 
analogues [221]. 
Only whole-animal experiments with an animal exposed to healthspan-risk 
and low levels of polyphenols in its normal diet, combined with a broad anal-
ysis of the whole organism, can accurately determine the efficacy of any single 
polyphenol. While such a methodology may preclude ultimate explanation of 
polyphenol action it would at least present an accurate reflection of the pa-
tency of the polyphenol or polyphenol mixture which reductionist methods 
cannot deliver. 
The current research into polyphenol neuroprotection allows for the gen-
eration of several hypotheses which can be assayed using the antibodies intro-
duced in Chapter 1. These have been mentioned in the course of this chap-
ter. These hypotheses are that resveratrol would preserve healthy neurons into 
old age while eliminating degenerate neurons. This can be assayed using the 
SMI31 antibody. Resveratrol should cause the retention of proteins associated 
with cognitive function into old age. One such protein is Ll which can be 
monitored using the E587 antiserum. The literature also suggests that glial 
function should be maintained into old age. Using the anti-TNR and GFAP 
antibodies it is possible to quantify the numbers of astroglia and PNNs and 
their morphology. Assuming that gliosis is indeed detrimental then it would 
be expected for resveratrol-treatment to prevent gliosis. It is also expected that 
there should be a preservation of protein processing and homeodynamics. This 
can be assayed using GFAP antibodies as by Sloane et a1. [lOll and Korolainen 











Antibody markers for studying 
neurodegeneration in the 
Nothobranchius central 
nervous system 
And I heard, as it were the noise of thunder, 
one of the four beasts saying, Come and see. 
And I saw, 
And behold ... 
The man comes around, Johnny Cash 
This chapter was published in the Journal of Cytology & Histology, 2:1000120, 2011, 
reference [382]. The abstract of the article is not included here. 
4.1 Introduction 
Fish of the genus Nothobranchius, Peters, 1844 have a naturally short lifespan 
in which they develop several neurological biomarkers of aging [3]. Due to its 
short average lifespan of eight weeks (compared to three to five years for other 
vertebrate models) Nothobranchius furzeri is an excellent model organism for 
aging research. The aging of N. furzeri Jubb, 1971 progressed with an accu-
mulation of lipofuscin and senescence associated p-galactosidase expression 
[3,10] as well as a decline in operant learning and muscle strength which were 
correlated with neurodegeneration [5, 6, 10]. These age-related phenomena 
were retarded by resveratrol-treatment [5]. Further research of the neuropro-
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hampered by the lack of cell-type specific antibodies and other cellular mark-
ers of degenerative processes. Such markers are also needed to render results 
obtained in Nothobranchius comparable to other organisms for the elucidation 
of general mechanisms of aging and neuroprotection. 
For our study frozen sections of N. guentheri were prepared on which to 
test the antibodies and lectin. We focused our research on the visual system as 
this is well characterized in fish and was the focus of Valenzano et al. [5]. We 
assembled a toolbox of markers to study the aging of the Nothobranchius eNS 
by testing eNS markers of development, regeneration and degeneration which 
have been used on other species. Of ten antibodies tested, the five mentioned 
below displayed useful reactivity in N. guentheri. 
The SMI31 antibody recognizes phosphorylated neurofilament protein in 
neurons, axons, dendrites and neurofibrillary tangles (NFTs) in sections in a 
diverse array of species. Its accumulation in degenerate neurons is well doc-
umented [66, 67]. Glial fibrillary acid protein (GFAP), expressed by astroglia, 
is upregulated following CNS injury and in the process of neurodegeneration 
[119]. This pathological upregulation is typical of several model organisms 
making the availability of a GFAP antibody important to Nothobranchius ag-
ing research. 
L1 is a glycoprotein neural recognition molecule of the CAM-
immunoglobin supedamily related to NCAM [158] which has evolved from 
a family of evolutionary well conserved proteins [383]. It is expressed byas-
trocytes, oligodendrocytes and growing axons in zebrafish, and is involved in 
development, regeneration, plasticity and maintaining synaptic contact[123, 
158,163,383]. It has also been implicated in neurodegeneration through the 
work of Strekova et a1. [47]. 
Tenascin-R (TNR) is a matrix glycoprotein expressed by oligodendrocytes 
and is implicated in eNS regeneration and axonal path-finding [123, 384]. 
It has been reported to act as a barrier to microglial migration in tissue cul-
ture experiments [385] and plays what is thought to be a neuroprotective role. 
However, no such microglial repulsion effect was observed in the lizard species 
Gallotia galloti [384]. TNR is associated with lipid rafts where they form a 
scaffold for signaling proteins such as integrins [148]. Disruption of integrin 
signaling is linked with impaired neurogenesis [112, 386] and inhibition of 
apoptosis of degenerate neurons [118]. TNR appears to be linked to many 
facets of eNS development, maintenance and degeneration (as well as regen-
eration) but is largely unexplored in these regards. 
Microglia are involved in eNS inflammation, after insult, and in the course 
of neurodegeneration [105,119,291]. Kim et a1. [27] demonstrated an increase 
in microglial proliferation in mice in the course of normal aging and after eNS 
insult, as well as a relative decrease in aging associated proliferation with calo-
rie restriction, using BS-I Isolectin B4 (also called GS-I isolectin B4). The role 
of microglia in degeneration is still disputed and it would be useful to know 
if and how resveratrol and other anti-aging interventions affect them during 
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role in vitro by inhibiting neuroinflammation [291, 387]. The availability of a 
Nothobranchius microglial marker would enable us to test this hypothesis in 
situ using Nothobranchius. 
Immunohistochemistry studies on sections show that these cellular probes 
reliably label specific cell types in the Nothobranchius CNS. This was sup-
ported by Western Blots which yielded similar banding patterns to other 
species using the aforementioned antibodies. These results enable research 
at the cellular level into neurodegeneration and resveratrol induced neuropro-
tection in Nothobranchius. 
4.2 Methods and materials 
4.2.1 Captive maintenance of N. guentheri 
N. guentheri were obtained from Mr. O. Schmidt of Bishops Court, Cape Town, 
South Africa and maintained as per N. furzeri [388]. Fish were fed twice per 
day for six days and fasted one day per week. A 50% water change was per-
formed weekly. Water for the water changes was prepared before the time 
using 15 g iodated coarse salt, 2 g MgS04' and 2 g KHC03 per 20 L and then 
filtered over limestone to compensate for the soft municipal tap water and its 
unstable pH. Fish were maintained in accordance with ethical standards of 
animal care. 
4.2.2 Buffers 
All dry chemicals, unless otherwise noted, were obtained from Merck. 
The protein extraction buffer (pH 7.2) was composed of 0.1 M TRIS, 
1% Nonidet P-40 substitute (Sigma, 74385), 0.01% sos, 1 Jlg/mL Aprotinin 
(Roche, 10236624001) and 0.1 JIM PMSF (Sigma P7626) (from a 0.1 M stock 
prepared in isopropanol). The buffer was chilled to 4 DC before use. 
Phosphate buffed saline (PBS) solution consisted of 140 mM NaCl, 2.7 mM 
KCl, 8.8 mM Na2HP04 and 1.47 mM KH2P04 (pH 7.4). For Western Blots 
500 JlL of Tween (Sigma P1379) was added per L to produce the PBS-To 
A TRIS buffered saline buffer (TBS) was employed for microglial staining 
with isolectin: 50mM TRIS, 150mM NaCl, 20mM MgCl and 10mM CaCl2 
(pH 7.4). Blocking solution consisted of 1 % BSA (Roche, 735078) in PBS or 
TBS. A 5% milk solution in PBS was used as blocking solution for Western 
Blots. 
SOS-PAGE gels were prepared as per Current Protocols [389]. 
Tank buffer for SOS-PAGE was made up of 3 g TRIS together with 14.4 g 
glycine and 10 mL 10% SOS to 1 L with mQH20. Transfer buffer was com-
posed of 44 mM TRIS, 182 mM glycine and 200 mL methanol diluted to 1 L 
with mQH20. 5x loading dye was prepared from 4 mL 10% SDS mixed to-
gether with 2 mL 100% glycerol, 1 mL ~-mercaptoethanol, 2.5 mL 0.5 M TRIS 
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Anti-fade mowiol mounting medium was prepared by adding 2.4 g mowiol 
(Farbwerker Hoescht, Frankfurt Germany) to 6 mL glycerol, left to stir until 
completely dissolved whereafter 6 mL mQH20 was added. To this, 12 mL 0.2 
M TRIS (pH 8.5) was added. The solution was incubated for 1 hour at 50 0 e and 
then centrifuged at 12 000 xg for five minutes. The supernatant was collected 
and stored at -20 oe. For use. an aliquot was thawed to room temperature and 
a spatula tip of n-propyl gallate (Sigma, P3130) was added. the aliquot vigor-
ously shaken, left to stand overnight at 4°e and then centrifuged at 12 000 xg 
for five minutes. The anti-fade mowiol was stored at 4°C. 
4.2.3 Dissection and preparation of tissue samples 
Fish were sacrificed and the tissue dissected in cold PBS as discussed in [5]. 
The lenses were removed following which the cranial bones were pried apart 
and the brain (with eyes attached) placed into 4°e PBS and then into tissue 
freezing medium (Jung. 020108926) and left to stand on ice for 30 minutes to 
dehydrate the brain prior to freezing at -80°C. 
For protein extraction. the eyes were severed from the optic nerve and the 
spinal cord severed from the brain below the cranial nerves and then placed 
into an eppendorf test tube containing 200 /lL protein extraction buffer. The 
tissue was homogenized and then centrifuged and the debris discarded. Pro-
tein samples were aliquoted and stored at -80 oe. 
4.2.4 Histochemical staining 
For wax mounting and sectioning whole fish were fixed in Bouin's Solution 
[390] and sectioned at 5/lm. Sections were stained with Kluver & Barrera 
Luxol Fast Blue/Cresyl Violet. All techniques, fixatives and stains prepared as 
in Bancroft & Gamble [391]. 
4.2.5 Immunohistochemistry of brain sections 
Frozen brains with attached eyes were sectioned at 20 /lm (for confocal analy-
sis) at -20 °e in a cryostat and sections 1 fixed to APTES coated slides. 
Sections were permeabilized in -20oe methanol for 10 minutes and then 
given three washes in PBS. Sections where then incubated for one hour in 
blocking solution and then overnight at 4°e in blocking solution with primary 
antibodies2• Antibody dilutions are summarized in Table 4.1. After incuba-
tion with primaries, the sections were washed three times in PBS and then 
incubated for 90 minutes at room temperature in the dark with anti-rabbit 
1 Transverse sections were cut through the ON and OT. Due to difficulty in orientating the small 
brain in tissue freezing medium and it shifting during freezing this ideal tissue orientation was 
rarely obtained. 
2 As negative controls sections were incubated with primary excluding secondary and without 
primary but including secondary. No-unspecific binding was observed with respect to the secon-
daries (data not shown). Preahsorption of the primary with the antigen was not feasible on account 
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Alexa 488 (Molecular Probes, Invitrogen) and anti-mouse Cy3 (Jackson Im-
muno Research) (each diluted 1:1500). After secondary incubation, sections 
were washed in PBS and then mounted in anti-fade mowiol. 
For biotinylated lectin staining, endogenous biotin was blocked for one 
hour at room temperature with DAKO Vector-Stain kit avidin-DH (Vectastain, 
PIC6100) added to TBS with 1% BSA according to the manufacturers specifi-
cations whereafter the slides were rinsed in TBS and incubated in 0.1 mg/mL 
biotin (Sigma, B4501) for 15 minutes and then washed in TBS. After washing, 
the BS-I isolectin B4 (Sigma, L3140) was incubated overnight on the sections 
at 1:60 dilution of 1 mg/mL isolectin solution into a TBS blocking solution of 
0.1 mg/mL biotin and 1 % BSA. After incubation, the sections were washed and 
incubated under streptavidin-Alexa 488 (Sigma) diluted 1:500 in TBS block-
ing solution for 90 minutes; and then washed and incubated under 0.5 pg/mL 
DAPI for 10 minutes before being washed and mounted in anti-fade mowio!. 
4.2.6 SDS-PAGE and westem blotting 
Protein determinations of homogenates were done using the Pierce BCA pro-
tein assay (Pierce, 23225). Samples were read at 695 nm on a Kayto RT-2100C 
microplate reader. 
Protein samples were incubated at 95°C in loading dye for two minutes. 
Samples which were to be incubated with E587, anti-TNR were incubated at 
95°C in a loading dye without p-mercaptoethanol. For the E587, TNR and 
Table 4.1: Antibodies used in this study along with dilutions and reactivity results. 
Antibodies which were not reactive on IHe sections were not tested against Western 
Blots. 
Antibody 
Immunohistochemistry Westem Blots 
dilution reactivity dilution reactivity 
E578 anti-Ll t 1: 2000 yes 1: 2000 yes 
GA-S mab antiGFAP (Sigma G6171) 1: 2000 yes 1: 2000 yes 
rabbit anti-bovine GFAP (DAKO Z0334) 1: 2000 yes 1: 2000 yes 
SMI31 (Covance SMI-31 OR) 1 :400 yes 1: 1000 yes 
mab anti-rat TNR* 1 :400 yes 1 :400 yes 
rabbit anti-mouse S100 (Sigma S2644) 1: 1000 inconsistent 1: 1000 no 
anti-Integrin fl1 (Sigma SAB4501582) 1: 200 no N/A N/A 
rat anti-mouse MBP§ 1: 20 no N/A N/A 
anti-zebrafish TAG' 1: 200 no N/A N/A 
anti-mouse fl-tubulin (Covance PRB-435P) 1: 1000 no N/A N/A 
f Gift from C. Stuermer, Konstanz Germany. 
t Gift from P. Persheva, Bonn Germany. 
§ Gift from C. Linington. Munich Germany. 
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SMl31 blots, 20 pg protein was loaded onto a 7.5% SOS-PAGE gel (acrylamide, 
Sigma, A3574). For the GFAP blots, 5pg protein was loaded onto 12% SOS-
PAGE gels. pQGold IV protein marker (pQLab, 27-2116) was used. Elec-
trophoresed protein was transferred to Amersham Hybond-ECL (General Elec-
tric) paper using transfer buffer at 100 V for one hour. 
The blot was blocked for one hour in 5% commercial milk powder in PBS-T 
buffer whereafter the primary antibody was added together with 5% milk in 
PB8-T and incubated overnight at 4°C. Antibody dilutions are summarized 
in Table 4.1. The blot was washed four times in PBS-T and then the secondary 
antibodies were added: goat anti-rabbit-HRP (Biorad, 170-6515) and goat anti-
mouse-HRP (Biorad, 170-6516) at 1:1500 dilution for 60 minutes. For autora-
diograph visualization the blot was washed four times in PBS-T and then Su-
perSignal West Pico Chemiluminescent reagent (Pierce, 34080) was applied. 
Alternatively the blots were developed using a metal intensified OAB protocol 
based on Adams [392]. 
Sizes were calculated using a linear regression of a graph of molecular mass 
(kOa) vs the log of the migration distance (in millimeters) through the gel. The 
largest marker band was 170 kOa and the smallest 5 kOa. 
4.2.7 Microscopy 
Images were obtained using a Zeiss Confocal microscope (Jena. Germany). Im-
ages are representative of several specimens and were edited for publication 
using Adobe Photoshop CS2 v9.0.2. 
4.3 Results and discussion 
4.3.1 Results of SM.31 and antl .. GFAP labeling 
Figure 4.1 shows a luxul fast bluel cresyl violet stain of an 5 pm optic tectum 
(OT) section of N. 8uentheri and serves as reference for the below text3• 
It is expected that the SMI31 and rabbit anti-GFAP antibodies would label 
nerve fibers and astroglial-like structures (radial glia in particular as is typical 
for fish) respectively. 
Figure 4.2 shows a section through the optic nerve (ON). The nerve is 
filled with SMI31 immunoreactive nerve fibers as well as large anti-GFAP 
immunoreactive glial processes. Signals do not colocalize. Figure 4.3A-G 
show a strong anti-GFAP immunoreactive layer corresponding with the stra-
tum zonale (SZ, see Figure 4.1 in reference to OT layers) which is lined with 
radial glial cell bodies. This layer stretches into the stratum opticum (SO). 
There is also strong anti-GFAP reactivity in the stratum griseum periventricu-
lare (5GPV) as would be expected for radial gIla. The 5MI31 signal is seen in 
five discrete zones: 51 the stratum griseum superficiale (SGS) and SO; 52 the 
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upper stratum. griseum intermediale (uSGI); S3 the stratum griseum. interme-
diale (SGI); S4 the stratum album. intermediale (SAl); and S5 the SGPV which 
are composed mostly of axon fibers and dendritic projections as shown for 
goldfish [394]. SMI31 and anti-GFAP signal colocalize in cage-like structures 
in the SGS which are enlarged in Figures 4.3D-G. SMI31 signal was observed 
in both one week old fry (data not shown) and aged fish. In Nothobranchius 
species the epitope targeted by SMI31 may be present on neurofilament re-
gardless of age and degenerative state as has been demonstrated by Lee et a!. 
[395] in rats. 
The SMI31 Western Blot(Figure 4.4) showed bands in the rat lane of ap-
proximately 226 and 155 kDa which corresponds with the predicted masses 
of the phosphorylated heavy and medium isoforms [66, 396]. This antibody 
produces a single band of ~120 kDa in the zebrafish lane. Two bands are visi-
ble in the N. guentheri lane. These are approximately 114 and 134 kDa. With 
extended development a third band of ~123 kDa became visible, which ulti-
mately developed into a smear from 114 to 134 kDa. This mUltiple banding 
is typical of phosphorylated neurofilaments [67]. The size of the N. guentheri 
SMI31 immunoreactive bands and those of the mammalian medium chains, 
which range from 110 to 145 kDa, are coincidentaL The lamprey neurofila-
ment proteins range from 180 kDa to 50 kDa, with one neurofilament being 
132 kDa [397]. The SMI31 antibody merely recognizes the same evolutionary 
conserved tyrosine-phosphorylation motif common to phosphorylated neuro-
filaments [398]. No smaller SMI31 reactive bands were observed 
The rabbit anti-cow GFAP antibody reacted with the homogenates to reveal 
several bands in each lane (rGFAP, Figure 4.4). Two bands were detected in the 
rat lane, the major band being ::=:52 kDa, the other close to 70 kDa, possibly 
corresponding with neurofilament L which polyclonal GFAP antibodies are 
known to cross-react with [399]. A 50 kDa band is detected in the zebrafish 
lane with additional larger bands. Five bands are visible in the N. guentheri 
lane: the major band is ~55 kDa (and appears to be a smear of two very similar 
sized bands), the two smaller bands are 45 and 51 kDa. One of the larger bands 
is ::=:61 kDa and the other ~69 kDa. 
The polyclonal GFAP antibody used by the authors, Z0334 from DAKO, 
was used by Korolainen et al. [381] against aged and demented brain sam-
ples and also yielded a mUltiple banding pattern with a major band at 50 kDa 
and several smaller bands down to 35 kDa. The bands were confirmed to be 
GFAP and its post translational products by means of HPLC-ESI-MS/MS. This 
multiple banding pattern was observed for rainbow trout brain homogenates 
where a polyclonal anti-goldfish GFAP antibody was used [400]. However, 
trout astroglia grown in culture only produced a prominent band at 51 kDa 
suggesting that in fish, as in mammals, there is Significant post-translational 
modification (as well as oxidation and degradation) of GFAP in the intact eNS 
in addition to multiple isoforms being expressed. It is known that the GFAPE 
isoform is post-translationally modified by presenilin proteins [169]. The mul-
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outcome of using GFAP antibodies against brain homogenates. To obtain a 
solitary ~50 kDa band would be extraordinary against a brain homogenate. 
The neurofilament tyrosine-phosphorylation motif is common to GFAP and 
nuclear lamin [398] but SMI31 does not cross-react with other proteins on the 
blots. However, the polyclonal anti-GFAP does cross-react with proteins of 
approximately 61, 69 and 114 kDa as predicted from [398, 401]. Middledorp 
et a1. [399] observed GFAP expression in degenerating neurons in culture us-
ing the Z0334 polyclonal GFAP antibody. This antibody was reacting against 
neurofilament L, a ~68 kDa protein in humans. They hypothesize that the 
inclusion of neurofilament L into NFTs renders it susceptible to recognition 
by GFAP antibodies. On Western Blots using the GA-5 and Z0334 antibod-
ies bands of 61 and 69 kDa are detected and the neurofilament L gene which 
has been cloned from the lamprey [397] is shown to share 44% amino acid 
sequence homology with the human neurofilament L and have an apparent 
molecular mass of 64 kDa. Nuclear lamins are ~ 70 kDa but as the structures 
in Figure 4.3F occur outside of the nucleus it is unlikely to be cross reactivity 
with lamins but with the neurofilament L. An alternative explanation is that 
of ghost tangles. These are extracellular NFTs which are insoluble debris from 
degenerate neurons and have also been observed to be GFAP positive remains 
of astrocytic processes into the NFTs [120]. These ghost tangles do take on a 
cage-like appearance in sections. 
As the SMI31 antibody did not cross react with neurofilament L on the blot 
the structures whereSMI31 and polyclonal GFAP colocalize must also include 
the 114-132 kDa neurofilament proteins. Whether the GFAP signal in Figure 
4.3F is the product of Z0334 reactivity against neurofilament L in NFTs or 
GFAP in ghost tangles remains to be determined. Research is underway to 
determine if the frequency of these cage-like structures can be correlated with 
age and the incidence and location of tangles and plaques in the OT of N. 
guentheri4• 
4.3.2 Results of GA-5 antl·GFAP and E587 labeling 
We expect the E587 antiserum to colabel astroglia in the ON and OT as well 
as to label neurons and nerve fibers independently of the GA-5 monoclonal 
anti-GFAP antibody. 
Figure 4.5 shows strong colocalization between E587 and GA-5 antibodies 
and the structures are consistent with those of astrocytic projections through 
the ON. In. Figure 4.6 there is colocalization between E587 and GA-5 antibod-
ies, both in the SZ and in radial glial-like structures which span the OT. The 
E587 signal is distributed through six distinct layers (Figure 4.6D): the SZ, SO, 
uSGI, SGI, SAl and SGPV. These results are consistent with the expected pat-
tern of L1 distribution through the OT. Some large E587 cell bodies are visible 
in the OT (arrow head, Figure 4.6F). 
4After publication of this article the quantification of the cage-like structures was suspended 
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The anti-human GFAP antibody, clone GA-5, reveals one band at ::::52 kDa 
for the rat brain homogenate (Figure 4.4). Zebrafish brain homogenate reacts 
with GA-5 to reveal two major proteins of approximately 43 kDa and 50 kDa 
in size. For N. guentheri there are five bands: a major band at 55 kDa paired 
with a smaller one of about 51 kDai and another major band at ::::43 kDa to-
gether with two less prominent larger bands of approximately 45 and 48 kDa. 
The GA-5 clone is known to give the observed banding pattern, as can be seen 
for the Santa Cruz GA-5 antibody (sc-58766) [402], but still reliably labels as-
troglia only [398, 403]. Similarly, the JI-31 clone also gives a multiple banding 
pattern against whole brain homogenates but also reliably labels only astro-
cytes [401]. Garcia eta1. (40 I] attribute this multiple banding pattern to phos-
phorylation and degradation of GFAP. With longer exposure other bands man-
ifested in all lanes when using both the rabbit anti-GFAP and GA-5 antibodies 
(data not shown). For all species, using the GFAP antibodies, bands appear 
between the 100 and 130 kDa. These could be the product of cross-reactivity 
between GFAP antibodies and neurofilaments. 
The human L1 is 220 kDa and is cleaved at multiple sites by several differ-
ent enzymes [47,404]. The 220 kDa protein is cleaved into a membrane bound 
C-terminal fragment of 80 kDa and a soluble 140 (by plasmin) or 180 kDa frag-
ment (by neuropsin). Cleavage by ADAMI 0 and 17 as well as y-secretase re-
sults in a 28-32 kDa membrane bound fragment and a ~200 kDa soluble frag-
ment [159]. The concentration of the large soluble fragments in patients with 
dementia have been observed to increase compared to age-matched controls 
[47]. This array of post-translational modifications could generate an eight 
band pattern on a blot using a polyclonal serum. The mUltiple banding pat-
terns shown in Figure 4.4 is expected for a protein which undergoes such ex-
tensive post-translational modification in addition to glycosylation. 
The E587 antiserum detected bands of approximately 269, 238, 157, 125 
and 85 kDa in the rat lane (bands RI-R5). Based on the human pattern 
a ::::30 kDa was expected but could not be resolved on the 7.5% gel. The 
band sizes which do arise are within the expected range for mammalian Ll 
[47,159,404] based on the errors associated with bands larger than 170 kDa. 
Bands of 190, 120 and 70 kDa are expected for E578 against zebrafish [164]. 
The authors, using a metal intensified DAB developed blot, demonstrate bands 
of 199, 125 and 97 kDa (ZI, 2 & 4 respectively, Figure 4.4) in addition to sev-
eral other bands. The observed differences to Weiland et al. [164] could be due 
to differences in the origin of our zebrafish (an outbred aquarium strain) or 
the limits of the chemiluminescent method employed by Weiland et a1. [164] 
which is prone to over-develop some bands at the expense of other bands. Z4, 
5 & 6, of molecular masses 97, 52 and 42 kDa sum to 199 kDa which is the 
same size obtained for Zl. Similarly the three smallest visible bands in the 
N. guentheri lane, N4, 5 & 6 (68,60 & 48 kDa), sum to 176 kDa which is the 
same size as Nl. The E587 antibody is producing a similar banding pattern 
against the rat, zebrafish and N. guentheri brain samples. The observed differ-
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in post-translational modification of the full length protein as well a differ-
ences in total length. E587 is probably reacting against a structurally similar 
protein in each sampleS. 
4.3.3 Results of SMI31 and E587 labeling 
SMI31 and E587 signal is expected to colocalize in dendrites and in some axons 
fibers. E587 is also expected to label neurons. Figure 4.7 shows SMI31 signal 
in axon fibers in the ON as per Figure 4.2. Fibers are predominantly SMI31 
positive but there is also strong E587 signal in some axons. E587 signal is 
also present in the astroglial projections in the ON as seen in Figure 4.5. The 
colocalization between SMI31 and E587 immunoreactivity in Figure 4.7 could 
be due to upregulation during axon extension and then down-regulation once 
the connection with the target neuron is established in accordance with its role 
in axon guidance [123, 405, 406]. 
Figure 4.8 shows five SMI31 positive layers in the OT as well as five of the 
six E587 layers seen in Figure 4.6. Layers L2-L6 and SI-55 overlap (Figure 
4.8d) and correspond with the SGS/SO, uSGI, SGI, SAl and SGPV. A complex 
of SMI31 and E587 positive fibers in the SGS/SO where fibers from the ON are 
expected to synapse with neurons in the SGS are visible in Figure 4.8E. The 
neurons of the SGS synapse with neurons in the uSGI and SGI. These fibers 
are strongly positive for both SMI31 and E587. These neurons synapse with 
neurons in the uSGI and SGI. These fibers are strongly positive for both SMI31 
and E587 and are most likely dendrites expressing Ll in regard to Ll's role in 
plasticity. In addition, the E587 antiserum also labels large cell bodies in the 
OT. 
4.3.4 Results of antl-TNR and E587 labeling 
Figure 4.9A-C shows anti-TNR signal restricted to the myelin layers of the 
ON, with no colocalization with the E587 signal which labels astroglia and 
nerve fibers. Figure 4.90-F show the anti-TNR signal ordered over four layers 
corresponding with the SO (Tl); uSGI (T2); SGI (T3); and SAl (T4) into the 
SGPV. These layers appear broader than the corresponding E587 layers and 
each layer fades in the direction of inner layers of the OT. Figure 4.9G-I shows 
that anti-TNR signal is localized to small cellular bodies. This punctate pattern 
of anti-TNR staining is unlike that of astroglial, neuronal or axonal labeling by 
the other antibodies. As expected, the anti-TNR antibody labels the myelinated 
nerve fiber tracts in the OT. 
E587 labelled oligodendrocytes in the goldfish [406] though it did not colo-
calize with TNR in N. guentheri. It may be that N. guentheri oligodendrocytes 
SSee Appendix A.2.3.1 for further discussion with additional antibodies which were obtained 
after publication in an effort to resolve this question. The £S87 antiserum is almost certainly 
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either do not express L1 at all or do not express an L1 recognizable by E587. It 
has been reported that glia and neurons express different forms of L1 [407]. 
The anti-TNR antibody produced three bands for the rat but only one for 
N. guentheri and zebrafish (Figure 4.4). These proteins are glycosylated in situ 
and as such the determinations of molecular masses by Western Blotare unre-
liable. Also, all prominent bands (except one of the rat bands) fall outside of 
the marker band range. Mammalian TNR has a molecular size of 160-180 kDa 
and can form dimers and trimers [408, 409]. Only the ~165 kDa band falls 
within the marker range of the Western Blotand is of the expected size. The 
TNR antibody does not cross react with smaller proteins on the blot indicating 
high specificity. The fish anti-TNR reactive proteins did not migrate into the 
resolving gel and appears to be of similar size to the band at the top of the 
rat lane. No cross-reactivity with other proteins was observed in the Notho-
branchius lane. The Western Blotdata together with the IHC data provides no 
evidence to suppose that the TNR antibody is not labeling TNR in N. guentheri 
tissues. 
4.3.5 Results of labeling with BS-I lsolectln B4 
Figure 4.10A-C is of the ON containing microglia labelled with isolectin and 
DAPI. Figure 4.10D-F are enlargements of the microglia indicated in A-C. 
These show the typical microglial form. Unexpectedly, the same sections 
used to observe microglia in the ON showed no microglia in the OT (data not 
shown). Within the OT the BS-I isolectin did bind to the cell walls of blood ves-
sels confirming that the lectin was present over that part of the tissue section 
during the incubation step. The absence of BS-I isolectin positive microglia in 
the OT was unexpected. However, the possibility exists that there are microglia 
present in the OT but that they are not labelled by BS-I isolectin. 
There is no evidence thus far that TNR is repulsive of Nothobranchius mi-
croglia. 
4.3.6 Other antibodies tested 
Five other antibodies were tested on N. guentheri sections but found to be 
inactive or inconsistent (results not shown). These are summarized in Table 
4.1. The inactivity of the MBP antibody was surprising as it has been effective 
against goldfish, Xenopus, Gallotia galloti and rodents in our laboratory. The 
~-tubulin antibody has also been ineffective against zebrafish. The ineffective-
ness of the TAG and integrin antibodies suggest that these proteins may be 
too evolutionary diverse in nature to be generally useful. Strong s 1 OOB stain-
ing was obtained in one cohort of aged N. guentheri but was totally absent 
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4.4 Conclusions 
The Nothobranchius research community now has available to it antibod-
ies against nerve fibers (SMI31), astroglia6 (anti-GFAP) and oligodendrocytes 
(anti-TNRf in addition to the E587 antiserum which labels young axons and 
radial glial fibers, and the BS-I Isolectin which labels ON and retinal microglia. 
SMI31 was consistent with expectations of neurofilament distribution in 
neuronal tissues. Together with the data from the Western Blots we find no 
evidence to believe that the SMI31 is not targeting neurofilament protein in N. 
guentheri and is a reliable label ofaxons and dendrites. 
Some uncertainty exists as to the fidelity of E587 and GFAP antibodies. The 
combination of IHC and Western Blotdata indicate that the E587 antiserum is 
labeling an Ll-like protein or proteins in N. guentheri. We cannot exclude 
that the E587 antiserum is not detecting other NCAMs in addition to Ll (such 
as CHLl, a 185 kDa protein in mammals), but if it is unreliable for detecting 
L1 in rat and N. guentheri brain homogenates then our blots reveal that it is 
equally unreliable for zebrafish as several additional bands developed on our 
blot compared to that published by Weiland et al. [164). If the structures in 
Figure 4.3F prove to be neurodegenerative features then the reactivity of the 
polyclonal GFAP would be consistent with expectations based on the litera-
ture. Both GFAP antibodies reliability labelled astrocytes and did not label 
non-astrocytic structures. 
Regardless of the uncertainties, all of the antibodies have been shown to re-
liably label expected cell types and structures in the Nothobranchius nervous 
system which makes it possible to detect aging-related changes at the cellular 
level in the Nothobranchius CNS. This research highlights the need to clone 
and express the respective proteins believed to be labelled by these antibodies 
and generate more specific antibodies against these proteins. 
Experiments are underway to study neurodegeneration in N. guentheri us-
ing these antibodies as cellular markers as well as test them against other 
Nothobranchius species. 
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The effect of aging and 
resveratrol-treatment on 
neuron density in the optic 
tectum 
I don't remember, it doens't ring a bell, 
And when you call me everything is swell, 
I tend to forget about the times we had, 
Now it doesn't matter 'cause I feel so sad, 
I've been disconnected. 
Disconnected, Goo Goo Dolls. 
5.1 Introduction 
Polyphenols are reported to have a neuroprotective effect. Specifically, 
they are expected to prevent neuronal cell death caused by neurodegener-
ative processes or prevent these processes entirely [413]. As they inhibit 
neurodegenerative-aging they are expected to modulate lifespan by increas-
ing healthspan. This increase in healthspan is expected to increase median 
lifespan as well as maximum lifespan. 
Valenzano et al. [5] showed that Nothobranchius furzeri (of the extremely 
short lived Gonerezhou population) exhibited reduced operant conditioning 
and increased FJB signal in the OT as they grew older. This wei interpreted 
as a consequence neurodegeneration, in particular the accumulation of NFTs. 
These fish, fed a diet supplemented with resveratrol [5], lived longer than 
aged-matched controls as well as exhibited lower levels of FJB signal and im-
proved operant conditioning. As neurodegeneration results in neuronal death 
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we reasoned that the neuroprotective action of resveratrol was due to the 
preservation of neurons into old age. No cell-type specific probes were avail-
able to test this hypothesis. The Author recently published an antibody toolbox 
by which to investigate neurodegeneration in Nothobrancruus [382] (Chapter 
4) and set out to test whether resveratrol did preserve neurons into old age 
using the 5MI31 antibody and E587 antiserum. 
The 5MI31 antibody was demonstrated to react against Nothobrancruus 
neurons and axons. The 5MI31 antibody recognizes abnormally phosphory-
lated neurofilament protein of the heavy and medium chain forms [66]. Abnor-
mally phosphorylated neurofilaments have been found within NFfs [69,70]. 
5MI31 has been used to label degenerating neurons wherein its epitope accu-
mulates. This has been observed in culture and Alzheimer's Disease (AD) brain 
tissues [66] and using an AD model mouse [67]. This antibody has also been 
shown to label healthy neurons in rats [395]. 
The E587 antiserum has been used to label 11 in other fish species 
[123,163,164]. 11 is a member of the NCAM family and its role in neurode-
generation was reviewed in Chapter 2.4. It is expressed by a subset of neurons 
[414] where it plays a role in synaptogensis [415]. It occurs both on the neu-
ronal and axonal surface [414J and within the synaptic cleft [162]. The 11 
protein itself has been reported to be neuroprotective [416] while its signaling 
cascades have been implicated in neuroprotective responses [165]. The ex-
pression of 11 and other NCAM is down-regulated in aging [166]. This down-
regulation is reversed by dietry restriction. The E587 antiserum was therefore 
used as a marker of neuron vitality and synaptic integration. 
In this study the Author grew N. guentheri to old age, both with and with-
out resveratrol-treatment. Resveratrol-treatment began at 12 weeks of age 
when the fish were sexually mature. Brains were sampled at two time points: 
12 and 34 weeks of age. Whole brains were fixed and stained with SMI31 and 
E587 antibodies and the 5G5 examined. The FJB Signal was most intense along 
the upper surface of the OT in N. furzeri. Because of this wholemounts were 
a convienient means to study the tissue without introducing sectioning arti-
facts or otherwise damaging the tissue through fixation, dehydration, freezing 
or wax imbedding. Differences were observed between the young and old fish 
and a detailed study of the SG5 and glia limitants was performed and the neu-
rons counted and analyzed. 
Using immunostained wholemounts the Author presents evidence that 
5MI31 immunoreactivity accumulates in a particular subset of neurons with 
age along with a decrease in neuron density. In resveratrol-treated fish this 
subset of neurons is less abundant. We also present evidence that N. guentheri 
resveratrol-treated fish have a lower SG5 neuron density per mm2 compared 
to young and age-matched controls; but that the proportion of E587+ neurons 
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5.2 Methods and materials 
5.2.1 Animal care and experimentation 
Fish were cared for as in Genade & Lang [382]. Fish were raised in our lab-
oratory as described in Genade [388]. Experimental fish were given resver-
atrol (Sigma R5010) as described in Valenzano et al. [5]. The dose was ::::12 
I'g resveratrol! fish/day. The fish were fed twice per day with a resveratrol-
supplemented cube of Chironomus larvae set in 5% gelatine. The quantity of 
resveratrol was adjusted to the number of fish to which the cube of food was 
fed [388]. For N. guentheri, resveratrol-treatment began at 12 weeks of age af-
ter the fish had reached sexual maturity. Resveratrol stocks (1.2 mg/mL) were 
prepared in 96% ethanol to ensure chemical stability. 
5.2.2 Dissection and Immunohistochemistry 
Wholemounts were chosen in preference over sections for several reasons. (1) 
The difficulty in positioning the brains for frozen sectioning which would have 
made obtaining reproducible date difficult (possibly culminating in wasting 
the fish). (2) Several artifacts were noticed in the sectioned tissue (such as 
the GFAP/SMI31 colocalization in Section 4.3.1 which were not noticed in the 
testing of the wholemount method. (3) In addition, during the freezing and 
sectioning process there was noticeable distortion of the tissue which made 
reaching anatomical conclusions difficult. 
Fish were euthanized as described in Valenzano et al. [5] the whole brain 
carefully dissected out and the eyes severed. The brains were fixed for 10 min-
utes in 4% PFA and then post.fixed in -20°C methanol for another 10 min-
utes. This method was chosen over intracardially perfused due to the small 
size of the fish and that the current method of post-fixation was already stan-
dard practice for working with these fish. 
Fixed brains were washed in 4°C PBS three times for 15 minutes and 
then incubated in PBS blocking solution of 1 % bovine serum albumin and 1 % 
DMSO. Whole brains were blocked for 24 hours at 4°C and then incubated 
with primary antibodies for 48 hours at 4 0c. The following primary anti-
bodies were used at 1:400 dilution in blocking solution: SMI31 (Covance SMI-
31R) and counterstained with E578 anti-Ll antiserum (a gift from C. Stuermer, 
Konstanz Germany) or rabbit anti-bovine GFAP (DAKO Z0334). After primary 
antibody incubation the brains were washed three times in PBS and then in-
cubated for 48 hours with the secondary antibodies diluted 1 in 500 blocking 
solution: anti-rabbit Alexa 488 (Molecular Probes, Invitrogen) and anti-mouse 
Cy3 (Jackson Immuno Research). After secondary staining the brains were 
washed three times in PBS and soaked in mowiol (with anti-fading agent n-
propylgallate) overnight at 4°C. After the mowiol soak the brains were placed 
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5.2.3 Microscopy and Image analysis 
Wholemount images were obtained using a Zeiss L5M 510 Meta NLO Confocal 
microscope (Jena, Germany). Images are representative of several specimens 
and were edited for publication using Adobe Photoshop CS2 v9.0.2. 
Three 110.5 x 110.5 pm2 optical frames were recorded for each of the ante-
rior, mid and posterior OT (henceforth referred to as aOT, mOT and pOT) as 
indicated in Figure 5.2, page 95. These areas were selected as examples of ma-
ture (aOT) and developing OT (pOT) with an intermediate area for a temporal 
analysis for any differences between the aOT and pOT. Each frame was 2.0 pm 
thick and spanned the SZ (containing the radial glial and 5GS. Due to incon-
sistency of the antibody penetration (which was often complete in young fish 
but only 10-15 pm in aged fish, data not shown) it was decided to only exam-
ine the upper layers (SZ-upper u5GI) for neurons. Within the 2 pm imaging 
depth all neurons of the SGS were included (see Figure 4.1) and in sharp focus 
(negating the need for the time consuming generation of a z-stack). 
Within each of the large frames a smaller optical delimiter of 100x 100pm2 
was used to count cells (Figure 5.3A, page 96). Images were obtained in the Cy3 
channel with the maximum signal intensity threshholded to the most intensely 
SMI31 labelled cellular body. The image was manipulated in PhotoShop to in-
tensify under-exposed cells. Cells which were clearly visible before PhotoShop 
enhancement were defined as SMI31 +++, i.e. neurons which have accumulated 
SMI31 epitope. Cells touching the bottom and left boundary of the delimiter 
were not counted. Some optic tecta were damaged during the dissection and 
could not be analyzed. The number of fish (N) and images analysied (n) are 
reported along with the corresponding data sets in the results section. 
Neurons were categorized based on the pixel diameter of the PhotoShop 
Brush tool needed to completely obscure the neuron. Using the 50 pm scale bar 
as a size reference the pixel diameter was used to estimate the diameter of the 
neuron in pm. The numbers of neurons of a particular size were tallied and 
used to generate Figure 5.3E to determine the size categories. Neurons were 
categorized as small, large, giant, long or amorphous as described in Section 
5.3.2 and Figure 5.3B & c. 
5.2.4 Statistics 
Survival analysis was carried out using the Log-rank test available online at 
http://in-silico.net/statistics/survivor developed by SA Joosse. 
One-way Kruskal-Wallis Ranked ANOVA analysis were performed using 
SigmaPlot 11 (Systat Software, Inc., San Jose, CA USA) followed by Tukey, 
Dunn's or Holm-Sidak tests for statistical differences between the groups. Sta-
tistical differences between data sets are reported simply as being p < 0.05. 
Statistical differences are indicated on the graphs by means of an asterisk 
for differences between the 12 weeks old and other groups; and an exclamation 
mark between the resveratrol-treatment and 34 weeks old groups. Error bars 
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more stringent, but less powerful Mann-Whitney Rank Sum Test, was used to 
guard against false negatives. 
5.3 Results and discussion 
5.3.1 Resveratrol extends N. guentherlilfespan 
Figure 5.1 shows the survival curves for the control and resveratrol-treated 
fish. Median survival for the resveratrol-treated N. guentheri was 50 weeks 
compared to 35 weeks for the non-treated control fish (a 42.9% increase in sur-
vival, p < 0.0001). Maximum (10%) survival was 62 weeks for the resveratrol-
treated fish and 53 weeks for the controls (a 17.0% increase in survival). The 
oldest control fish died at 63 weeks of age and the oldest resveratrol-treated 
fish died at 66 weeks of age (a 4.8% difference), 
Resveratrol-treatment had little effect on total lifespan but had a large ef-
fect on median lifespan which is associated with healthspan. These results 
mirror current experiments underway in Jena, Germany, by Prof. Cellerino 
(pers. comm.) using N. furzeri. The same N. furzeri strain which lived 8-
9 weeks on average in Pisa, Italy is now living 12 weeks on average in Jena. 
The maximum lifespan has also increased suggesting that the resveratrol ex-
periments carried out in Pisa [5) increased the healthspan of the fish under 
conditions of high extrinsic lifespan risk. Once the fish were removed from 
these risks their lifespan increased with total lifespan tending to the intrinsic 
maximum lifespan of the organism. Similarly, resveratrol-treated N. guentheri 
display a large sensitivity to increased extrinsic lifespan risk which is remedied 
by resveratrol-treatment. This could be on account of inbreeding in aquariums 
for several generations as is hypothesized for N. furzeri Gonarezhou [12). The 
same phenomenon is observed when resveratrol was given to high-calorie fed 
mice and control mice [214, 250). In accordance with Gavrilov's Reliability 
Theory of Aging: maximum lifespan is less affected by extrinsic lifespan risk 
and thus less susceptible to intervention strategies [210). 
5.3.2 Neurons of various sizes occur In the SGS 
228 neurons were measured to make an estimate of their size and the data 
graphed (Figure 5.3E, page 96). The graph revealed at least three size groups. 
The first group of small neurons was 4.7 ± 0.61lm SD. The cut-off point be-
tween small and large was designated as 5.9 Ilm based on the difference in 
the abundancies of the 5.41lm and 6.1 JlM neurons and large size interval be-
tween them of two small neuron standard deviations. Neurons from 5.91lm 
diamter onwards had a more oval form. The large group was not as numerous 
in number nor as uniform in size as the small subset and no criteria by which 
to differentiate a medium subset could be found. The upper size limit of the 
large subset was designated as 11.7 Ilm. The large subset was 8.2 ± 1.61lm. The 
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Figure 5.38 is a representative image of the OT showing neurons of var-
ious sizes. Small neurons were often encountered as quartets of three small 
and one larger neuron (Figure 5.30). Large neurons were often encountered 
in pairs. Members of these pairs were in close enough proximity to obscure 
one another. Using the E587 antiserum the borders of these neurons could be 
better discerned. Neurons classified as long were no wider than the diameter 
of a small neuron but at least three times longer than they were wide. Neu-
rons were classified as amorphous if they had an irregular shape, the normal 
shapes being round, long or oval. Whether these neuron types represent gen-
uine neuron subtypes or a progression from healthy to degenerate neurons will 
be discussed below. 
5.3.3 Neuron density declines with age 
To determine whether the total number of neurons in the SGS were declining 
with age all neurons in the SGS were counted. This data is presented in Figures 
5.4 and 5.5 as well as Table 5.1. There is a decline in SMI31 immunoreactive 
neurons with the age of the fish (regardless of resveratrol supplementation) as 
well as an increase in neuronal density with the youth of the OT area. A subset 
of SMI31 + neurons were immunoreactive with the E587 antiserum (Figure 5.4). 
Using the sizing criteria established in Section 5.3.2 the neurons were 
counted in each OT area. This data is presented in Figure 5.5, page 98. On av-
erage, there is a statistical decline in neuron density with age between 12 and 
34 weeks old fish. Relative to both the 12 and 34 weeks old fish, resveratrol-
treated fish had a lower neuronal density. This difference was present between 
the 12 and 34 weeks old groups in the pOT. In the mOT both the 34 weeks old 
and resveratrol-treated fish neuron density was significantly less compared to 
the 12 weeks old fish. Resveratrol has a larger effect on the younger area of the 
OT than on the older areas. 
When assessing the density of small neurons the resveratrol-treated group 
had significantly more neurons in the mOT compared to the 34 weeks old fish 
but not the 12 weeks old fish. Resveratrol-treated fish had on average more 
small neurons than the 12 and 34 weeks old groups. There were no signifi-
cant differences between the resveratrol and control groups with respect to the 
large neurons. Resveratrol-treated fish had on average statistically fewer giant 
neurons compared to the 12 and 34 weeks old fish. There was no statistical dif-
ference in the number of giant neurons between the 12 and 34 weeks old fish. 
The 34 weeks old fish have consistently fewer giant neurons. A larger sample 
size may reveal a statistical difference. No significant difference was found in 
the pOT between any of the groups. In both the anterior and mOT resveratrol-
treated fish had significantly fewer giant neurons compared to the 12 weeks 
old fish. When comparing the average values the resveratrol-treated fish had 
significantly fewer amorphous neurons compared to the 12 and 34 weeks old 
fish. This significant difference between the resveratrol and 34 weeks old con-
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Table 5.1: Table of statistical differences of SM131 + counts per mm2 between the three 
OT areas within each experimental group: 12, 34 weeks old and resveratrol-treated 
(RT). Samples sizes were N = 6 & n = 32 for the 12 weeks old group; N = 9 & n = 39 
for the 34 weeks old group; and N = 5 & n = 27 for the resveratrol-treatment group. 
Statistically significant results are underlined. 
Total SMI31 + per mm2 
12 weeks old 34 weeks old RT 
pOT > aOT p<O.OS pOT>aOT p <0.05 pOT>aOT p<O.OS 
pOT> mOT p<O.OS pOT> mOT p <0.05 pOT > mOT p<O.OS 
aOTvsmOT p> 0.05 aOTvsmOT p >0.05 aOTvsmOT p>O.OS 
Proportion small SM131 + per total SM131 + per mm2 
pOTvsaOT p =0.653 pOTvsaOT p=0.967 pOTvsaOT p = 0.123 
pOTvsmOT p =0.653 pOTvsmOT p= 0.967 pOTvsmOT p=0.123 
aOTvsmOT p=0.6S3 aOTvsmOT p=0.967 aOTvsmOT p=0.123 
Proportion large SM131 + per total SM131 + per mm2 
pOTvsaOT p=0.2S9· pOTvsaOT p=0.442 pOTvsaOT p=0.21~ 
pOTvsmOT p=0.2S~ pOTvsmOT p=0.442 pOTvsmOT p=0.21~ 
aOTvsmOT p=0.2S~ aOTvsmOT p=0.442 aOTvsmOT p=0.21~ 
Proportion giant SM131 + per total SMI31 + per mm2 
pOTvsaOT p =0.232 pOT>aOT p<O.OS pOTvsaOT p=0.214 
pOTvsmOT p =0.232 pOT > mOT p <0.05 pOTvsmOT p=0.214 
aOTvsmOT p=0.232 aOTvsmOT p=0.943 aOTvsmOT p=0.214 
Proportion amorphous SMI31 + per total SMU1 + per mm2 
pOTvsaOT p >0.05 pOTvsaOT p= 0.882 pOTvsaOT p=0.663 
pOT > mOT p<O.OS pOTvsmOT p= 0.882 pOTvsmOT p=0.663 
aOT>mOT p<O.OS aOTvsmOT p=0.882S aOTvsmOT p=0.663 
Proportion long SM131+ per total SM131+ per mm2 
pOT > aOT p <0.05 pOT > aOT p <0.05 pOT>aOT p<O.OS 
pOT> mOT p<O.OS pOTvsmOT p >0.05 pOTvsmOT p> 0.05 
aOT vs mOT p>o.OS aOT<mOT p <0.05 aOTvsmOT p> 0.05 
• A One-Way Analysis of Varianceretumed a p-value greater than 0.05 but the statistical power 
of the test (0.104) was below needed to be sure of the result (0.800). A more powerful analysis or 
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to 12 weeks old fish the 34 weeks old fish had significantly fewer amorphous 
neurons in the pOT. This data could indicate that over time neurons are pruned 
from the neural network and that resveratrol-treatment encourages this prun-
ing. 
34 weeks old and resveratrol-treated fish had significantly more long neu-
rons in both the mOT and on average compared to the 12 weeks old fish. Long 
neurons were often encountered lying adjacent to E587 immunoreactive blood 
vessels on the OT (Figure 5.41). 
That more small neurons exist on average in resveratrol-treated fish com-
pared to controls suggests that newborn neurons are surviving in the estab-
lished OT of resveratrol-treated fish. The alternative argument that the small 
neurons in resveratrol-treated fish are surviving better than in the young and 
old controls is not supported by this data. As much as one half of the total neu-
rons are lost from the aOT with age but the small neurons increase by as much 
as 40% without upsetting the similarity in the proportion of large neurons be-
tween the groups. On the contrary, 34 weeks old fish also lose a significant 
proportion of their neurons from the aOT but exhibit no change in the pro-
portion of small neurons in this area. In addition, while there are significant 
. differences in neuronal density in the pOT with age and resveratrol-treatment, 
no difference is found in the proportion of small neurons in the pOT. New-
born (BrdU+) neurons have been observed in the aged OT of 34 weeks old 
and resveratrol-treated N. guentheri but were not quantified (Figure A.8, Ap-
pendix A.3). These neurons were observed along the dorsal edge of the OT, 
adjacent to the valvula cerebelli. Adult neurogenesis has been confirmed in N. 
furzeri and these newborn neuron do integrate [418]. These neurons arise in 
the torus longitudinalis adjacent to the valvula cerebelli and OT, and then mi-
grate into the ~T. Furthermore, resveratrol-treatment only began at 12 weeks 
so one can only expect the density of neurons in the anterior OT to decrease 
between the groups. They cannot increase unless new neurons were added to 
this area throughout the life of the fish. The long neurons could be new born 
neurons migrating into the ~T. If so, then the 34 weeks old fish launch as great 
a regenerative effort as the resveratrol-treated fish. Why doesn't this regen-
eration succeed in 34 weeks old fish? Is it because the giant and amorphous 
neurons remain synaptically active and get in the way of the integration of 
newborn neurons? It has been reported that the rate of neuronal apoptosis mir-
rors the rate of neurogenesis and neuron integration in the hippocampus [122]. 
Degenerate neurons which fail to undergo apoptosis and make way for new-
born neurons could upset this balance between neural pruning/neurogenesis 
and integration. 
Whether the size groups (small, larger, giant and long) reflect specific cell 
types or a gradual increase in cell size with age is an open question requiring 
further investigation. Aging-related changes in neuron size have been reported 
for humans [38]. No differences were found in the average density of the large 
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Table S.2: Table of statistical differences of SMI3I +++ counts per mm2 between the 
three OTareas within each experimental group: 12, 34 weeks old and resveratrol-
treated (RT). Samples sizes were N = 6 & n = 32 for the 12 weeks old groupi N = 9 
& n = 39 for the 34 weeks old group; and N = 5 & n = 27 for the resveratrol-treatment 
group. Statistically significant results are underlined. 
Total SMI31 +++ per mm2 
12 weeks old 34 weeks old RT 
pOT>aOT p<0.05 pOTvsaOT p= 0.199 pOTvsaOT p=0.05S· 
pOT> mOT p<0.05 pOTvsmOT p = 0.199 pOTvsmOT p=0.05S· 
aOTvsmOT p >0.05 aOT vs mOT p=0.199 aOTvsmOT p=0.05S· 
Proportion SMI31 +++ of total neurons per mm 2 
pOTvsaOT p>0.05 pOTvsaOT p=0.157 pOTvsaOT p =0.140 
pOT > mOT p<0.05 pOTvsmOT p= 0.157 pOTvsmOT p=O.I40 
aOTvsmOT p >0.05 aOTvsmOT p=0.157 aOTvsmOT p =0.140 
• The Mann-Whitney Rank Sum Test gives p-values of 0.124, 0.067 and 0.064 supporting the 
conclusion that these results are insignificant and not the result of low sampling size. 
5.3.4 Changes In SMI31 Immunoreactivity with age and 
resveratrol-treatment 
5MI31 labels phosphorylated neurofilament proteins. These phosphorylated 
neurofilaments have been shown to be included in NFTs [68]. In this study 
neurons could be categorized based on whether they exhibit excessive 5MI31 
immunoreactivity, SMI31 +++, or those exhibiting a lower level of SMI31 im-
munoreactivity as described in Section 5.2.3. SMI31 +++ neurons were counted 
and compared between the age groups and OT areas (Figure 5.6A, page 99). 
SMI31 +++ neurons decreased with the age of the OT and the fish. Statistical 
difference between the OT areaS within the groups are given in Table 5.2. The 
pOT of 12 weeks old fish had more 5MI31 +++ neurons than the aOT and mOT. 
There was no statistical difference in SMI31+++ neuron numbers between the 
OT areas of the 34 weeks old and resveratrol-treated fish. 
Resveratrol-treated 34 weeks old fish had significantly less 5MI31+++ neu-
rons in the posterior and anterior OT compared to the 12 weeks old fish. Only 
the aOT was statistically different between the 34 weeks old and resveratrol-
treated fish. There was no statistical djfference between the 34 weeks old 
and resveratrol-treated fish in the mOT and pOT. On average, the number of 
5MI31 +++ neurons was the same in 12 and 34 weeks old fish and significantly 
less in resveratrol-treated fish (p < 0.05). As with the Case of the total neurons, 
there was a trend for the chronologically younger OT areas to possess more 
5MI31 +++ neurons. 
As neuronal density declines with age and resveratrol-treatment the ques-
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neurons? The density of SMI31 +++ neurons were therefore expressed as a pro-
portion of the total neurons in each OT area as well as on average. These re-
sults are shown in Figure 5.6B and Table 5.2. This analysis showed that on 
average the SMI31 +++ neurons did accumulate disproportionally in 34 weeks 
old fish and that resveratrol-treated fish had significantly less. No difference 
in SMI31 +++ abundance was observed between the different areas in 34 weeks 
old fish while the pOT of 12 weeks old fish had more SMI31 +++ than the mOT. 
No difference was found between the resveratrol-treatment group OT areas. 
Rather than be associated with age of the tissue, SMI31 +++ neurons are as-
sociated with the youth of the tissue. It seems more reasonable, in the case 
of N. guentheri, to conclude that SMI31 +++ neurons are unintegrated neurons. 
NFTs have been shown to inhibit apoptosis by disrupting p-catenin signaling 
[118], This signaling pathway is involved in neurogensis [112], neural migra-
tion [419] and the integration of newborn neurons into the neural network 
[420]. When the neuron fails to establish synaptic contacts they could use 
NFTs to disrupt p-catenin signaling to stave off apoptosis while synaptic con-
nections can be forged. In the pOT there are many more SMI31 +++ neurons 
because many more neurons are produced than can be successfully integrated. 
As such, the mice of Yang et al. [67], could have accumulated a larger density 
of unintegrated neurons as AP disrupted the synaptic connections. 
With the age of the fish there is an average increase in the proportion of 
SMI31+++ neurons as predicted from the work of Yang et a1. [67] and Wang 
et a1. [66] who report that the accumulation SMI31 immunoreactivity is a sign 
of neurodegeneration. It is reasonable to assume that these are NFT laden 
neurons undergoing either degeneration or a failure to integrate. Whether 
resveratrol is preventing neurodegeneration, aiding in neuron integration or 
stimulating degenerate neurons to undergo apoptosis instead of linger in the 
tissue is unknown. The data indicates that with age the proportion of un-
integrated neurons increases. SMI31 +++ neurons could serve as a marker of 
neuronal circuit malfunction. As there is no difference in the proportion of 
SMI31 +++ neurons between the OT areas of 34 weeks old fish, SMI31 +++ accu-
mulation (as a proportion of total neurons) is a reliable indicator of eNS aging 
and dysfunction. 
Resveratrol could be potentiating malfunctioning neurons to apoptosis or 
autophagy by restoring p-catenin signaling. There is some support for this hy-
pothesis. Wu et al. [421] have reported that resveratrol induced autophagy in 
a cellular model of Parkinson's Disease. Furthermore, Liu et al. [240] speculate 
that resveratrol could cause neuronal death under excitotoxic stress, particu-
larly of cells which are energetically compromised (as discussed in Chapter 2, 
Section 2.5 on page 20). Alternatively, resveratrol-treatment could be improv-
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5.3.5 Changes In E587+ neuron abundance with age and 
resveratrol-treabnent 
Using the sizing criteria established in Section 5.3.2 the number of E587 im-
munoreactive (E587+) neurons were counted in each OT area. This data is 
presented in Figure 5.7 (page 100) and Table 5.3. 
On average, resveratrol-treated fish had significantly more E58~ neurons 
than the 34 weeks old control fish. There was no significant difference between 
the resveratrol-treatment and 12 weeks old fish. Both had significantly more 
E587+ neurons than the 34 weeks old fish. These differences between the 12 
weeks and resveratrol-treatment groups versus the 34 weeks old fish were also 
present in the pOT. Resveratrol-treated fish had more E587+ neurons in the 
mOT, but not the aOT which had established before resveratrol-treatment be-
gan. 34 weeks old fish had fewer E587+ neurons in the aOT than the 12 weeks 
old fish but there was no difference between the 12 weeks and resveratrol-
treated fish. While resveratrol had not rescued E587 immunoreactivity to 12 
weeks old levels in the aOT it had slowed E587+ loss from this area. 
With age there Was a significant decline in the proportion ofsmall E587+ 
neurons both in the pOT and on average. Resveratrol-treated fish had a sig-
nificantly higher proportion of E587+ small neurons in the aOT, perhaps im-
plying that resveratrol had preserved the functional capacity of this OT area. 
With the decrease in chronological age of the OT there was a decrease in the 
proportion of small E587+ neurons in the resveratrol group whereas there was 
an increase in the 34 weeks old fish implying that resveratrol-treatment pre-
served the functional integrity of older OT areas. Increases in the 12 weeks old 
fish is concomitant with growth. 
Referring to the proportion of large E587+ neurons there was only a sig-
nificant difference between the 12 and 34 weeks old fish in the aOT. The 
resveratrol-treated fish also had a lower proportion of large E587+ neurons 
in the aOT. There was no difference between the 34 weeks old and resveratrol-
treated groups in the aOT. On average, the resveratrol group had more E587+ 
large neurons than the 34 weeks old fish but no difference to the 12 weeks old 
fish. Based on the successful lifespan extension by resveratrol in this species, as 
regards the SGS of the OT, it is most likely the small and large neurons which 
are functionally significant. 
Resveratrol-treated fish had on average significantly fewer E587+ giant and 
amorphous neurons compared to the 12 weeks old fish. Also, resveratrol-
treated fish had significantly fewer amorphous but not giant E587+ neurons 
compared to 34 weeks old fish. The proportion of E587+ amorphous neurons 
is almost double that ofE587+ giant neurons. Comparing Figure 5.5E with its 
counterpart, Figure S.7E, it is apparent that almost half of the amorphous neu-
rons in the 34 weeks old OT are E587+. 12 weeks old and Resveratrol-treated 
fish had fewer E587+ neurons than the 34 weeks old fish suggesting that these 
neurons are the dysfunctional neUron subtype. Resveratrol-treatment selec-











Chapter 5.3. Results & discussion 90 
Table 5.3: Table of statistical differences of the proportion E587+ neurons of the total 
SMI31 + neurons per mm2 between the three OT areas within each experimental group: 
12,34 weeks old and resveratrol-treated (RT). Samples sizes were N = 3 & n = 15 for 
the 12 weeks old group; N = 4 & n = 21 for the 34 weeks old group; and N = 5 & n = 27 
for the resveratrol-treatment group. Statistically Significant results are underlined. 
Proportion E587+ oftotal SMI3t+ per mm2 
12 weeks old 34 weeks old itT 
pOTvsaOT p=0.219 pOTvsaOT p= 0.541 pOT > aOT p<0.05 
pOTvsmOT p=0.219 pOTvsmOT p= 0.541 pOTvsmOT p>0.05 
aOT vs mOT p=0.219 aOTvsmOT p=0.541 aOTvsmOT p>0.05 
Proportion small E58r per total SMI3t+ per mm2 
pOTvsaOT p=0.240 pOTvsaOT p=0.238 pOTvsaOT p =0.182 
pOT vs mOT p=0.240 pOTvsmOT p= 0.238 pOTvsmOT p=0.182 
aOT vs mOT p=0.240 aOTvsmOT p= 0.238 aOT vs mOT p=0.182 
Proportion large E58r per total SMI31+ per mm2 
pOTvsaOT p=0.461 pOTvsaOT p=0.478 pOT>aOT p<0.05 
pOTvsmOT p=0.461 pOTvsmOT p = 0.478 pOT> mOT p<0.05 
aOT vs mOT p=0.461 aOTvsmOT p= 0.478 aOTvsmOT p>0.05 
Proportion giant E58r per total SMI31+ per mm2 
pOTvsaOT p=0.246 pOTvsaOT p= 0.306 pOTvsaOT p = 0.155 
pOT vs mOT p=O.246 pOTvsmOT p= 0.306 pOTvsmOT p =0.155 
aOTvsmOT p=0.246 aOTvsmOT p= 0.306 aOTvsmOT p = 0.155 
Proportion amorphous E587+ per total SMI3t + per mm2 
pOTvsaOT p=0.199 pOTvsaOT p = 0.867 pOTvsaOT p =0.930 
pOTvsmOT p=0.199 pOTvsmOT p= 0.867 pOTvsmOT p=0.930 
aOTvsmOT p=0.199 aOTvsmOT p= 0.867 aOT vs mOT p=0.930 
Proportion long E587+ per total SMI31 + per mm2 
pOT>aOT p<0.05 pOTvsaOT p=0.318 pOT>aOT p=0.067& 
pOTvsmOT p>0.05 pOTvsmOT p=0.318 pOTvsmOT p=0.067 
aOTvsmOT p>0.05 aOT vs mOT p=0.318 aOT vs mOT p=0.067 
• The Mann-Whitney Rank Sum Test gives p = 0.020 for the difference between the pOT and aOT. 
The differences for pOT vs mOT and aOT vs mOT is still inSignificant using this test (p = 0.491 
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other neuron types in the SGS. 
There were no differences between the groups as regards the proportion 
E587+ long neurons but there is a consistent trend for resveratrol-treated fish 
to have more than the control groups. A larger sample size may prove this 
trend to be significant. 
The average proportion of E587+ neurons was significantly reduced in 34 
weeks old fish compared to 12 weeks old fish; but the proportion of E587+ neu-
rons was preserved to the level of 12 weeks old fish in the resveratrol-treated 
fish (Figure 5.7 A). Most of the E587+ neurons were either small or large neu-
rons (Figure 5.7B&C). 34 weeks old fish had reduced small, large and giant 
E587+ neuron proportions but no change in the proportion of amorphous neu-
rons. While 12 weeks old fish had signicantly more amorphous SMI31 + neu-
rons than 34 weeks old fish, 34 weeks old fish had the same amount of amor-
phous E587+ neurons. In effect, aging increased the relative density of the 
amorphous neurons to the other neuron types. Resveratrol-treatment reduced 
the number of these amorphous neurons. It seems likely that it is the inabil-
ity to remove malfunctioning neurons which could be driving Nothobranchius 
neurodegeneration, not the loss of neurons per se. 
This restoration of E587 immunoreactivity in resveratrol-treated fish pro-
vides a beginning for a molecular explanation for the improved operant learn-
ing observed in N. furzeri given resveratrol [5] as well as in other species 
[221,246]. 
5.4 General discussion and conclusions 
Resveratrol neuroprotection is believed to be due to resveratrol activating cell 
survival programs, be this through the activation of AMP-kinase [246] or the 
inhibition of microglial activation [291]. Various mechanisms were reviewed 
in Chapter 3. Resveratrol is predicted to preserve neurons into old age but here 
the opposite is shown: that resveratrol-treated fish have fewer neurons than 12 
and 34 weeks old fish (Figure 5.5)-and there is no question that resveratrol 
did extend N. guentheri lifespan. Articles pertaining to resveratrol's neuro-
protective role are studies of CNS injury or disease and not normal aging, for 
example see references: Wang et a1. [358], Lee et a1. [422] and Liu et a1. [423]. 
These studies of pathological aging could be presenting a false impression of 
the mechanism of resveratrol neuroprotection. Widespread neuron loss is not 
a feature of normal aging [28, 29] so the preservation of neurons into old age 
is not needed as it would be in pathological aging such as AD and PD. 
The neurobiologist, Steven Rose, contends that during development the 
brain produces many more neurons than it needs and that as these extra neu-
rons are pruned they are replaced with gIia and synapses [424]. This enhances 
connectivity and improves brain function. The improvement in connectivity 
is, according to Rose, associated with the maturing of the brain while in later 
senescence the synapses atrophy, causing a decline in connectivity and brain 
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cline in neurons may, in itself, not be a sign of neurodegeneration in N. guen-
theri. In the rat there is significant neuron pruning in the superior colliculus 
after birth which does not affect the number of optic connections [425]. In the 
goldfish the synaptic terminals have been observed to shift with age as the fish 
grows [124]. As the zebrafish grows as much as 95% of the neurons in the OT 
are new cells which have integrated into the existing OT or have been added 
on to expand the organ. The fish is dependent on constant plasticity in the OT 
as well as persistent route markers, much like the mammalian basal ganglia 
and limbic system which must retain plasticity while still anchoring long-term 
memories. The increased immunoreactivity to the plasticity marker E587 an-
tiserum, against goldfish L1 [123, 163, 164], in resveratrol-treated fish (Figure 
5.7) is more meaningful than the loss of neurons. 
The inability with age to clear the amorphous E587+ neurons (which may 
have been unintegrated or disconnected degenerate neurons) could be what 
prevents or upsets the maturing of the ~T. The inability to mature the OT 
could be what leads to the short-circuiting of the neural circuitry which mani-
fests as cognitive deficits. 
This study focused on the SGS of the OT. Antibody penetration was ~ 10 I'm 
in old fish. The effect of aging and resveratrol on neuron density in the deeper 
layers is still unknown with respect to the antibodies used in this study. One 
criticism which could be voiced is that in flattening the wholemounts between 
the coverslips the surface area was deformed. Volume increases exponentially 
relative to surface area. In flattening out the wholemounts of the larger, older 
fish the surface area would be spread out more. This is a valid concern which 
must be kept in mind when interpreting these results. This could hide an 
accumulation of neurons with age or create a false impression of neuron loss. 
For this reason the E587 immunoreactive results are most valuable. 
Whether or not dilution occurred with the flattening of the OT, the den-
sity of E587 immunoreactive neurons increased in the resveratrol-treated fish 
relative to the 34 weeks old fish and the proportion of giant and amorphous 
neurons was reduced. Also, there was no change in the proportion of SMI31 + 
large neurons and an increase in the number of SMI31 + small neurons indi-
cating that dilution of the neuronal density was meager. Another possibility 
which was not explored is that the resveratrol brains may have been larger in 
volume than the 34 weeks old control fish but this option would still need to 
contend with the similarity of the average density of large neurons and the 
increase in the small neurons. 
Another methodological issue is that of using the correct stereological tools 
[426]. The method applied to determine neuron size subsets is not an accurate 
way to determine neuron diameter. When consistently applied it is an accurate 
means to determine neuron subtypes by their relative size. Accurate neuron 
sizes need to be determined using the Nucleator tool. 
These results inspire several interesting questions, the most important of 
which is whether the E587 immunoreactivty correlates with behavioral out-
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in neuron size from small to giant as the neurons become dysfunctional, or 
different types of neurons (fulfilling different functions) is another question 
which needs to be addressed. In OT sections this variety of neurons is missed 
and thus ignored by the literature. The long neurons are closely associated 
with blood vessels running over the OT. Are these newborn neurons migrat-
ing from the proliferative zone adjacent to the valvula cerebe11i? Both the 34 
weeks old and resveratrol-treated fish have a higher density of long neurons 
but only the resveratrol-treated fish have more E587+ small and large neurons. 
Whether the E587 immunoreactivity correlates with increased synaptogenesis 
in the OT is another question which needs to be explored. Rose postulates 
that the dying neurons are replaced by glia and synapses. Does the density 
of synaptic contacts change with aging in Nothobranchius as in other animals 
[427]; and does resveratrol correct for any decline which may occur? Changes 
in glial density have been measured and will be the focus of Chapter 6. 
With reference to Rose's postulate, we hypothesize that resveratrol-
treatment allows N. guentheri to more thoroughly clear dysfunctional neu-
rons and, by so doing, enhance synaptic connectivity. In accordance with this 
hypothesis the number ofE587+ neurons should correlate with behavioral out-
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The effect of age and 
resveratrol on Nothobranchius 
glia 
You lacerate me with all of these memories, 
And now I wear these scars out on my sleeve. 
Chasing shadows at midnight, Pillar. 
6.1 Introduction 
In the previous chapter an age-related decline in OT neuron density was re-
ported. This decline in neuron density was not remedied by resveratrol-
treatment. Resveratrol-treatment did reduce the relative density of SMI31 +++ 
neurons which can be interpreted as a decline in NFf bearing neurons. This 
was the interpretation of the resveratrol-treatment related decline in FJB signal 
reported by Valenzano et al. [5). Damjanac et al. [25] reported that FJB labelled 
gliotic astrocytes and microglia. The FJB stain did stain the glia limitants of N. 
furzeri [10]. In the course of experiments to identify antibodies which could 
be used to label neurons and glia in the Nothobranchius CNS [382] differences 
were observed in the quality of the glia limitants between 12 and 34 weeks old 
N. guentheri. In this chapter the results of investigations of the N. guentheri 
glia limitans in the course of normal aging and resveratrol-treatment will be 
reported. 
Wholemounts of 12 and 34 weeks old fish and resveratrol-treated 34 weeks 
old fish were prepared and incubated with antibodies against TNR, L1 and 
GFAP. These antibodies labelled defined CNS structures and cell types and are 
also implicated in synaptic plasticity. 
TNR has a role in axon guidance [123] as well as the formation of PNNs 
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volved in plasticity: they are very active in laying down a suitable ECM which 
facilitates synapse formation. This is reviewed by Faissner et a1. [138]. While 
PNNs are typically associated with oligodendrocytes the production of many 
PNN protein constituents are expressed by astrocytes and neurons [140]. TNR 
has been observed to associate with brevican (from astroglia) in PNNs [428]. 
While the E587 antiserum (against goldfish Ll) labelled many structures and 
two cell types (neurons and astrocytes) in the N. guentheri CNS. It was used 
as an astrocyte marker. 
PNN density has been observed to decline in specific brain regions in a 
functional and age-related manner in rats [147]. The knock out of cartilage 
link protein in mice resulted in persistent juvenile levels of ocular dominance 
plasticity as well as visual acuity sensitivity to visual deprivation [429] indicat-
ing that PNNs anchor neural circuits. PNNs have been demonstrated to play 
a role in establishing long-term memory [430]. They have also been shown to 
surround GABAergic neurons in the brain, the loss of which results in a loss 
of functional synaptic plasticity [137] implying that PNN surrounded neurons 
partake in top-down modulation of neural circuits. The operant learning as-
say employed by Valenzano et al [5,6] was a visual task. It is reasonable that 
resveratrol may have exerted its operant learning preserving effect in N. Eurz-
eri by preserving the PNNs of the OT (and other brain regions). Such PNNs 
have previously been reported for gymnotiform fish [431] as well as goldfish 
[432]. TNR is reported to be expressed on the surface of oligodendrocytes in 
the CNS of mammals [140]. 
There is very little research on the effect of long term resveratrol supple-
mentation on astrocytes and other gUa. Most research has focused on astrocyte 
cultures or tissue slices. These results are reviewed by Quincozes-Santos & 
Gottfried [349]. Astrocytes are known to atrophy with age while a subset of as-
trocytes become gliotic and contribute to pathology [41, 110]. D'Angelo et a1. 
[212] has demonstrated that Nothobranchius do not have astrocytes in the OT 
per se, but instead have radial glia lining the OT surface and ventricular zones. 
The Author thus set about comparing the state of the radial glia of young and 
old fish as well as fish administered resveratrol during the course of aging. As 
the OT was the object of focus in Valenzano et a1. [5,6] the Author continued 
to concentrate on this brain region. 
Changes in radial glial density and morphology that were related to both 
aging and resveratrol-treatment were observed. Also observed were changes 
in the GFAP expression profile and the density of PNNs. In general, resvera-
trol had a positive effect on radial glial morphology, density per mm2 and the 
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6.2 Methods and materials 
6.2.1 Animal care and experimentation 
Fish were cared for and killed as described in Chapter 5. All immunohisto-
chemical experimental procedures are as described in Chapter 5. Differences 
from Chapter 5 are mentioned below. 
6.2.2 Immunohistochemistry 
The following primary antibodies were used at 1:400 dilution in blocking so-
lution: E578 anti-L1 (gift from C. Stuermer, Konstanz Germany), GA-5 mab 
anti-GFAP (Sigma G6171), rabbit anti-bovine GFAP (DAKO Z0334) and mab 
anti·rat TNR (gift from P. Persheva, Bonn Germany). 
6.2.3 PTAH staining for gllotlc astrocytes 
Fish were killed, the belly slit open, and fixed in Bouin's Solution for 24 hours. 
Fixed tissue was dehydrated in sequential 24 hour washes in 70% ethanol be-
fore being processed for paraffin impregnation. Fixed fish were imbedded 
in wax and sectioned at 5 pm and then fixed to APTES coated slides. Sec-
tions were taken to water and developed by the modified phosphotungstic acid 
hematoxylin (PTAH) method of Manlow & Munoz [433] after a 10 minute wash 
in 70% ethanol with a few drops of saturated lithium carbonate added (to ex-
tract the picric acid from the tissue). 
6.2.4 Microscopy 
Whole mount images were obtained using a Zeiss LSM S1 0 Meta NLO Confocal 
microscope (Jena, Germany). Images are representative of several specimens 
and were edited for publication using Adobe Photoshop CS2 v9.0.2. 
For the counting of PNNs and large radial glial processes 221 x 221 pm2 
optical frames were used. These frames were projections generated from a z-
stack of::::l 10pm thick. For the counting of radial glia 110.5 x 110.5pm2 optical 
frames were used. These frames were of a single 1.6 pm optical slice: PNNs 
and radial gUa are present in the same plane. Only in-focus radial glia with a 
well defined shape were counted. Within the 1l0.5x 110.5Jlffi2 frame a second 
50 x 50pm2 optical delimiter was applied for counting. Samples were taken 
as shown in Figure 6.1 and counts were made in triplicate for each area using 
11 0.5 x 11 0.5 pm2 frames. 
All PTAH positive cells in the entire stratum griseum periventriculare 
(SGPV) of the OT were counted. Only OT sections which passed though the 
valvula cerebelli (as in Woodhead & Pond (390)) were counted. Using a 40x 
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6.2.5 Western blotting 
Western Blots were performed as in Genade & Lang [382] except that two 
extraction buffers were used: the NP-40 based buffer and a RIPA buffer. 
Composition of the RIPA buffer is as follows: 150 mM NaCe, 20 mM TRIS, 
1% Triton X-I00 (BOH, 30632) and deoxycholate (Sigma, 06750) and 0.1% 
SOS (Sigma, L4390). To complete the extraction buffer 20 I'L 25x CPIC 
(Roche, 11697498001), 2.51'L PMSF (Sigma P7626), 0.5 I'L Aprotinin (Roche, 
10236624001) and pepstatin A (Roche, 11359053001) was added to make 
up 500 I'L buffer. The NP-40 buffer was composed as described in Chapter 
4.2.2. The RIPA, on account of deoxycholate and SOS, is a strong disruptor of 
protein-protein interactions [434] whereas the NP-40 buffer is not. Extraction 
buffers were chilled to 4°C before use. 
GA-5 was used for western blotting. The blots were developed using 
chloronaphthol as follows: after secondary antibody incubation the blots were 
washed in pH 7.4 50 mM TBS where after the developing medium was added. 
The developing medium consisted of 0.03% chloronaphthol in TBS. '(he mix-
ture was filtered and H202 was added to a final concentration of 0.03% and 
then added to the blot. The blot was left to develop until the bands were re-
solved and the reaction stopped by rinsing in PBS. Blots were immediately 
dried and scanned. Blots which were to be compared were developed simulta-
neously in identical buffers and reagent solutions. 
Scanned blots were analyzed using Image] [435]. Densitometric measures 
were standardized against the Ponceau S staining of the appropriate lane [436]. 
To determine relative changes in expression 12 weeks old and resveratrol-
treated samples were measured and expressed as a fraction of the GFAP ex-
pression of the 34 weeks old control fish. To determine whether there was 
a change in the proportion of each GA-5 immunoreactive band between the 
age and treatment groups each band was measured relative to the total GA-5 
immunoreactivity per lane. 
6.2.6 Statistics 
All statistical analyzes were performed as described in Chapter 51 page 82. 
6.3 Results and discussion 
6.3.1 Radial glial density declines with age and Is partly re-
versed by resveret:rol 
Representative images of the OT of 12, 34 weeks old and resveratrol-treated 
34 weeks old N. guentheri are shown in Figure 6.2 (page 115). Statistical dif-
ferences between the OT areas pertaining to Figure 6.3 are given in Table 6.1. 
With age the density of the radial glia declines (Figure 6.3A, page 116). Sig-
nificant differences were recorded between 12 and 34 weeks old N. guentheri 










Chapter 6.3. Results & discussion 105 
Table 6.1: Table of statistical differences of radial glia counts per mm2 between the 
three OT areas within each experimental group: 12, 34 weeks old and resveratrol-
treated (RT). 
Radial glia per mm2 
12 weeks old 34 weeks old RT 
(N = 10 &n= 38) (N=8&n=34) (N =4&n =24) 
pOT > aOT p<0.05 pOT vsaOT p=0.807 pOT>aOT p < 0.001 
pOT> mOT p <0.05 pOTvsmOT p=0.807 pOT> mOT p <0.001 
aOTvsmOT p>0.05 aOTvsmOT p=0.807 aOT<mOT p < 0.001 
Large radial glial processes per mm2 
12 weeks old 34 weeks old RT 
(N=7) (N=5) (N=4) 
pOT <aOT p <0.05 pOTvsaOT p=O.I25 pOTvsaOT p =0.376-
pOTvsmOT p>0.05 pOTvsmOT p=0.125 pOTvsmOT p =0.376-
aOT < mOT p<0.05 aOTvsmOT p=0.125 aOTvsmOT p =0.376-
• A One-Way Analysis of Variance returned a p-value greater than 0.05 but the statistical power 
of the test (0.063) was below needed to be sure of the result (0.800). A more powerful analysis or 
more data may prove the differences to be significant. 
significant differences were recorded between the mid, posterior and average 
radial glial counts. There was no statistical difference between the 12 weeks 
old and resveratrol-treated fish. Within the 12 weeks old group the glia be-
come more diffuse with age and GFAP immunoreactivity becomes less. Com-
paring the 12 and 34 weeks old groups the glia have also become dysmorphic: 
they have lost their neat donut shape. 
As well as there being a significant difference in radial glial density there 
was a visible change in radial glial morphology. There is a deterioration in the 
quality of the glia Iimitans with age both within the same age group moving 
from the anterior to posterior area as well as between age groups. As GFAP 
does not penetrate the fine processes [109J it was impossible to determine if 
these radial glia had differences in their domain size. It was impossible to 
control against different radial glial subtypes which would have confounded 
attempts to quantify the visible change in size. For these reasons no attempt 
was made to quantify this visible change in glial morphology. 11 is a surface 
protein in neurons and if so for g1ia as well then the coloealization of the E587 
and GA-5 in Figure 6.2 could be taken as evidence for the shrinking of the glia 
with age. The radial glial cell bodies of 12 weeks old fish were well defined 
and rounded in shape compared to those of 34 weeks old fish (Figure 6.2). 
This rounder shape was retained by resveratrol~treated fish but the resveratrol-
treated fish had larger radial glia as would be expected of gliotic glia. E587 
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E587 signal obscuring the radial glia. 
Using E587 radial glia could be counted in young but not in aged fish. The 
E587 labelled wholemounts show that the glia are less well defined and ob-
scured by some form of proteinaceous E587 serum immunoreactive matter. 
The brains of patients who had suffered from dementia have been reported to 
have more of the cleaved form of 11 (measured from the cerebrospinal fluid) 
compared to age-matched controls (with and without other neurodegenera-
tive diseases) [47]. It is tempting to speculate that this E587 immunoreactive 
substance is cleaved 11 but until proteomic analysis of the E587 immunore-
active bands in Chapter 4 are completed this can only be an interesting, but 
undemonstrated, possibility. The glia limitans of resveratrol-treated fish had 
an appearance more like that of 12 weeks old fish: the glia were better defined 
(but still diffuse in the mid and anterior areas) but were also larger and showed 
stronger GFAP immunoreactivity. 
A change was observed in the number of large glial processes (Figure 6.2, 
page 115 and Table 6.1). These (including their branches) were counted by 
eye and the counts shown in Figure 6.3B, page 116. On average, 12 weeks 
old fish had more processes than 34 weeks old fish. As the aT ages (from 
posterior to anterior) the number of large processes increases significantly in 
12 weeks old fish. In 34 weeks old fish there is no change in the number of 
large processes between the aOT and mOT while there were no large processes 
in the pOT. Resveratrol-treated fish exhibited large processes in all areas with 
the posterior areas having significantly more. The average across all areas was 
significantly different between the resveratrol-treated fish and 34 weeks old 
groups. There was no difference on average between the resveratrol and 12 
weeks old fish. 
The increase in the number of processes in 12 weeks old fish indicates that 
this is a sign of healthy aging and maybe functional maturity. In the rat, a de-
crease in astrocyte [437] and tanycyte [438] processes has been observed with 
age. This decline in processes was paralleled with an increase in GFAP in the 
rats. GFAP is one of several intermediate filament proteins in astrocytes which 
are involved in several physiological functions of astrocytes, not least of which 
is stabilizing the astrocytic processes [439]. 
Both the increase in large processes and hypertrophic form of the 
resveratrol-treated group glia are indicative of reactive gliosis [41]. In ex-
periments using 3xTg-AD transgenic mice such hypertrophic astrocytes with 
large processes were observed associated with plaques [110]. Atrophic astro-
cytes were also observed and these correlated with the chronological age of the 
mice. It is now believed that reactive gliosis is an initially beneficial process 
(reviewed by Middeldorp & HoI [26]). The increase in processes may be an 
adaptive response to the aging/maturing tissue, perhaps making up for glia 
which have atrophied or the increase in synaptic maintenance. As can be seen 
from the data, this adaptive response is absent in aged fish. 
As the glia in the aged brains carry a higher metabolic burden (they are 
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demands placed on them and hence become hypertrophic. As the fish grows 
over time the burden becomes greater but where normally aged glia are over--
come the glia of the resveratrol-treated fish continue to react to the needs of 
the neurons. This would explain the observation that GFAP levels appeared to 
increase in dietary restricted N. furzeri [9]. The N. furzeri in the dietary re-
striction experiments also had improved operant learning indicating that their 
brains were healthier than age-matched controls. 
6.3.2 PTAH staining shows an age':related Increase In gllotlc 
gila 
The modified PTAH stain was used to assess the number of gliotic glia in each 
experimental group. Figure 6.4 (page 117) shows gHotic glia in the SGPV of 12 
weeks, 34 weeks and resveratrol-treated 34 weeks old N. guentheri. There is a 
Significant difference between 12 week and 34 weeks old fish but no statistical 
difference between 34 week and resveratrol-treated fish. 
The PTAH stains confirm that in the SGPV of the OT there are gliotic radial 
glia in both the 34 week control and resveratrol-treated fish in the SGPV and 
that there is no meaningful difference between the counts. This stain could 
not be used to assay the number of gliotic glia in the glia limitans as the stain 
also binds to blood cells. The microtome-nicked blood cells were difficult to 
distinguish from nicked gliotic glia. It was impossible to estimate the number 
of processes in this area. That there are hypertophic/ gliotic radial glia in both 
the SGPV and glia limitans but a significant lack of processes in the glia limi-
tans of 34 weeks old control fish indicates to the Author that while the control 
group glia may stain PTAH positive, implying gliosis, these gliotic glia are no 
longer "reactive" to the extent that they do not participate in the compensation 
function of reactive glia in aging. Another method is required to distinguish 
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6.3.3 Changes In GFAP Western Blotproflle with age 
To confirm that GFAP levels were elevated in the resveratrol-treated fish West-
ern Blots were developed using brain homogenates of the 12, 34 weeks old 
and resveratrol-treated fish. Proteomic analysis of GFAP from the brains of 
Alzheimer's Disease victims revealed that with age there is an increased mis-
processing and concomitant aggregation of GFAP [381]. Protein was thus ex-
tracted using two different extraction buffers, the mild NP-40 based buffer and 
the harsher RIPA buffer. A formic acid extraction could not be performed at 
the time and there were only enough resveratrol-treated fish for the RIPA ex-
traction. A large volume of protein was used in optimizing chemiluminescent 
detection. It was not possible to achieve adequate exposure of the faint bands 
without overexposure of the more prominent bands, rendering them unquan-
tifiable. It was decided to revert to the chloronapthanol method which, being 
a simple cholormetric method, avoids the problem of overexposure of prom i-
nentbands. 
Results pertaining to GA-5 anti-GFAP blotting are shown in Figure 6.5, 
page 118. The inset in Figure 6.5 is representative of anti-GFAP blots and 
shows four prominent GFAP bands from RIPA extracted 12, 34 weeks old 
and resveratrol-treated protein homogenates (each N = 3, n = 6) and NP-40 
homogenates from 12 and 34 weeks old fish. The bands are 55, 51, 45 and 
43 kDa. The 55-45 kDa bands are only clearly visible in aged and resveratrol-
treated fish. 12 and 34 weeks old protein homogenates extracted using the 
NP-40 buffer were fainter. For the 12 weeks old fish only the 43 kDa band was 
clearly visible while larger bands are visible in the aged fish. Graph A of Figure 
6.5 shows the relative change of each band compared to the protein levels of 
34 weeks old fish while Graph B shows the proportion of each band compared 
to the total GFAP calculated from the sum of the bands for each fish. 
For each band in Graph A there is an age-related increase. The GFAP levels 
of resveratrol-treated fish were less than for the 34 weeks old controls except 
for the 43 kDa band. 34 weeks old fish had twice as much GFAP as 12 weeks 
old fish. Resveratrol-treated fish had Significantly less GFAP than 34 weeks old 
fish. 34 weeks old fish had significantly more of the 55 kDa band. Resveratrol-
treatment restored the quantity of the 55 and 45 kDa bands to 12 weeks old 
levels. 
Resveratrol-treated fish had a GFAP isoform proportion similar to that of 
12 weeks old fish. There was no statistical difference between the 12 weeks 
old and resveratrol-treated proportions of the 55 and 43 kDa bands. This was 
even though there had been a relative increase in the quantity of the protein 
represented by the 43 kDa band with resveratrol-treatment. 
Even though only three individuals of each age group were used for each 
of the RIPA and NP-40 extractions a clear difference was obtained between the 
three groups, with resveratrol preserving a level of GFAP expression closer to 
that of 12 weeks old fish. Also, there was less variation between the groups 
when comparing the ratios of the GFAP immunoreactive bands to the total im-
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varies between individuals there is little inter-individual variation in the pro-
portions of the isoforms. The relative proportions of the GFAP isoforms mat-
ters. 
To make sense of the data in Figure 6.5 and understand how it can ex-
plain the observations of increased GFAP immunofluorescence in the whole-
mounts we need recall that GFAP forms part of the cytoskeleton of glia and 
is involved in protein-protein interactions. The 55 kDa protein could be 
considered the full length protein and the others the degradation products 
[381]. Alternatively, the bands can be interpreted as different GFAP isoforms 
[26]. The isoforms vary in size, for example the human isoforms are GFAPa 
(49.9 kDa), GFAP{)fe (49.5 kDA), GFAP-135, (44.5 kDa), GFAP-164 (42.1 kDa) 
and GFAP-exon6 (39.8 kDa) (E.M HoI, pers comm, Netherlands Institute of 
Neuroscience). Fish do not have a full length exon 7 a and thus do not make 
a GFAPc5 of equal length as humans [440). The GFAPc5 isoform is associated 
with the human glia limitans and is indicative of cells with high cytoskeletal 
content. The ratio of the different isoforms to each other has been observed to 
affect the functionality of the cytoskeleton [441, 442]. A disproportionate in-
crease in some isoforms causes a collapse of the cytoskeleton, generating pro-
tein aggregates [169,441,442]. 
The 55 kDa bands are not visible when the protein is extracted using the 
NP-40 buffer without deoxycholate. This indicates that the 55 kDa band is 
involved in strong protein-protein interactions and aggregated in the buffer, 
precipitating out of solution. 34 weeks old fish have significantly more of this 
isoform. As the disproportional expression of isoforms causes the collapse of 
the cytoskeleton this could explain the smaller size of the 34 weeks old radial 
glia (Figure 6.2). This could also explain the observed increase in GFAP im-
munoreactivity (as judged by IHq of dietary restricted N. furzeri compared 
to age-matched controls [9] as well as the Author's observation of increased 
immunoreactivity in resveratrol-treated N. guentheri. 
If the cytoskeleton collapses due to GFAP aggregation the GFAP epitopes 
would be unavailable for immunoreaction with antibodies. The increased im-
munoreactivity observed by the Author, as well as that observed by Terzibasi 
et a1. [9], could be the result of the increased availability of the immunoreac-
tive epitopes. The higher proportion of GFAP in the dietary restricted fish is a 
product of the low reactivity of the aggregated GFAP of old fish. The observed 
hypertrophy in Figure 6.2 is a consequence of increased metabolic demand on 
the surviving glia as well as the immuno-availability of the reactive epitope. 
Resveratrol-treated fish do have less GFAP than the age-matched controls. Re-
peating the dietary restriction experiments on N. furzeri along with proteiomic 
analysis could possibly confirm that those fish also have less GFAP and with 
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Table 6.2: Table of statistical differences PNN counts per mm2 between the three OT 
areas within each experimental group: 12, 34 weeks old and resveratrol-treated (RT). 
Samples sizes were N = 4 & n = 11 for the 12 weeks old group; N :: 4 & n = 7 for the 34 
weeks old group; and N = 2 & n = 7 for the resveratrol-treatment group. 
PNNpermm2 
12 weeks old 34 weeks old RT 
pOTvsaOT p=O.315 pOT>aOT p=O.073- pOTvsaOT p=O.12~ 
pOT vs mOT p=O.315 pOTvsmOT p=O.073 pOTvsmOT p=O.12~ 
aOT vs mOT p=O.315 aOTvsmOT p=O.073 aOTvsmOT p=O.12~ 
·The Mann-Whitney Rank Sum Test gives p = 0.017 for this comparison. For the other sets p = 
0.376 and 0.318 respectively. A larger dataset could provide statistically significant results. 
·The statistical power for this test was 0.239 which is below the desired power of 0.800. A more 
powerful test or additional data could determine a statistical difference. 
6.3.4 Resveratrol preserves PNNs Into old age 
PNN are observed among the radial glia of the glia limitans of the OT (Fig-
ure 6.6, page 119). Antibodies penetrated approximately 10 Jlm deep in 34 
weeks old fish and almost all the way through 12 weeks old fish. The Au-
thor cannot exclude the presence of PNNs in the deeper tissue of the tectum 
but has observed them around the nerves exiting/entering the spinal cord of 
wholemounted embryos which were ready to hatch (Figure A.I0, page 148) 
indicating that they are widespread in the CNS of Nothobranchius. 
With age there is a decline in PNN density between the 12 and 34 weeks 
old groups (Figures 6.6). Statistical difference between the OT areas is given 
in Table 6.2. PNNs are almost totally absent in the aOT in 34 weeks old fish. 
In both the mid and posterior section of the OT there is a statistically signif-
icant decrease in PNN density. There are almost three times as many PNNs 
in 12 weeks old fish compared to 34 weeks old fish. Resveratrol-treatment 
preserved PNNs with age in the mid and posterior areas of the ~T. When av-
eraging the total number of PNNs between old and resveratrol-treated fish a 
significant difference was recorded. There was also a significant difference be-
tween 12 and 34 weeks old fish. There was large variation between fish and 
even between OT hemispheres. There was no statistical difference between the 
OT areas within each age group indicating that the changes in PNN density are 
the consequence of intrinsic aging of the fish and does not have anything to do 
with the maturation of the ~T. 
Resveratrol-treatment partially preserved the density of PNNs in the an-
terior area of old fish while totally preserving PNNs in the mid and posterior 
areas. This indicates that not only did resveratrol preserve existing PNNs into 
old age but also preserved the functional capacity of the fish CNS. This is also 
seen in the E587+ dataset were resveratrol-treatment increased the proportion 
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circuits, and these circuits are used, they would be lost [147]. The rescue of 
the PNNs in the mid and posterior areas could indicate that the brain retains 
aspects of plasticity which are lost in 34 weeks old controls. Regrettably, be-
havioral studies with the N. guentheri were not performed. 
The decline in PNNs parallels the decline in radial glial density. The 
counter stain for the PNN counts was the rabbit anti-GFAP antibody or E587 
antiserum and these stains were used to derive the radial glial counts and in so 
doing effectively linking the two datasets. While the PNN data set is small it 
is supported by the larger radial glial dataset. There is evidence for astrocytes 
regulating the expression ofTNR [443]. In the enlarged images (Figure 6.60, R 
& L) glial processes can be seen to penetrate the PNNs. Astrocytes (and oligo-
dendrocytes) lay down the ECM which forms the PNNs so the preservation of 
active astrocytes may be all that is needed to preserve the PNNs [138]. Astro-
cyte transplants have restored visual system plasticity [134]. The inability of 
aged radial glia to support the PNNs could be a reason for their decline. The 
preservation of PNNs with the preservation of the radial glia is to be expected. 
6.4 General discussion and conclusions 
Fish grow throughout their lives. In the case of the OT, growth is from the 
anterior to the posterior, with new cells added at the posterior edge. Thus 
the anterior area of the OT is chronologically older than the posterior area. 
This provides the opportunity to assess the effect of aging not only on existing 
tissues but also on newly formed tissues. Data was presented which shows that 
the quality and quantity of the radial glia and PNNs change in the course of 
aging and resveratrol-treatment. 
Radial glia and astrocytes play an important role in plasticity and synap-
togenesis along with their role as metabolic support cells [444]. Terzibasi 
et a1. [9] has demonstrated an increase in GFAP in dietary restricted N. furzeri 
which was concomitant with improved operant learning. Resveratrol is re-
garded as a dietary restriction mimic [278] so the lack of any increase in GFAP 
in resveratrol-treated fish is unexpected given the results in N. furzeri. This 
discrepancy can be explained away by Terzibasi et a1. [9] not performing West-
ern Blots to confirm the GFAP levels of the fish. GFAP has been reported to 
be misprocessed with age in humans [381], monkeys [101] and now N. guen-
theri. This misprocessing has been demonstrated to cause cytoskeletal collapse 
which would hide GFAP-antibody epitopes creating a false impression of re-
duced GFAP in age-matched controls. This discontinuity between the results 
of IRC (Figure 6.2) and Western Blots (Figure 6.5) highlight the need for re-
liable controls when comparing anti-aging interventions to age-matched con-
trols. As discussed in Chapter 2.5, protein aggregation anomalies are common 
in aging. FJB could be staining dysfunctional glia in Nothobranchius along 
with degenerate neurons. The interpretation of results from N. furzeri where 
the FJB stain was used should be treated with caution. 
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MAPK activation in cultured astrocytes [312] indicating that it does affect glia 
beneficially. It is possible that the increased activity of the glia in the dietary 
restricted and resveratrol-treated Nothobranchius is what ensures successful 
neurological aging in these species and the preservation of the PNNs which are 
required for cognitive retention [430], plasticity [139] and motor acuity [147]. 
It is also possible that resveratrol is directly disrupting protein aggregation 
[270] which would ordinarily cripple a cell (see Chapter 3.2, page 42). 
The retention of the PNNs and active astrocytes into old age is one hypo-
thetical means whereby operant learning is retained into old age in Notho-
bran chi us. Karetko-Sysa et al. [445] showed that following discrete cortical 
injury, the PNNs adjacent to the injury were lost but there was little loss of 
neurons. They suggest that the loss of PNNs may be to release the brakes on 
synaptic plasticity [139] so that the brain may functionally regenerate, how-
ever, in old N. guentheri they do not regenerate. Neurons in the SGS are lost 
with advancing age (Chapter 5) and in particular E587+ neurons. With the 
decline in E587+ neurons, indicating a decline in synaptogenesis, the neurons 
in the PNNs may be unable to reintegrate into the neural circuitry (and thus 
never reform the PNN). PNNs not only put the brakes on synaptic plasticity 
but also serve as anchors for the neural circuits. The loss of the PNNs would 
prevent surviving neurons from functionally integrating into the OT as well as 
hinder attempts at regeneration. 
Sample sizes for the determination of radial glial density, PTAH positive 
gliotic astroctyes and the number of processes were sufficient for statistical 
analysis. The Western Blotdata correlates with the statistically meaningful 
results and the PNN counts are linked to the statistically relevant glial den-
sity data as a counter stain. The Western Blotdata becomes more meaningful 
in conjunction with the larger data sets, both explaining and reaffirming the 
conclusions drawn from the larger datasets. It is the opinion of the Author, 
based on the coherency of the data, that with age there was a dysregulation of 
the GFAP isoforms represented by the four bands (whether these are protein 
degradation products or genuine isoforms the Author cannot conclude at this 
time); and that resveratrol-treatment returned the banding profile to that of 12 
weeks old fish. With regard to PNNs, there is an age associated loss of PNNs. 
Resveratrol-treatment preserved the PNNs implying that resveratrol improved 
OT health and function. 
To aid further research the cloning and characterization of the Notho-
branchius GFAP gene and its processing, together with proteomic analysis of 
identified bands are needed. Antibodies specific to each band are essential 
to allow for cytological studies, not only to observe where the various isoforms 
localize to but how they interact with the cytoskeleton. More interesting, is de-
termining whether there are radial glia subtypes [26, 399] in Nothobranchius 
which may play different physiological roles. In light of the glial simplicity and 
accessibility of this model organism it could be exceedingly useful in learning 
the roles of the various glial subtypes (should they exist in the fish as in mam-
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glial atrophy and human age (and senile dementia) than with pathological neu-
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General Discussion and 
Conclusions 
Who is this man? 
Caesar, he is but a soothsayer, 
he is old and his brain is addled, 
pay him no mind! 
Caeser, Iggy Pop. 
The purpose of this study was to identify cytological probes by which to 
study neurodegeneration in Nothobranchius. To accomplish this purpose N. 
guentheri was selected as our experimental subject on account of its ease of 
culture and longer lifespan. The longer lifespan allowed for better temporal 
resolution between youth and old age which could allow for easier identifica-
tion of aging-dependent cellular and anatomical changes. Three experiments 
were performed. In the first experiment: fish were raised to sexual maturity 
and allowed to age normally with the intention of analyzing 12 and 34 weeks 
old brains in search of aging-dependent changes. In the second experiment: 
fish were raised to sexual maturity and treated with resveratrol through the 
course of their natural lives with the intent of identifying resveratrol-treatment 
dependent differences between resveratrol-treated and 34 weeks old control 
fish. Thirdly, while the fish aged a variety of antibodies were tested for im-
munoreactivity against N. guentheri tissue and protein extracts. The results of 
these experiments are discussed in this chapter with references to the expected 
outcomes raised in the review chapters and within the framework of aging re-
search. Also included in this chapter (because it would have necessitated a 
large digression from the focus of Chapter 5) are the results and discussion of 
the hazard functions pertaining to resveratrol-mediated lifespan extension of 
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7.1 Review of the antibody toolkit 
The results of antibody testing are reported in Chapter 4. The E587 antiserum 
and SMI31, GA-5 anti-GFAP and Z0334 anti-GFAP and anti-TNR proved use-
ful but unanswered questions persist. The nature of the multiple GFAP im-
munoreactive bands needs to be resolved, particularly with respect to Chapter 
6. Likewise, just what E587 is reacting against needs to be determined. It is 
almost certainly reacting against Nothobranchius Ll-NCAM but may in ad-
dition be reacting against other NCAMs. These antibodies were effective for 
the purpose they were used for: labeling particular cellular structures and cell 
types as well as determining age-related changes. 
While the fish neurofilament proteins are of various sizes [397] they are 
used much the same across the evolutionary lineages [396]. The SMI31 anti-
body labels a specific evolutionary conserved phosphorylated neurofilament 
epitope [398]. These phosphorylation sites are important for the dynamic reg-
ulation of the neurofilaments [396]. The dynamics of Nothobranchius neu-
rofilaments are probably not very much different to that of mammals. Simi-
larly, the evolutionary conserved L1 [383, 446] seems to be at work in Notho-
branchius as in other species: playing a role in neuron preservation [165, 416] 
and possibly synaptogenesis [415]. As in rodents L1 appears here to also be 
expressed by only a subset of neurons [414]. 
The GFAP banding is remarkable. While most demonstration blots (by an-
tibody manufacturers) only show a single band of the typical size the reality is 
that GFAP antibodies label several bands over a defined size range [381]. The 
human GFAP exists as several isoforms ranging in size from 49.9 to 38.9 kDa. 
A similar variety of GFAP bands were observed against the Nothobranchius 
brain homogenates implying that Nothobranchius GFAP may be processed 
much the same as in mammals. 
Further research is required to confirm the identities of the antigens la-
belled by the antibodies as well as confirm the function of these proteins in 
Nothobranchius. In so doing the changes observed at the cellular level can be 
related to molecular physiology of these proteins. 
7.2 Does N. guentheri age like other species? 
For Nothobranchius to be useful models of aging they must manifest signs of 
aging common to other species and in particular they should show signs of ag-
ing in common with mammals. Several signs of neurodegenerative-aging were 
discussed and from them predictions were made of what would be discovered 
using the antibodies introduced in Chapter 1. 
These predictions are as follows: 
• Nothobranchius would accumulate SMI31 epitope in a subset of their 
neurons as in other species undergoing neurodegeneration. 
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• GFAP expression would increase in the course of aging as ... 
• ... glia are observed to malfunction. 
• Nothobranchius would show a decrease in PNNs with age. 
• That neurodegenerative-aging would involve one or several protein ag-
gregates or misprocessed proteins. 
The neurodegeneration literature predicts massive neuronal loss but this 
is based on pathological aging, not normal aging. Normal aging correlates 
more with a general atrophy of the white matter, not that of the gray matter. 
Whether Nothobranchius neurodegeneration would show pathological aging 
(with massive neuron loss) or normal aging, characterized by glial atrophy, 
was a question the Author wished to answer. 
7.2.1 SMI31 epltope accumulates with age 
In Chapter 5 evidence was presented supporting the use of the SMI31 anti-
body to label degenerating neurons. With age SMI31 immunoreactivity did 
accumulate in a subset of neurons in Nothobranchius even though it also la-
belled healthy neurons as has been previously reported and discussed in Sec-
tion 5.1 (Figure 5.6). Using the SMI31 antibody several possible neuron sub-
types could be discerned in the OT of Nothobranchius. Of interest were the 
small and large neurons which appear to be the normal, functional neurons. 
This was hypothesized based on changes in the expression of E587 antigen on 
the neurons (discussed in Section 5.4). 
The accumulation of SMI31, which is linked with the accumulation of NFTs 
in neurons, supports our initial interpretation of FJB accumulation in N. furz-
eri being due to an increase in NFTs [5]. However, as there is also evidence of 
glial malfunction, the increase in FJB signal could be the consequence of glial 
malfunction as well as NFT accumulation. In the light ofOamjanac et a1. [25] it 
is better to consider FJB a general marker of neurodegeneration than a specific 
indicator of NFTs or glial malfunction. 
7.2.2 Neuronal expression of E587 antigen declines with age 
The use of the E587 antiserum, raised against goldfish Ll, revealed that there 
is a E587+ population of neurons in the Nothobranchius OT (Figure 5.7). The 
E587+ subpopulation of neurons declines with age as predicted from research 
performed on mammals [47, 166] where the loss of NCAM was concomi-
tant with the decline in cognition of mammalian model organisms. Notho-
branchius have been demonstrated to exhibit such a decline in cognition with 
age. This is useful information for the formulation of hypotheses to tie func-
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7.2.3 GFAP expression and mlsprocesslng Increased with age 
With age GFAP accumulated in the radial glia of N. guentheri (Chapter 6, 
Figure 6.5). Analysis of Western Blots indicates that with age there is a signif-
icant increase in one of the GFAP immunoreactive protein bands and that the 
proportion of the GFAP isoforms was disturbed. Western Blots of protein ho-
mogenates extracted using different buffers indicate that the disproportionate 
increase in the 55 kDa GFAP isoform caused the GFAP filaments to aggregate 
and precipitate out of solution. This discovery explained why, even though the 
34 weeks old fish had more GFAP than the 12 weeks old fish, the wholemounts 
of 12 weeks old fish appeared to express more GFAP. A similar misprocessing 
of human GFAP is reported by Korolainen et al. [381]. 
7.2.4 Radial gila atrophy with age 
There was a significant decline in the abundance of radial glia as the fish aged 
(Chapter 6, Figure 6.3). This is congruent with research on mammals where 
similar glial atrophy has been observed [110] even while there was an age (or 
disease) related increase in GFAP expression [447] in the same organism. The 
aged gIia of N. guentheri were not only fewer in number but also less respon-
sive as judged by the number of large processes emanating from them. 
7.2.5 PNN abundance declines with age 
With age the number of PNNs declined (Figure 6.6). The loss of PNNs with age 
in mammals has been associated with a decline in CNS cognitive and motor 
function [147]. Further more, this loss in PNNs was brain-region specific. The 
loss of the PNNs of the OT can be regarded as evidence of an age-related loss 
in OT use and/or functionality. As PNNs are the concerted product of the 
astroglia, neurons and oligodendrocytes their decline is evidence of a possible 
general dysfunction of the CNS at the cellular level. 
With age the ECM of N. guentheri was observed to change but this change 
could not be quantified (Section 6.3.1). As discussed in Chapter 2 the ECM is 
both the foundation on which the cells of the CNS organize themselves as well 
as the conduit by which the cells communicate with each other. Changes in the 
expression of the ECM proteins, TNR and NCAMs (such as L1), would disrupt 
the CNS milieu and perhaps facilitate (if not exacerbate) the loss of the PNNs, 
neurons and glia with age as these changes hinder regeneration in the course 
of injury and disease [448]. 
7.2.6 Protein aggregation In the Nothobranchlu5 eNS 
Two types of protein aggregation have already been mentioned in this chapter. 
These were misprocessed GFAP and NFTs. Whether there are other forms of 
protein aggregation is not known at this time. Further research will, in all 
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7.3 N. guentherl lived longer on resveratrol-
treatment 
Aging has been defined as the accumulation of biological changes that ren-
der organisms progressively more likely to die [30]. From this definition, and 
critical to a successful anti-aging experiment, is the demonstration of a signifi-
cant decrease in the likelihood of death. Such evidence is presented in Figures 
5.1 and 7.3 (to be discussed in the next section). If resveratrol had not ex-
tended lifespan then the observed cellular differences between the aged and 
resveratrol-treatment groups could not be described as evidence of resveratrol 
mediated anti-aging. 
Resveratrol-treatment was expected to affect Nothobranchius aging in sev-
eral ways. These were mentioned in Chapter 3 and are restated below: 
• Nothobranchius would have fewer degenerate neurons than age-
matched controls. 
• Proteins associated with synaptic plasticity would be up-regulated. 
• Glia would be positively affected. 
• The problem of protein aggregates would be ameliorated. 
7.3.1 Resveratrol-treated Nothobranchlu5 have fewer degen-
erate neurons 
Resveratrol-treatment increased the loss of neurons from the N. guentheri OT 
(Figure 5.5). There was a 38% loss of neurons in resveratrol-treated fish com-
pared to the 23% loss with age. Whereas there was a 31% increase in the 
proportion of SMI31 +++ neurons with age there was an 8% decrease follow-
ing resveratrol-treatment (compared to 12 weeks old fish) and a 33% decrease 
relative to the age-matched controls (Figure 5.6). Resveratrol-treatment did 
cause there to be fewer degenerate neuron in the OT of aged N. guentheri OT 
but there were also less neurons in total. 
This is a new finding in a neuroprotective paradigm which purports that 
resveratrol protects neurons against death [239]. That resveratrol caused a loss 
of neurons, and the large scale of this loss of neurons, is unexpected and dif-
ficult to explain. As discussed in Chapter 3.2 (page 35), the probability of 
noticing the removal of energetically compromised neurons by resveratrol was 
small in anticipation of the larger neuroprotective action of resveratrol. While 
the explanations given may be largely speculative they do at least provide hy-
potheses for testing. 
Were it not for the increase in lifespan with resveratrol-treatment these 
results of exacerbated neuron loss would be cause for serious concern. 
Resveratrol-treatment could well extend human lifespan but the evidence pre-
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mortality rate in midlife but exacerbate the mortality rate at advanced age. 
This subject will be elaborated on in the next section. 
7.3.2 Proteins associated with synaptic plasticity are up-
regulated 
Resveratrol-treatment resulted in a proportional increase in E587+ neurons 
among aged fish (Chapter 5, Figure 5.7). The proportion of E587+ neurons was 
retained to that of 12 weeks old fish. It also preserved PNNs into old age which 
imply a preservation of OT function (Chapter 6, Figure 6.6). These results 
are in accordance with experiments on N. furzeri where resveratrol improved 
cognitive and motor function into old age. 
While resveratrol-treatment may have exacerbated the loss of neurons with 
age it selectively preserved E587+ neurons suggesting that it is these neurons 
which are important for youthful OT function. While it cannot be determined 
whether the neurons in the PNNs were lost with age or the TNR PNN compo-
nent was lost-the PNN can persist even though one or several of its compo-
nents are absent [144]-it can be claimed that resveratrol-treatment preserved 
the PNNs and this simultaneously preserves the function of the neurons en-
closed by the PNN. 
These results again force us to reconsider our theories of neuroprotection. 
These theories aim for wholesale preservation of neurons. The experiments 
with N. guentheri imply that CNS function can be preserved even though neu-
rons are lost and it is the preservation of synaptic plasticity which is crucial to 
lifespan extension. 
7.3.3 Radial gila were preserved 
Resveratrol-treatment preserved radial glia into old age as well as preserved 
their ability to react to their environment (Chapter 6, Figure 6.3). This is a 
novel finding. 
Resveratrol research on glia has focused on cell culture experiments em-
ploying high concentrations of resveratrol. Here, with a low dose of resvera-
trol, the aging-related loss of glia was prevented. These glia remained reac-
tive, that is to say they were able to react to their cellular environment rather 
than they were gliotic glia (which are considered to be pathological). The 
resveratrol-treated glia did appear to be larger than those of 12 weeks old fish 
and could have been hypertrophic and considered to be gliotic gliaj but this 
would add weight to the emerging belief that gliotic glia are not themselves 
pathological [26]. The number of PTAH stained gliotic glia did not change be-
tween aged and resveratrol-treated fish supporting the idea that there may be 
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7.3.4 GFAP Protein aggregation was ameliorated 
34 weeks old control fish had an unbalanced proportion of the observed GFAP 
isoforms relative to 12 weeks old fish. Resveratrol-treatment restored the 
GFAP isoform proportions to that of 12 weeks old fish as well as reducing 
total GFAP (Figure 6.5). This restoration of the GFAP isoform proportions 
could have prevented intracellular aggregation of the GFAP which would have 
caused the collapse of the glial cytoskeleton. 
While it cannot be claimed that resveratrol-treatment prevented NFT for-
mation it did clear the NFTs by either preventing the NFT formation or causing 
the death of the NFT bearing neurons. 
7.4 Nothobranchlus neurodegeneratlve-aglng and 
neuroprotectlon In context 
Rose [424] put forward that as the brain matures, excess neurons are shed and 
replaced with synapses and glia. The data shows that with the chronological 
age of the OT there is a decline in neuron density in 12 weeks old fish (Fig-
ure 5.5) but, as predicted by Rose, there is no change in the level of E587+ 
(synaptically active) neurons. We also see that with chronological age of the 
OT there is an increase in glial processes while the number of glia remain con-
stant (Figure 6.3, page 116). Rose reports that as the animal ages synapses are 
lost. While synapses were not quantified the markers of synaptogenesis and 
plasticity (E587+ and PNNs) did decline with age. This decline was concomi-
tant with an increased loss of neurons. Resveratrol-treatment either restored 
the markers of synaptogenesis to 12 weeks old levels or increased them beyond 
those levels but had no positive effect on the total number of neurons. 
These data indicate that neuronal plasticity is key to polyphenol neuropro-
tection, and not neuron survival alone. The rescue of E587 immunoreactivity 
together with glial and PNN density indicate that the functioning of the CNS 
is dependent on proper interaction between neurons and glia and further ex-
perimentation should take this into account. The small size of Nothobranchius 
and their short lifespan makes them accessible to more thorough examination. 
As argued by Genade et a1. [3], Nothobranchius are excellent models of aging 
and readily accessible for experimentation and examination. 
7.5 Aging, anti-aging and the benefits of using 
Nothobranchlus 
A selection of hypothetical survival curves, to aid in the discussion of anti-
aging, are presented in Figure 7.2. The goal of many anti-aging researchers is 
an overall increase in lifespan (Curve B) but this comes with a set of problems. 
One serious problem, from a human perspective, is a longer working life to 
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Figure 7.2: Survival curves and two hypothetical options to lifespan extension. Curve A is a hypo-
thetical normal curve for human beings with median life expectancy of 75 years of age (included 
as a dashed line in B & q. Curve B is the hypothetical doubling of lifespan. Note the longer tail 
period of lower quality of life. Curve C represents an extension of median lifespan by increasing 
health span. Maximum lifespan is unaffected. Note the short tail to the right of low quality life. 
into old age then this option would also be associated with a longer period of 
low quality life and debilitation. The cost on society with respect to financial 
resources and time for the care of the elderly will be tremendous [2]. Curve B 
is not the ideal. The ideal is to shorten the tail to the right as much as possible, 
that is to increase the healthspan. This is graphically presented by Curve C. In 
Curve C median lifespan is extended but maximum lifespan doesn't change. 
The tail to the right is compressed meaning that individuals are likely to live 
long healthy lives with a brief period of debilitation. Some would argue that 
the ideal is a curve with the shape of C but age range of B. This matter will be 
returned to below when Gavrilov's Reliability Theory of Aging is revisited. 
Resveratrol-treatment of N. guentheri extended median lifespan by 42.9% 
without extending maximum lifespan by very much (4.8%). This is contrary to 
N. furzeri where median lifespan was increased 33% and maximum lifespan 
27% [5]. The extremely short lifespan of the Gonarezhou N. furzeri is extraor-
dinary and resveratrol lifespan extension may not be typical in this species2 
Resveratrol-treatment had no effect on the lifespan of standard-diet fed mice 
but it did improve health [250]. In those mouse experiments there was a small 
but statistically insignificant increase in median lifespan. This subject was dis-
cussed in Chapter 5.3.1, page 83. 
Gavrilov's analysis of the lifespans of various human populations shows 
that the death rate at advanced age approaches the same rate for all popula-
tions regardless of the factors affecting their median lifespans [210]. This could 
imply that there is an intrinsic limit to lifespan beyond which lifespan cannot 
be extended. In this analysis Curve B is unlikely to become reality but Curve C 
becomes possible. It is precisely the approaching of Curve C which resveratrol 
hints at in the N. guentheri and mouse experiments. 
2Or. Alexander Dom (pers comm.), who is conducting resveratrol experiments at the Leibniz 
Institute for Age Research, Fritz Lipmann Institute of Jena on N. iurzeri, reports that the large in-
crease in total lifespan has disappeared under the water conditions there. In addition, the median 











Ch~pr.r 75 Aging, .nti-~8ing &- !he OO!l<'Jits of using Nothobranchiu. 129 
' 00 
U 
• ~ ' 0 > § > ffi 
0 m ' " 
~ 
" ~ W w 2 ~ ~ 0., • , - - H , ""'''' ~ - " " C -- ,,, "' • • JO - -- "'~". (,, ' . 2<>b) N U • " lo i -- "T( ... . n ) ~1l 0. ' w C1.-,J~_ , 0.0 
" " " '" ro 
age (weeks) 
F;~~,. 7.3, CO<nI'l';"'" of ,~"i .• l .nd n.,.ard plu" .I"',M' th.t w"n .g. tn. Kaplan-
M.;., h .. v.,d funct_ (prob.obility 01 do"h) of .""h group ,~<r .... ,_ This ina •• ,. 
""'ur> lot" ill tho .-..v.,."ul-tr."",,,,,t (RT) group tn,,, tho ,,,,,,,01 group. Th. "ati> -
lical diff.reno< betv.~ the control and ,,,,v<r.trol-tr •• trn . nt h""",d fuoctiOll plot. i. 
P ~ 0,017. Poo: mos! the dm.IiOll of tho triil tho h.zard func1ion of tho control yO\!p i . 
largo. rhan rh. r<>v<larro1-trea1men! youp. 
As tho fi.h ag~ th. i, p.ob. bility of d .. th (h .Hrd function) inc ...... (Fig-
ur~ 7 .3). R~sveratrol-treatment succ~ds in delaying not only th~ ;ncre ... in 
the h.l.1..rd function bUI for mo,l the lif~.p .n of the resveratTol-tTO.ted fish 
their h""ard functions aTe low .. tIl. n th.t of the control h.h , Aging n •• ~ffec­
tively been 5l.ved off. But. when one n.mine, the life trajectories .nd hoz.rd 
functiom , t various ages. differ<nt . ri of conclu.ion> c.n be drawn. T.ble 
7.1 gives a r.elfftion of h.l.1.ard function v.lue< at age, which correspond with 
the 7~", 30%, 2~" and 1 ()'X, mrvival mark. of th~ group" At 10%, exoctly " 
predicted from Gawil",,'. theo<ies, the hazard functions are equivalent_ Old 
resveratrol-treated fish ore a, likely to die a. old ",nltol fi.h, At both the 25 
and 50'!'. , uITiv.1 m.rls the hazard functJO[\, 0( the T~,v ... t,oI -treated fuh 
i, gre.ter th.n th . t of the control fi ' h; but at the control-group 30% sUfviv.1 
mark the h.l.1.ard of the re",,,.trol-treated fish is 7ero At the 25· ... survival 
mark the resveratlQl-treat~d fi,h had double the pIObability of death", the 
control group_ What i. mor e, at th~ control group SO% survival mark there 
hos l>eon. significa nt declin e in neurons (Le. redu nd.nt c.pacity) rather than 
pr"geTving them, eV<n though function w . ' rdotned , Resveratrol-tre.tmrnt 
del ay • • ging (sy.tem hilun) but accelerate. the aging-lelated decline later in 
Iif<--the e>.hau.tion or redund.nt c.pacity make, the fi,h more likely to , uffer 
a f , tal in,ult. Roswratwl-lToatment correspond, with CUTve C on d is not the 
elhir 01 youth_ 
Resveul,,~ .nti-.ging re.ults ore no! • • de or in mou,e ~'p"rimen .. [25D[_ 











Chapter 7.5. Aging, anti-aging & the benefits of using Nothobranchius 130 
Table 7.1: Comparison of hazard functions between the control and resveratrol-
treatment (RT) groups at specific ages. At the 10% survival point the hazard function 
(probability of death) is the same for both groups. At 25% survival the hazard function 
of the resveratrol-treatment group is 2.75x greater than the control. 
age Control Group RT-group 
(weeks) % survival hazard function % survival hazard function 
25 75% 0.073 75% 0.140 
35 50% 0.038 68% 0.000 
46 25% 0.120 60% 0.023 
51 170/0 0.054 50% 0.053 
53 10% 0.357 49% 0.030 
58 1% 0.000 25% 0.330 
63 0% N/A 10% 0.357 
treated mice's median lifespan can be explained by the high living standards 
and low-risk lifestyles of the mice (that is, fed a high quality diet and kept in 
clean conditions where they are not exposed to pathogens). Similarly, as med-
ical technology has advanced, so the median lifespan of humans has increased 
in low-risk human populations. Returning to Gavrilov's Reliability Theory of 
Aging, the low-risk environment means a slower exhaustion of the redundant 
capacity of our physiological systems. Given the high polyphenolic diet (sal-
ads, fruits, juices etc ... ) associated with low-risk populations (i.e. those who 
exercise what is currently considered a healthy lifestyle) resveratrol may have 
no measurable effect at all. Indeed, it may be only because of the carnivo-
rous nature of Nothobranchius that resveratrol-treatment (in the absence of 
confounding polyphenols in the natural diet) can have such remarkable re-
sults. Recalling the results of high-calorie fed resveratrol supplemented mice, 
the resveratrol did eliminate the health risk associated with a high-calorie diet 
[214], so resveratrol can compensate for a high-risk lifestyle. The question is 
just what risks can it counter? As pessimistic as this analysis is, it is impor-
tant to retain the glimmer of hope afforded by the research of Krikorian et al 
[237,249] which indicates that berry phenolics can improve the mental func-
tion of aged humans. 
Nothobranchius have several qualities which make them excellent models 
of aging. Their carnivorous diet which is naturally low in exogenous polyphe-
nols makes them good models to test polyphenols for anti-aging properties. 
The nature of their environment and social structure exposes them to ex-
trinsic lifespan risk which enables the experimenter to better detect effects 
on healthspan and median lifespan. It can be argued that the sterile low 
risk conditions which mice are maintained under are essential for elucidating 
the mechanisms of polyphenol action but such conditions are not the natural 
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polyphenol anti-aging if the anti-aging effect cannot be observed in the exper-
imental system? In addition, as discussed in Chapter 3, deducing this mech-
anism of action may be impossible given the limits of our technology. Notho-
branchius age like other organisms. Based on neuroprotection experiments 
performed on mammalian models predictions were made as to what the out-
comes of Nothobranchius polyphenol anti-aging experiments would be and 
these predictions proved true. The causes of aging are evolutionary conserved 
and give rise to a process which is common among multicellular organisms. 
Nothobranchius represent an excellent compromise between a short lifespan, 
experimental accessibility and a common vertebrate biology. This is not to say 
that there is no room for mice, only that there is also room for Nothobranchius. 
7.6 Looking forward 
The results reported in this thesis inspire further inquiry. These research av-
enues have been discussed in Chapters 4 through 6 and will not be repeated 
here. In this section research options inspired from this chapter will be ad-
dressed. 
The markers of synaptic plasticity indicate that the OT of resveratrol-
treated fish is more synaptically active than age-matched controls. This data 
corresponds with various experiments (examples are indicated in Chapter 3) 
which indicate that resveratrol preserves CNS function into old age. Taken 
together with the results of Krikorian et al [237, 249] there is hope that resver· 
atrol could be a useful supplement to improve cognition in the elderly. What 
needs to be determined is whether this improvement in cognitive function by 
late-in-life polyphenol supplementation will have the same effect on life- and 
healthspan as long term supplementation. There is a stark difference in the 
magnitude in operant outcomes comparing the resveratrol-treated N. furzeri 
[5] and the subjects of Krikorian et a1. 
In this Chapter there has been discussion of the problem of distinguish-
ing glia which remain responsive and gliotic glia. HSP27 (also called HSP25 
or HSPB1) antibodies could be used to distinguish between pathological and 
responsive glia [449]. HSP27 is expressed in response to cellular injury and 
may playa role in stabilizing the glial cystoskeleton. Glia which are still func-
tioning normally (that is to say glia which are still responsive) would expresses 
more HSP27 than glia which are dysfunctioning. Initial data from Western 
Blots suggest that the relative proportions of the GFAP immunoreactive bands 
could serve as a marker of properly functioning glia. In aged fish there should 
be a reduction in the 43 kDa band and an elevation of the 55 kDa band. An-
tibodies specific to these bands could be used to detect dysfunctional glia in 
wholemounts and sections. 
The SMI31 and E587 antibodies could not be used to identify distressed 
neurons or neurons which were neurodegenerative. If resveratrol functions 
by a purely hormetic mechanism, where it causes mild injury, then knowing 
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model of neuron death which is a consequence of the random initiation of 
apoptosis due to cellular insult. If resveratrol is causing the death of degen-
erate neurons then this is a good outcome. If, instead, it is causing the death 
of neurons at random then this is a deleterious outcome which may increase 
median lifespan but, by exhausting the redundant capacity of the eNS, would 
reduce maximum lifespan. To this purpose the anti-phospho-c-Jun antibody, 
which has been used to label distressed neurons in the retinal ganglion cell 
layer, could be useful [451]. If there is a selective decrease in phospho-c-
Jun following resveratrol-treatment then this would confirm that resveratrol 
is clearing degenerate neurons. 
There is a need to identify more markers of neurodegeneration, regenera-
tion and plasticity for Nothobranchius in order to properly take advantage of 
the rapid aging and anti-aging intervention experiments employing these fish. 
The nature of GFAP and E587 immunoreactivity needs to be clarified. The na-
ture of the gliotic glia in Nothobranchius needs to be further investigated to 
address the question of whether there are different glial subtypes in the SGS 
of the OT, and whether the GFAP immunoreactive bands correspond with dif-
ferent subtypes. Behavioral experiments also need to be performed and the 
results correlated with the neuron, glial and PNN density to better elucidate 
which plays the larger role in resveratrollifespan extension. While the modi-
fied PTAH stain of Manlow & Munoz [433] is a simple and easy way to assess 
the aging-related increase in gliosis it is not very useful in differentiating be-
tween normal aging and resveratrol retarded aging. Thicker fixed sections will 
need to be made of the brain and probed using the GFAP antibodies to de-
termine if the PTAH positive cells in the SGPV represent pathological gIia or 
not. 
Resveratrol-treatment is expected to modulate the immune system. BS-
isolectin has been established as a means to monitor microglia in the Notho-
branchius retina and ON. This analysis needs to be completed. As the BS-
isolectin did not label microglia in the brain there is a question of whether 
this is a limitation of the BS-isolectin stain or an indication that the Notho-
branchius brain does not contain microglia. Additional microglia markers are 
needed to answer the question of whether the Nothobranchius brain does or 
does not contain microglia. 
The antibodies mentioned in this thesis need to be tested against other 
Nothobranchius species to prove their effectiveness. Repeating the neuronal 
and glial experiments in N. furzeri (both long and short-lived strains) is an 
important next step to confirm whether these are evolutionary conserved pro-
cesses of aging in Nothobranchius. Whether the plasticity related features of 
N. furzeri Gonarezhou decline faster than the long-lived strains is an impor-













Now, mama, don't you worry none, 
From small things, mama, hig things one day come. 
From small things big things come, Bruce Springsteen. 
A.l Introduction 
This appendix contains data of two sorts: results which were uninformative or 
of a poorly substantiated nature for inclusion in the main narrative but which 
could still prove to be useful; and data which supports the results reported in 
Chapter 5 and 6 but also had no real place in the main narrative. These results 
were gathered in the process of identifying targets for detailed research which 
would yield informative and interesting data for hypothesis generation. These 
results will be afforded neither narrative or detailed discussion in this chapter. 
They are presented here as a matter of record and for the benefit of those who 
would continue the Nothobranchius aging research. 
A.2 Additional antibodies tested 
A.2.1 Aim 
Further antibodies were sought which could label CNS proteins and cells or 
which could be used as protein loading controls. These antibodies are listed in 
Table A.I along with the protein they were generated against. 
Commentary from reviewers of Genade & Lang [382] prompted the Au· 
thor to conduct further tests to determine how reliable the E587 antisera was 
reacting against Ll. Three other antibodies were available and Western Blots 
were prepared in the hope of definitively demonstrating that the E587 anti-
serum is reacting against Ll and not other NCAMs. These results are reported 
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Table A.I: Additional antibodies used in this study along with dilutions and 
reactivity results. 
Antibody Cellular target 
Western Blots IHC 
dilution reactivity dilution reactivity 
rabbit E987 goldfish Ll NCAM 1: 500 yes N/A N/A 
antiserumt 
E587mab· goldfish Ll NCAM 1: 200 yes N/A N/A 
rabbit anti-Ll· ratLl NCAM 1: 500 yes N/A N/A 
acetyl-tubulin tubulin in neurons 1: 1000 yes 1: 200 yes 
(Sigma T7451) 
rabbit anti-p38 p38, all cells 1: 1000 yes N/A N/A 
(Sigma M0800) 
rabbit anti-BDNF BDNF in neurons 1: 200 yes N/A N/A 
(Sigma AV41970) 
rabbit anti-tau· tau in neurons 1: 200 yes 1:200 yes 
f Gift from C. Stuermer, Konstanz Germany. 
• Generated by Dirk. M. Lang in the lab of C. Stuermer, Konstanz Germany. 
• 17025 antibody produced by Dr. Virginia Lee, Univ. Pennsylvania. 
From Chapter 3.3.2 it was hypothesized that resveratrol would effect p38 
expression and activity. Other researchers in the lab were employing p38 as a 
loading control on their blots. Western Blots were performed and probed using 
the Sigma polyclonal antibody. This antibody had been used to label p38 of the 
killifish, Fundulus heteroclitus [452]. The result of this experiment is reported 
in Section A.2.3.2. 
The acetyl-tubulin antibody has been used to label the neurons and neu-
ronal processes of zebrafish [453]. This antibody was tested in order to identify 
an antibody which could label all neurons in the Nothobranchius CNS and in 
so doing determine whether the SMI31 antibody was labeling all neurons in 
the OT or just a subset thereof. 
Exercise has been shown to increase BDNF expression [378]. Green tea and 
Gingko biloba extracts [252, 454] as well as oral resveratrol-treatment [455] 
have also been reported to increase BDNF expression. Whether resveratrol-
treatment of Nothobranchius also caused an increase in BDNF was an impor-
tant question to answer and a BDNF antibody to answer this question was 
sought. 
Hyperphosphorylated tau is the cause for the development of NFTs. There 
are six isoforms of tau in mammals and these are incorportated into NFTs at 
different proportions to one another [456]. Being able to observe tau by IHC 
and quantify its expression with age and anti-aging treatments is an impor-
tant requirement to fully utilize Nothobranchius. A sample of the 17025 tau 
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A.2.2 Materials and Methods 
All methods and materials, unless otherwise recorded here, were as per Chap-
ters 4-6. Antibody dilutions are recorded in Table A.l along with their efficacy. 
Proteins were extracted using either a NP-40 based buffer or a RIPA buffer. Un-
less otherwise stated, Nothobranchius protein samples are pooled samples of 
four 12 weeks old and four 34 weeks old fish. 
For Western Blots using the Sigma M0800 p38 antibody the blot was 
blocked with 5% milk in PBS for one hour followed by primary incubation 
in PBS without milk. 
Images of Western Blots have been manipulated in PhotoShop. Lanes of 
the same blot were spliced together for display purposes. Spliced blots will be 
indicated in the figure legends. 
A.2.3 Results and discussion 
A.2.3.1 E987 antls.Rlm and E587 monoclonal and antl·L1 polyclonal anti· 
body efftcacy 
Results of blotting using four different Ll antibodies are shown in Figure A.l, 
page 141. All antibodies detected a band of ~220 kDa in each lane. In the 
anti-rat blot this band is clearly a doublet of approximately 220 and 200 kDa, 
the latter being the product ofthe first cleavage [159]. Both the E587 and anti-
rat L1 blots show a band in the Nothobrancmus lane of ~50 kDa. The anti-rat 
Ll antibody gives a similar banding pattern as that shown for zebrafish on the 
E587 blot and Nothobranchius on the E943 blot. There is a band of ~130 kDa. 
The enzymatic processing of L 1 and the expected band sizes were discussed in 
Chapter 4.3.2, page 64. Both the 50 and 130 kDa bands, which are common 
among the blots, are expected from the sequential enzymatic cleavage of the 
full length protein. 
The E587 and E943 antisera could be reacting against NCAM but the blots 
demonstrate that these antisera are definitely also binding L1. Proteomic anal-
ysis and protein sequencing are required to be absolutely sure of the identity 
of E587's protein target. 
A.2.3.2 p38 MAPK antibody efftcacy 
The Sigma M0800 p38 antibody proved a reliable marker of Nothobranchius 
p38. This antibody labelled many bands on the blot (Figure A.2). The identity 
of these bands is unknown. 
No significant difference in p38 expression was observed (p = 0.412) but 
the power of the test (One Way Anova) was below that needed (0.049 vs the 
required 0.80) to yield a reliable result. The observed elevation in p38 expres-
sion in N. guentheri could be real. A larger sample size is required to resolve 
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The data indicates that p38 is possibly not a reliable loading control for 
protein blotting. 
A.2.3.3 Acetyl-tubulln antibody efficacy 
Western Blots (Figure A.3) and wholemounts (Figure A.4) were prepared using 
the acetyl-tubulin antibody. 
Western Blots revealed a band of 60 kDa for all three species and in accor-
dance with the expected band size. For all three species two smaller bands 
of 38 and 35 kDa were also detected. The Nothobranchius bands were not 
sharp and could indicate that there are multiple isoforms, each with a small 
difference in size. Alternatively these could be phosphorylated forms of the 
protein. When run on a non-denaturing gel two bands are visible of 52 and 
50 kDa. This indicates that there could be protein-protein interactions which 
the {3-mercaptoethanol disrupts. Densitometry of the blots run on the non-
denaturing gel showed no aging-related difference. Densitometry of the bands 
on the denatured protein indicates that the abundance of the small isoforms 
changes with the age of the fish. This difference was not explored further but 
could be indicative of neurodegeneration or an artifact of sample preparation. 
Staining of wholemounts with the acetyl-tubulin antibody was uninforma-
tive. No clear differences were apparent by eye and no in depth study of the 
wholemounts was undertaken (other research directions promised to be more 
informative). Whether the holes in acetyl-tublin immunoreactivity correlate 
with the density of PNNs is one interesting avenue of research. No cell bodies 
in the OT were apparent at low magnification using this antibody but such cell 
bodies were visible in other brain regions (data not shown). This could indi-
cate that only certain neurons expressed acetyl-tubulin. Whether the acetyl-
tubulin was expressed by the neurons enclosed in the PNN could not be tested 
as both the acetyl-tubulin and TNR antibodies were both mouse monoclonals. 
Acetyl-tubulin expression is continuous in mature integrated neurons but 
fragmented in degenerating and apoptotic neurons [4531. It could serve as a 
useful marker by which to quantify the level of disconnectivity in degenerating 
brain tissue. Using an antibody against neurofilament-light as counter stain 
the expression of acetyl-tubulin along dendrites could be monitored. Synap-
tophysin could be another interesting counter-stain. The use of this antibody 
in Western Blotting as a marker of the total number of neurons between age-
groups is not possible as it only gives an indication of the synaptically stable 
axons and neurites. In addition, as the fish grow with age and more neurons are 
added to the brain along with new synaptic connections any decrease in acetyl-
tublin associated with aging or neurodegeneration could be masked. Without 
another protein which is known to be stably expressed through aging by which 
to compare acetyl-tubulin expression this antibody can tell the experimenter 
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A.2.3.4 Sigma AV41970 BDNF antibody efficacy 
Results of western blotting are shown in Figure A.5. Protein extracted with-
out deoxycholate (which disrupts protein-protein interactions) should yield 
bands of ~29 kDa. Protein extractions with deoxycholate would yield bands of 
~15 kDa. The N. guentheri proteins were extracted using RIPA which has 1 % 
deoxycholate and a band of ~16 kDa was observed. 
The densitometry of the blot shows that there was a change in BNDF ex-
pression with age. 34 weeks old fish had on average less BDNF than 12 weeks 
old fish. BDNF expression of resveratrol-treated fish could not be performed 
as the protein had been exhausted. 
BDNF expression changes with age and resveratrol-treatment need to be 
examined more extensively in future. 
A.2.3.5 17025 18u antibody eflk:acy 
Mammalian tau ranges from 55-65 kDa in size [457]. The multiple banding 
smear pattern in the rat lane shown in Figure A.6 is typical of a protein ex-
pressed as multiple isoforms which undergo phosphorylation. A similar band-
ing pattern was obtained for the fish samples but of a slightly different size 
range. Most rat bands were between 64 and 39 kDa while for N. guentheri 
most bands were between 40 and 26 kDa. Zebrafish and goldfish tau ranges 
from 32-55 kDa [458]. Nothobranchius tau is probably processed differently 
to that of mammals and fish of the family Cyprinidae (such as gold- and ze-
brafish). 
Wholemounts of 34 weeks old fish brains were incubated with anti-tau and 
SMI31 (Figure A.7). The tau antibody reacted against neuron cell bodies as 
well as fine processes between them. There was no colocalization between the 
tau antibody and SMI31. Some colocalization of SMI31 and tau was expected 
as hyperphosphorylated tau is found in NFTs along with abnormally phos-
phorylated neurofilament protein. This could be because the tau epitope was 
unavailable within the NFT. The tau antibody reacted against the periphery 
of the neurons and fine processes but did not react against the SMI31 + ax-
ons. This is unexpected as tau plays a role in stabilizing neurofilaments and 
would be expected to colocalize with SMl31 + axons. Counter staining using 
a neurofilament-L antibody which binds to dendrites would confirm whether 
the tau antibody is labeling dendrites. 
The Western Blotand wholemount shows that the 17025 antibody is prob-
ably reacting against Nothobranchius tau. This could be a useful structural 
label in Nothobranchius aging research. 
A.2.4 Conclusions 
Preliminary testing of the antibodies discussed above indicate that they could 
be useful in Nothobranchius aging research. The acetyl-tubulin and BDNF an-
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changes in expression and protein processing. Changes in tau expression with 
age could not be tested for on account of damage to the blot over the 12 weeks 
old lane. Future research conducted using these antibodies could yield valu-
able data regarding Nothobranchius aging and resveratrol-treatment. 
A.3 BrdU positive cells occur In the epidermis and 
optic tectum of 34 weeks old fish 
A.3.1 Aim 
Resveratrol had been demonstrated to extend the mitotic lifespan of progen-
itor cells in culture [375] and is expected to preserve stem cell proliferative 
capacities in vivo [459]. The aim of this experiment was to determine whether 
aged fish have a lower rate of mitosis than young fish; and whether resveratrol-
treated fish have a rate of mitosis similar to that of 12 week or 34 weeks old 
fish. Bromodioxyuridine (BrdU) was used to gauge the level of mitosis. 
A.3.2 Materials and Methods 
Only female fish were used and females have a more uniform growth than 
males (anecdotal observation). No growth curves were made to control for 
this. 
BrdU was prepared as a 5 mg/mL solution in aquarium water. Female fish 
were incubated in the solution for four days with the solution replenished on 
the second day. On the fourth day, 96 hours after BrdU exposure was began, 
the fish were killed and fixed in Bouin's Solution as described in Section 6.2.3. 
Sections were rehydrated and the Bouin's extracted in 70% ethanol with 
several drops of saturated lithium carbonate added (10 minute wash). There 
after the protocol of Tang et al. [460] was followed using the Becton-Dickinson 
antibody (#347580). Anti-mouse Cy3 (Jackson Immuno Research) was used 
as secondary. Fixation caused autofluoresence in the Alexa 488 channel. This 
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A.3.3 Results and discussion 
A sample of results are shown in Figure A.S. There were many BrdU positive 
cells in the epidermis of the normal skin as well as the layer which covers the 
eye. BrdU positive cells were observed in the brain of all 34 weeks old fish 
examined. These cells were observed emerging from the torus longitudinalis 
adjacent to the valvula cerebelli. No such cells were observed in 12 weeks old 
fish. Five fish were examined of both age groups. 
The observation of BrdU positive cells in aged brain but not young brain 
was unexpected. 12 weeks was the age where the fish sexed out and became 
reproductively active. It could be that at this age there is a momentary pause in 
growth as energy is devoted to reproduction. As no growth curves were made 
there was no means to prove that growth paused at this point in the lifecycle 
of the female fish. This line of inquiry was suspended in order to pursue more 
promising research options. 
This line of inquiry should be returned to and the proper controls applied. 
A.4 PTAH positive glia In the retina 
A.4.1 Aim 
The goal was to determine whether resveratrol-treatment decreased the inci-
dence of gHotic glia in the N. guentheri CNS. The PTAH stain [433] was em-
ployed to answer this question. Half of the results are reported in Chapter 
6.3.2. 
A.4.2 Materials and Methods 
All methods as in Chapter 6. 
A.4.3 Results and discussion 
No statistical difference was found between 34 weeks old and resveratrol-
treated N. guentheri with regard to the number of gliotic glia in the ~T. How-
ever, a significant difference was present in the retina between the 34 weeks 
old fish and resveratrol-treated fish (Figure A.9, p < 0.001). This difference in 
resveratrol-treatment response was unexpected and cannot be explained with-
out fanciful speculation. It was thus excluded from discussion from the main 
body of the thesis. There were 4.7x as many PTAH positive cells in the 34 
weeks old retina as compared to the OT (p < 0.001) indicating that the retina 
may be under more metabolic stress than the ~T. 
Referring back to Chapter 4, microglia have only thus far been observed 
in the retina and ON. This difference in microglial distribution could be the 
cause of the disparity between the OT and retinal gliotic glia. The aid of mi-
croglia in dealing with any neuron loss may reduce the stress on the glia. Mi-
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Also, additional methods are needed to confirm the absence of microglia in the 
Nothobranchius brain. 
A.S Perlneuronal nets along the spinal cord 
A.S.l Aim 
Early on in the project an attempt was made to study normal neurological de-
velopment using the antibodies mentioned in Table 1.1. To this end fully de-
veloped unhatched N. guentheri embryo wholemounts were prepared. 
A.S.2 Materials and Methods 
Wholemounts were prepared as in Chapter 5 and anti-TNR was used as in 
Chapter 6. Fully developed embryos (identifiable by a blue-gold iridescent 
ring around the developed eye) were dissected out of the egg, the yolk sack 
removed, and fixed in 10% PFA. 
A.S.3 Results and discussion 
On account of the dark pigmentation and advanced state of Nothobranchius 
fry development antibody signal could not be observed in the spinal cord and 
cranium of the fry. Nerves exiting the spinal cord were visible. Only the anti-
TNR antibody experiment yielded useful data. 
Figure A.10 is a projection of a z-stack of confocal images. TNR positive 
PNNs are visible along the spinal cord. Similar structures have been observed 
in rats [461] and zebrafish[462] providing some evidence for TNR being used 
for the same structural purpose in fish and rats. 
Until an albino strain of Nothobranchius is obtained for experimentation 
this use of wholemount embryos will be of little use in studying the Notho-
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There ain't no grave can hold my body down, 
when I hear that trumpet sound, 
I'm going to raise right out of the ground, 
ain't no grave can hold my body down. 
Ain't no grave, Johnny Cash. 
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